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 Spherical agglomeration is a size enlargement technique which is highly suited to high value 
products with problematic morphologies. The addition of a partially immiscible bridging liquid to a 
suspension allows the formation of dense, spherical agglomerates with superior properties, i.e. 
flowability and compressibility. These products reduce further downstream processing requirements, 
and thus, the associated energy, time, and cost.  
 Currently, the mechanistic understanding of the process is limited, and few studies specifically 
investigate and elucidate these mechanisms to further a wider understanding as a whole. Conversely, 
the current literature provides a detailed account of the influence of process and formulation 
parameters on the final agglomerate properties. One such parameter is the bridging liquid-solid ratio, 
of which an optimal range can be found. Within the range, superior agglomerates are formed. 
However, these are specific and change for each system under consideration, due to failure to account 
for bridging liquid miscibility.  
 To address this, a new parameter is defined – the true bridging liquid-solid ratio (TBSR), which 
is defined as the volume of the bridging liquid rich phase divided by the volume of solid product. To 
evaluate miscibility between the bridging liquid and solvent, a ternary phase diagram is required. Here 
the phase diagram is determined through a novel combined approach using both experimental and 
computational studies. Analysis of these diagrams and computation allows the volume of the bridging 
liquid-rich phase to be calculated. This dimensionless parameter allows easy comparison across a 
variety of systems. The new definition has been partially validated through a rigorous experimental 
plan. The extent of agglomeration, and agglomerate size distribution is measured for salicylic acid 
(crystals) in several acetone-water solvent systems with three different bridging liquids at a solids 
loading of 3%. The results showed much closer alignment between the agglomerate profiles across 
different systems when TBSR is used to measure the required amount of bridging liquid.  
 A kinetic study of spherical agglomeration of paracetamol using immersion nucleation was 
performed. An optimal TBSR range of 0.7 – 0.8 was found. Five distinct operational zones were found: 
Zone A, insufficient bridging liquid for complete agglomeration; Zone B and C, high quality, well 
controlled agglomerates were formed; Zone D and E, poorer quality agglomerates were formed and 
the time to paste was short. These zones were found to be independent of the solid loading used. 
Experimental results were compared to a previously developed mathematical model, which correctly 
predicts the experimental trends. The model predicts results which are quantitatively very different in 
timescale, compared to experimental observations. 
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Symbol(s) Definition Units 
𝐴  Pre-exponential factor (constant) - 
𝐴𝑝  Proportionality constant - 
𝐶  Concentration mol m-3 
𝐶𝑖  Volume percentage of binding agent in the agglomerate i - 
𝐷  Diameter m 
𝑑𝑒𝑓𝑚𝑎𝑥  Contact surface radius m 
𝑒𝑓𝑓(𝑖, 𝑗, 𝑡)  Agglomeration efficiency - 
𝐹𝑎𝑑ℎ(𝑖, 𝑗, 𝑡)  Adhesion force N 
𝐹𝑏𝑟𝑖𝑑𝑔𝑒  Force exerted by a liquid bridge between two elementary particles N 
𝐹𝑠𝑒𝑝(𝑖, 𝑗, 𝑡)  Shear-induced disruptive force N 
𝑓(𝑖, 𝑗, 𝑡)  Product of the meeting probability - 
𝐺  Gibb’s free energy, Growth rate of agglomerates kJ mol-1 
𝐺𝑆  Surface energy kJ mol
-1 
𝐺𝑉   Volume energy kJ mol
-1 
ℎ  Covered distance in time t kJ mol-1 
𝑖 ; 𝑗   The size of a particle, or average of a class of particles - 
𝐽  Nucleation rate m-3 s-1 
𝑘  Boltzmann constant J K-1 
𝑘𝑎𝑘  
Agglomeration rate constant of k-type  
(Brownian, laminar or turbulent) 
Dependent 
on k  
𝐾(𝑖, 𝑗, 𝑡)  Agglomeration kernel - 
𝑀  Marchal’s relative size function - 
𝑚  Mass kg 
𝑛  Number  - 
𝑁  Agitation speed s-1 
𝑁𝑖(𝑡);𝑁𝑗(𝑡)  Concentration of agglomerating particles, 𝑖 and 𝑗 with time nb m-3 
𝑃  Dissipated power per unit mass W kg-1 
𝑟𝑐  Critical radius m 
𝑅𝐴  Rate distribution of agglomeration m
-4 s-1 
𝑟𝑎𝑔𝑔(𝑙, 𝑡)  Agglomeration rate of particles of rank l at time t nb m-3 m-1 
𝑆𝑖 ; 𝑆𝑗   Size of agglomerates, or particle, under consideration m 
𝑆𝑖𝑛𝑛𝑒𝑟   Inner section of the bed m
2 
   
 
xvi 
𝑆𝑓𝑖𝑛𝑎𝑙  Final agglomerate size m 
𝑆𝑅  Supersaturation ratio - 
𝑡  Time s 
𝑇  Temperature K 
𝑢  Collision velocity of particles or droplets m s-2 
𝑣  Kinematic Viscosity m2 s-1 
 
Greek Letters Definition Units 
𝛼(𝑖, 𝑗, 𝑡)  Target efficiency of the process - 
𝒫(𝑡)  Mean porosity of the agglomerates - 
𝜌𝑠𝑢𝑠𝑝  Density of suspension Kg m-3 
  Specific stirring power W kg-1 
ρ Density kg m-3 
Δ Difference  - 
ω Molecular volume  
𝜑  Porosity - 
σ Relative supersaturation - 
γ Surface energy, also referred to as interfacial tension J m-2 
𝜇  Viscosity  N s m-2 
𝜃  Wetting angle  - 
𝜏  Tortuosity - 
δ Weight coefficient of solid particles - 
δl Weight coefficient of liquid particles - 
𝜆𝑐  Taylor microscale  - 
𝛽𝑖,𝑗,𝑡  
Agglomeration constant of k-type, between particles of classes j and 
i 
m s-1 
𝜓  Number density function nb m-1 m-3 








Abbreviations Definition Units 
𝐴𝐷  Ammonia diffusion - 
𝐴𝑔𝑁𝑢  Agglomerate nucleation number - 
𝐵𝑆𝑅  Bridging liquid-solid ratio - 
𝑀𝑆𝑀𝑃𝑅  Mixed-suspension mixed-product removal - 
𝑃𝐵𝑀  Population balance modelling - 
𝑄𝐸𝑆𝐷  Quasi-emulsion solvent diffusion - 
𝑆𝐴  Spherical agglomeration  
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 The Pharmaceutical Industry 
 The global markets for prescription and over-the-counter medications in 2017 are valued at 
around $1tn and $140bn (USD) respectively [1]. However, despite improvements in technology in 
recent years, the number of new drugs reaching the market is steadily declining. This is mainly due to 
more rigorous and stringent requirements, designed by regulatory bodies to enhance patient safety 
[2]. A direct consequence of this is that batch-to-batch variability must be minimised to ensure 
consistent performance and quality of the product. These requirements have further implications on 
the production of such products, as they limit the design space and require processes to operate within 
a narrow operating window. This often means production processes become complex, energy-
intensive and have a reduced through-put which increases the time to market.   
 To negate these issues, a switch from batch to continuous processes could be highly beneficial 
[3]. Continuously operated processes have an increased throughput, allow reductions in production 
equipment size, reduce the footprint of facilities, and almost guarantee a consistent product through 
steady-state operation. Whilst the starting capital for such facilities is reduced, the operating capital is 
increased as operations run continuously. However, this is negated by the decrease in the time to 
market as a continuous stream of final product is manufactured and packaged.   
 Whilst other industries, predominantly those dealing with natural raw materials, have 
successfully transitioned to continuous manufacturing, the pharmaceutical industry is only part way 
there. There are several problematic processes in production which have not been successfully 
adapted to be operated continuously [3].  
 There is a key requirement for processes to have predictable performance, as being able to 
operate within the design space is a key requirement of regulatory bodies. The modelling of processes 
is vital as it allows engineers to be able to adapt to different situations, have a better understanding of 
the process, and identify issues as they arise.  
 
 Background to the Research 
 Crystallisation is a widely used process within the pharmaceutical industry. It is primarily used 
for the isolation and/or purification of target molecules. Crystallisation is often one of the initial 
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downstream operations used to separate target particles from solution. At this crucial stage in the 
manufacturing process, the properties of crystals directly influence the amount of further processing 
required [4]. Additionally, the target properties should be strictly controlled to ensure predictable shelf 
life and in vivo performance. Beneficially tailoring such properties here, prior to further downstream 
processing, can create redundancy in the manufacturing process and thus rapidly intensify the process.  
 Control of the wide range of these properties is paramount to ensuring pharmaceutical 
production does not encounter issues. The crystal size, size distribution and crystal morphology are all 
key properties. For oral solid dosages, particles within a specified size range may be required to achieve 
the desired performance or regulatory approval. In this instance, granulation may be used to increase 
the crystal size prior to tabletting [5]. Problems can arise however, especially if the binder formulation 
is incorrect: granules become excessive in size. In these instances, milling is required to reduce granule 
size and recycle the product. These unit operations, as well as drying, are energy and cost intensive. As 
granulation and milling are usually used in tandem, they also increase the time to market. A traditional 
process such as this is presented in a simplified format in Figure 1.1. 
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Figure 1.1. A simplified flowsheet for the traditional manufacturing of pharmaceutical products. 
  
 Spherical agglomeration provides a unique opportunity to improve and tailor these properties 
through the precipitation and agglomeration of initial crystals. These steps can be achieved 
simultaneously, or in sequence [6]. The method is reliant upon the relative solubilities of different 
solvents in each other, and the interactions between these solvents and the target molecule. Generally, 
an anti-solvent crystallisation causes uniform crystals of the drug to form. A third solvent is then used 
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Figure 1.2. A simplified schematic for the spherical agglomeration process. Adapted from Pitt et al [7]. 
 There are three major mechanisms, all of which are analogous to wet granulation: wetting and 
nucleation; growth and consolidation; breakage and attrition. The degree of agglomeration can be 
directly controlled, allowing tailoring of the size and porosity of agglomerates, both of which are 
important for the required bioavailability of the drug product [8]. These properties in turn infer the 
tabletability of the particles, with the potential for agglomerates to be directly compressed into a tablet 
form [9]. Narrow size distributions can be achieved immediately or through direct sieving, which 
removes the need for product recycling. In addition, the sphericity of agglomerates tends to be high, 
which vastly improves the handling of crystal particles, especially those that are acicular in nature [10]. 
Thus, spherical agglomeration has the potential to create redundancy in the manufacturing of oral solid 
dosages, as detailed in Figure 1.3.  
 Generally, the key focus of research has been geared towards improving a wide range of particle 
properties through modification of experimental procedures and parameters [11]. Causal relationships 
between these have been identified for a wide range of crystalline particles. However, there is a lack 
of literature which explores the mechanisms in detail, especially those which directly underpin the 
process itself. The few models which do exist are often based around the theory of granulation and its 
mechanisms [12]. Others are reliant on coalescence kernels and/or fitting parameters. Critically, many 
models fail to incorporate terms for all the mechanisms within the process itself. As such, none of these 
models can be relied upon for the accurate and robust prediction of process performance.  
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Figure 1.3. A proposed flowsheet for pharmaceutical manufacturing with spherical crystallisation. 
 
 Thesis Structure 
 Chapter 2 of this thesis presents a review of existing literature within spherical agglomeration. 
There are two specific areas of the literature which are given a stronger emphasis: the current 
mechanistic understanding of the process and the influence of the bridging liquid in spherical 
agglomeration processes. Within this chapter, the current gaps within the broader existing knowledge 
are also presented. The thesis objectives are listed at the end of the chapter. 
 Chapter 3 provides a detailed account of the materials used within the experimental work of 
this thesis. The methodologies used to perform experiments and characterise the outputs are also 
provided.  Sections are also provided to detail the simulation and theoretical works presented. 
 Chapter 4 presents the theory behind a new definition, the true bridging liquid-solid ratio. This 
includes development of the theory from both an experimental and simulation approach.  A variety of 
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 Chapter 5 presents the experimental validation of the true bridging-liquid to solid ratio. This 
includes the selection of several systems of interest to investigate whether the definition can be used 
over multiple bridging liquids and bulk solution compositions. Salicylic acid is used as the compound of 
interest. 
 Chapter 6 details the results from a novel study into the immersion nucleation wetting 
mechanism using paracetamol. Kinetic studies were performed to further elucidate the mechanisms 
of agglomerate growth. These results are framed in the context of mathematical studies, as a means 
of an initial validation step.  
 Finally, recommendations for future work are presented alongside the overall conclusions of 











 Crystallisation is a common processing method which, is utilised in a variety of different 
industries, including pharmaceutical, bulk chemicals and food processing. The process can be used for 
both the synthesis and purification of products. The crystallisation operation is usually the first instance 
in which the product is initially separated from a solid-liquid mixture. This provides engineers with the 
opportunity to produce crystals with desired attributes such as size and shape [13].   
 Crystallisation can be used to improve crystal properties, ensuring stable polymorphs, 
controlling crystal size and morphology etc. The size distribution of the crystals is also important. These 
properties directly relate to the functional properties of the product, including the flowability and 
compressibility, reactivity, and dissolution profile. These are all particularly important, especially within 
the pharmaceutical industry, as they dictate product performance. If these functional properties are 
not as desired, it may be extremely difficult to further process the product. This leads to product 
recycling or waste. Thus, improving product properties at this stage would include the vast reduction 
of downstream processing, which reduces operating expenditures, equipment costs and the time to 
market. Thus, exploring alternative techniques may be highly beneficial for the industry as a whole. 
 Spherical crystallisation is a group of such techniques, which provides the opportunity to 
beneficially tailor the key properties of crystal products, prior to further downstream processing. These 
techniques use binders, or bridging liquids, to agglomerate particles either during or after their 
precipitation. There are three main techniques which are discussed in more detail in Section 2.2: 
ammonia diffusion; quasi-emulsion solvent diffusion; spherical agglomeration. All the techniques 
involve the agglomeration of particles to form dense, spherical agglomerates, through the use of a 
solvent known as a bridging liquid. Spherical crystallisation techniques have already been successfully 
applied to some of these industries, especially those handling raw and/or bulk materials. Within the 
literature, the agglomeration of calcium carbonate, graphite, coal, heavy metals and sand has been 
reported previously [14–18]. Additionally, spherical crystallisation has also been used successfully in 
the food processing and biochemical industries [19,20]. Thus, spherical crystallisation has applications 
in other industries which use granulation, including the bulk chemicals and detergents industries [4]. 
  Within the pharmaceutical context especially, there has been more intensive research 
in the use of spherical crystallisation, and more specifically spherical agglomeration, despite a lack of 
industrial adoption. Spherical agglomeration processes have been investigated as a means of 
improving the properties of a variety of drugs, including lobenzarit disodium, mebendazole and 
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aceclofenac, amongst others [21–23]. The process has also been used for biopharmaceuticals, 
including bovine serum albumin [20]. The first paper exploring the spherical agglomeration of 
pharmaceuticals was in 1982 [10]. There, the authors demonstrated the full capability of the method, 
turning problematic needle-like salicylic acid crystals into dense, distinct, spherical agglomerates with 
improved mechanical properties (see Figure 2.1) [10]. The precipitated crystals alone would be 
unsuitable to be used in the formation of tablets, due to the brittle nature of their morphology. Thus, 
agglomerating the crystals into spherical, dense agglomerates, which have high flowability, vastly 
simplifies the downstream processing of the product.   
Figure 2.1. a) Primary particles of salicylic acid prior to addition of a bridging liquid, b) dense, 
spherical agglomerates of salicylic acid post addition of bridging liquid. Reproduced from Kawashima 
et al., [10]. Scale bars are 200 µm and 10 mm for a) and b) respectively. 
 
 Spherical Crystallisation Techniques 
 There are three common methods through which spherical crystallisation can be achieved: 
ammonia diffusion; quasi-emulsion solvent diffusion; spherical agglomeration. These are discussed 
individually in the following sub-sections. All the methods rely on the relative solubilities of the solid 
of interest in different solvents. The bridging liquid is a key solvent, which the solid of interest is 
partially soluble in. Upon drying of agglomerates, liquid bridges solidify between drug molecules, 
increasing the strength of agglomerates. The process of spherical crystallisation is directly dictated by 
numerous factors. Several of these are directly related to the solutions from which crystal particles are 
a) b) 
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precipitated. Thermodynamic mechanisms play an important role, including the solubility of the drug 
in different solvents, the interfacial tension level at the solid-liquid interface, and the temperature of 
the system [11]. These properties directly affect the kinetics of such systems, including the level of 
supersaturation and the metastable zone width of crystallisation. If agglomeration occurs post-
crystallisation, these kinetic properties directly dictate the formation of agglomerates. The influence 
of molecular interactions, including hydrogen bonds and non-covalent bonding, should also be 
considered. Thus, it is imperative that suitable solvents are identified and utilised based on these 
properties. 
 Ammonia Diffusion 
 The ammonia diffusion (AD) method consists of an ammonia solution which must be able to 
dissolve the crystal of interest. In this method, the initial solvent is also the bridging liquid [24]. An anti-
solvent is also used in this method, which must have high miscibility with the aqueous ammonia 
solution [11]. An additional solvent is required which is water-immiscible i.e. dichloromethane [25]. 
When the solutions are added together, the anti-solvent droplets become enveloped within the 
ammonia solution droplets. As a result, the drug is effectively forced out of the droplet and precipitates 
[25]. A second mechanism is also apparent in which droplets of ammonia are liberated by the 
immiscible solvent. This process is important as reducing the ammonia concentration around the 
crystals of interest reduces the amount of bridging liquid available, thus directly affecting the level of 
agglomeration [26]. Ammonia diffusion, unlike the other two common methods, can be used to 
agglomerate amphoteric solutes[26]. The method was first used in 1990 for the agglomeration of the 
drug enoxacin [25].  
 A schematic of the process is presented in Figure 2.2. Ammonia-water droplets (blue circles) 
contain the dissolved crystal of interest (grey rectangles). Immiscible solvent droplets (red circles) 
diffuse into the ammonia droplets causing the precipitation of the crystals of interest in and around 
the droplet (see Figure 2.2a). Ammonia is effectively expelled from the droplets, aiding the formation 
of liquid bridges (see Figure 2.2b). Over-time, further compaction of agglomerate nuclei allows dense 
agglomerates to form (see Figure 2.2c).  
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Figure 2.2. Mechanism for the ammonia diffusion method of spherical crystallisation. Ammonia-
water droplets are indicated by blue circles. Immiscible solvent is represented by red circles. The 




Figure 2.3. Spherical agglomerates produced via the ammonia diffusion method. Note the individual 
constituent crystals at the agglomerate surface. Reproduced from Ueda et al., [25].  
 
 Quasi-Emulsion Solvent Diffusion 
 Quasi-emulsion solvent diffusion (QESD) was first documented in 1989 [27]. The method also 
requires the drug of interest to be dissolved in a solvent, this solution is then added to the anti-solvent. 
Critically, the interactions between the dissolved crystal and the solvent it is dissolved in must be 
stronger than those between that solvent and the anti-solvent [28]. This principle accounts for the 
formation of quasi-emulsion droplets. Over time, the solvent from the emulsion transfers into the bulk 
solution of the anti-solvent. This, in turn, allows the anti-solvent to diffuse into the droplets [29]. As 
the dissolved crystals are insoluble in this solution, the anti-solvent reduces the solubility of the crystals 
inside the droplet, eventually causing precipitation inside the droplets. The crystals are then 
agglomerated within the droplets by the original solvent, which also acts as the bridging liquid in this 
instance.   
a) b) c) 
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 A schematic of the process is presented in Figure 2.4. The anti-solvent (red circles) and solvent 
(blue circles) are added together (see Figure 2.4a). The dissolving solvent contains the dissolved drug 
of interest. The anti-solvent diffuses into the droplets of the other solvent, effectively a solvent 
exchange mechanism. As this occurs, the drug solubility is reduced which causes initial precipitation 
and crystallisation (see Figure 2.4b). The remaining dissolving solvent acts as a bridging liquid causing 
crystalline bridges to form between agglomerates (see Figure 2.4c).  It has been reported within the 
literature the difficulty in ensuring the system remains emulsified to allow the diffusion of the two 
solvents [30].  
Figure 2.4. Mechanism for quasi-emulsion solvent diffusion method of spherical crystallisation. The 
anti-solvent is indicated by red circles, solvent by blue circles, and crystals by grey rectangles. 
Adapted from Nocent et al., and Peña & Nagy [31,32].  
 
 
Figure 2.5. Agglomerates as formed through the quasi-emulsion solvent diffusion method. Note the 
much more porous structure of agglomerates and absence of constituent crystals. Reproduced from 
Nocent et al., [31].  
 
a) b) c) 
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 Spherical Agglomeration 
Spherical agglomeration was first documented in the 1960s [33]. This technique also involves 
the crystal of interest being dissolved in a solvent and this solution added to the anti-solvent. The 
solvent and anti-solvent must be miscible with each other to allow the subsequent precipitation and 
crystallisation of the solute crystals. However, the addition of the partially immiscible bridging liquid 
makes such systems ternary, as opposed to the binary nature of AD and QESD. The bridging liquid must 
have a high affinity for the solute, as it is directly responsible for the agglomeration of the precipitated 
solid [11]. The strength of liquid bridges formed by the bridging liquid has been found to be 
‘proportional to the interfacial tension between the bridging liquid and the medium’ [34]. These 
bridges, when wet, effectively hold the agglomerate together through both interfacial tension and 
capillary forces [35]. It is worth noting that much of the research in spherical crystallisation has 
specifically focussed on this method; these studies are evaluated in Section 2.4.  
 A schematic of the process is presented in Figure 2.6. The schematic shows crystals and bridging 
liquid droplets only. In this example, crystals with varied sizes and aspect ratios are used. It is possible 
for all crystals to have the same morphology, and/or a comparable size, and spherical agglomeration 
be successful. Initially, the solvent containing dissolved crystals and the anti-solvent are generally, 
added together. Upon mixing, the precipitation of crystals occurs. Three distinct rate processes then 
follow. The addition of bridging liquid allows a dispersed phase to form. These droplets wet the 
particles of interest: wetting and nucleation (see Figure 2.6a). These nuclei densify and grow and 
incorporate other wetted particles, to form spherical agglomerates via drop-drop and drop-particle 
collisions: growth and consolidation. (see Figure 2.6b). At longer residence times, particles can be 
sheared from the surface of agglomerates and agglomerates may fracture: attrition and breakage (see 
Figure 2.6c). These rate processes are discussed in more detail in Section 2.3. 
Figure 2.6. Mechanism for the spherical agglomeration method of spherical crystallisation. The 
bridging liquid is indicated by blue circles and crystals of interest by grey rectangles. Note, the solvent 
and anti-solvent are not shown in this schematic. Adapted from Mahanty et al., [36].  
 
a) b) c) 
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 Comparison of Spherical Crystallisation Techniques 
 The three separate methods of spherical crystallisation discussed share some similarities, 
including the required knowledge of the properties of the solvents used during agglomeration, as well 
as the influence of operational parameters on the end-product (e.g. agitation speed, residence time, 
solids concentration). Table 2.1 displays a summary of the solvents used in different spherical 
crystallisation techniques.  
 Quasi-emulsion solvent diffusion (QESD) and spherical agglomeration (SA) techniques are the 
two techniques which have been investigated in the literature the most, due to the much higher 
likelihood of agglomeration success (compared to ammonia diffusion). Whilst the former of these is 
generally considered as a favoured technique, due to the simpler process operation, difficulties have 
been reported within the literature. A major issue is ensuring that the system itself remains as an 
emulsion, as if this does not occur, the efficiency of solvent exchange is drastically reduced [30]. Several 
authors have reported that this issue can be negated through the use of an emulsifier [31,37]. Spherical 
agglomeration is sometimes favoured due to the potential for simultaneous crystallisation and 
agglomeration [38]. In this sense, the technique is more flexible, and allows the end-product properties 
to be controlled to a greater degree. It is worth noting however, the difficulties in the initial 
establishment of the solvent system. Considerations must also be given for the potential of residual 
bridging liquid to remain in the agglomerates post-drying. A summary of solvents used in spherical 
crystallisation techniques is presented within Table 2.1.  
 
Table 2.1. Summary of solvents utilised in different spherical crystallisation techniques. Note the 
greater flexibility of SA processes. 
Technique Solvent Anti-solvent Bridging Liquid 












 Whilst there is a lack of studies which have explicitly compared spherical crystallisation 
methods for the same crystal loaded system, some do exist.  These studies tend to identify changes in 
the end-product between different spherical crystallisation techniques. Sano et al., investigated the 
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differences in the morphological and structural properties [37]. In the tolbutamide agglomerates 
formed by QESD, with a fatty acid ester emulsifier, the agglomerates were noted to be extremely dense 
which correlated with high mechanical strength. The authors also noted the highly spherical shape of 
agglomerates, resulting in excellent flowability. Whilst the agglomerates made via SA were not as 
dense, and therefore weaker, their structure was found to be more porous with a high specific surface 
area of constituent crystals. As a result, these agglomerates had superior dissolution properties.  
 To explain this phenomenon, the authors proposed that slightly different mechanisms of QESD 
and SA were responsible [37,39]. In QESD, quasi-emulsion droplets slowly become agglomerate nuclei 
through crystallisation. This is thought to be the reason why agglomerates formed by this method tend 
to be very dense and spherical in nature, with a smooth surface. In SA, agglomerates are formed over 
time through compaction and coalescence. As a result, the end-product usually has a lower density 
and can be covered at the surface by constituent crystal particles. These differences have also been 
noted by another study, where agglomerates produced by QESD were found to be much harder due to 
a higher level of plastic deformation [40].    
 Most studies recognise that each spherical crystallisation technique has both advantages and 
disadvantages. These are often most apparent in the end-product properties, which further highlights 
the need for well-established performance criteria of solid dosage formats. It may be beneficial for 
formulators to identify the most critical of these, and thus find the product property which is most 
significant. However, spherical agglomeration is the most well rounded of the techniques. Whilst the 
operational space for the desired agglomerate properties is narrow, overall a wider range of systems 
can be investigated, meaning the technique is more broadly applicable to different particles. For this 
involving crystallisation, it is possible to directly control crystal properties, and thus, the end 
agglomerate properties yielded.  
 
 Current Kinetic & Mechanistic Understanding of Spherical Agglomeration 
 Much of the spherical agglomeration literature is devoted to how the process parameters 
influence the agglomerates formed. These studies link the particulate properties of agglomerates (e.g. 
size, size distribution, sphericity) to their subsequent functional properties (e.g. flowability, 
compressibility, strength, solubility). These studies are discussed in more detail in Section 2.4. Most of 
these studies do not aim to improve mechanistic understanding of the process, and it is unclear which 
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rate processes control the properties previously mentioned. This knowledge is imperative to accurately 
predict the performance, as well as control the process in its entirety.   
 
 Wetting & Nucleation 
 A critical part of this mechanistic understanding for spherical agglomeration is when the 
primary particles first interact with the bridging liquid, often referred to as the wetting phase. A 
previous study has suggested two mechanisms which arise during wetting [21]. These mechanisms are 
differentiated by the size ratio of the bridging liquid droplets and particles of interest: 
i. Bridging liquid droplets are smaller: distribution mechanism occurs in which droplets coat 
particles prior to agglomeration, as shown in Figure 2.7, resulting in particles ‘sticking’ 
together. Through further compaction, bridging liquid becomes available. Crystalline 
bridges form upon agglomerate drying.   
ii. Bridging liquid droplets are larger: immersion mechanism occurs in which droplets envelop 
particles prior to agglomeration, as shown in Figure 2.8, with the agglomerate forming 
within the droplet initially. Particles also adhere to the droplet surface before the bridging 
liquid is removed through further compaction.  
 
 These mechanisms have also been observed when agglomerating limestone with kerosene, and 
are comparable to nucleation mechanisms during granulation [5,41].  
Figure 2.7. The proposed distribution mechanism for spherical agglomeration. Adapted from Subero-
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Figure 2.8. The proposed immersion mechanism for spherical agglomeration. Adapted from Subero-
Couroyer et al., [42]. 
 
 The wetting phase has also been visualised using image analysis employing a visualisation cell 
and a microscope [42]. The droplets were prepared to be much larger than the particles and the 
immersion mechanism was clearly observed. The same study also found that the droplets were more 
well dispersed at an increased agitation rate, noted by the smaller size of bridging liquid droplets; their 
surface area to volume ratio increased. The small size of the primary crystals, 5 μm, meant that there 
was a strong tendency for the formation of flocs. The authors noted the presence of some bridging 
liquid droplets amongst the flocs, as well as the penetration of some flocs into the bridging liquid 
droplets. The authors cited several key challenges with the experiment, including the difficulty in 
recognising droplets and particles and the analysis probe becoming obscured by particles. Post-
experiment, agglomerates were found to increase in size with the square of the bridging liquid-solid 
ratio.   
 The formation of bridges between precipitated crystals has also been observed using a 
microscale study to assess the bridging geometry and strength [43,44]. Glass ballotini beads were 
agglomerated using silicone oil and then submerged in liquid. The authors found that the force exerted 
by the liquid bridges could be accurately predicted through the variation in pressure in the liquid-bridge 
interface, verified experimentally.  
 Growth & Consolidation 
 Shear forces are responsible for the compaction and coalescence mechanisms which are 
thought to occur during agglomeration. Building on previous work, novel imaging has been used to 
observe spherical agglomeration in-situ, in combination with off-line characterisation [45]. During 
agglomeration, agglomerate size was found to decrease during the compaction of flocs. This occurs 
post-wetting. Agglomerates were found to reach a minimum size before coalescence occurs, mirrored 
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by a decrease in the number of agglomerates. The growth is found to be rapid initially, before slowing 
and the size distribution becoming narrow. The kinetics of fines was found to be much higher than that 
of larger agglomerates; fines are incorporated much more rapidly than agglomerate-agglomerate 
coalescence. Other mechanisms have  been previously suggested, including a ‘compaction and 
rearrangement’ mechanism in which primary particles are organised in a compact manner to form 
spherical agglomerates, and an ‘adhesion’ mechanism in which layered growth arises and is delimited 
by porous zones [45]. The latter of these has been verified experimentally.   
 The growth of agglomerates has also been compared to some of the mechanisms of wet 
granulation [4]. Capillary forces have been found to be responsible for increasing agglomerate size, as 
particles become bound to those with high amounts of bridging liquid [46]. Microcrystals have also 
been thought to form initial, loose agglomerates held together by the funicular state. With time, the 
shear force allows agglomerates to reach the capillary state through increased wetting by the bridging 
liquid [47]. These mechanisms are shown in Figure 2.9. Layering mechanisms have also been speculated 
to exist through analysis of agglomerate samples [46,48].  
 
Figure 2.9. Four types of liquid-particle interactions structures. Reproduced from Iveson et al., [5]. 
 
 The earliest work on spherical agglomeration mechanisms was conducted in 1979 and found 
that different growth regimes were present during the agglomeration of powdered glass [49]. The first 
regime, flocculation, is the formation of loose interconnected flocs of particles. The zero-growth 
regime immediately follows in which a reduction in the available bridging liquid limits growth. The fast 
growth regime is when the flocs are consolidated to form agglomerates. Further growth in size occurs 
as bridging liquid moves to the surface of the agglomerates. Eventually, an equilibrium occurs in which 
the size of agglomerates remains constant.  
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 Breakage & Attrition 
 Breakage mechanisms have also been speculated as being a part of the overall process, with 
shear forces splitting agglomerates into smaller particles, which then may be incorporated into 
remaining agglomerates. However, these mechanisms are traditionally not regarded as being part of 
the process, partly due to the deformable nature of early agglomerates; instead, disruptive forces to 
coalescence are more likely to occur [50]. It has also been found that agglomerates are significantly 
stronger after they have been allowed to dry, as a result of the bridging liquid evaporating and solid 
crystalline liquid bridges forming [45,51]. There has been no specific visual observations in-situ.  
 
 Analogies to Wet Granulation 
 For spherical agglomeration processes to be controlled accurately to achieve the desired end-
product properties, it is imperative that the mechanisms involved are well understood. Understanding 
of Some of these mechanisms, or rate processes, were developed as interest in spherical 
agglomeration increased [49]. Later studies draw analogies between spherical agglomeration and wet 
granulation mechanisms, including initial wetting [35], agglomerate growth [42] and agglomerate 
breakage [46]. Such comparisons are useful, as they allow development of the mechanistic knowledge 
of the process, as well as insights into the influence of such mechanisms on the agglomerates yielded.  
 As in wet granulation, the wetting mechanism is dictated by the size ratio between the bridging 
liquid droplets and crystal particles [52]. This is discussed in more detail in Section 2.3.1. As the process 
progresses, nuclei are subjected to continued shear which promotes their consolidation; this arises 
through either agglomerate-equipment or agglomerate-agglomerate collisions [10]. Due to this 
mechanism, there is generally a decrease in the mean size of the agglomerates as well as a reduction 
in the average porosity. Immediately preceding this, there is a lack of available bridging liquid for 
growth, and thus this phase is often referred to as the ‘zero-growth’ regime [49].  
 As agglomerates continue to compact and collide, eventually some of the bridging liquid is 
thought to be ‘squeezed out’, and thus becomes available for particle adhesion via coalescence. Both 
mechanisms can involve either individual crystal particles or formed agglomerate nuclei [45]. It is 
assumed that due to the collisions within the vessel, as well as the shear rate imparted on 
agglomerates, breakage and attrition must also occur. This mechanism occurs most likely in 
combination with the growth mechanisms previously discussed. Whilst generally breakage and 
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attrition will shift the agglomerate size distribution to the left, i.e. reducing the overall size. It is believed 
that fines and smaller agglomerates produced in these processes can be reincorporated into 
agglomerates. Over time, an equilibrium between these competing growth and breakage mechanisms 
is reached and, thus, no major changes in agglomerate size are observed.  A summary of the rate 
processes studied in both an experimental and modelling context is given in Table 2.2. The studies 
presented in are discussed in more detail in Section 2.4 and Section 2.5.    
Table 2.2. A summary of rate process studies in both experimental (E) and modelling (M) contexts. 






E + M  E + M  E + M [49] 
E + M E + M   E + M [53] 
 E E   [47] 
E E    [41] 
 E E E  [45] 
 E + M   E + M [44] 
 E + M E + M   [50] 
E     [42] 
 E E E E [46] 
E + M  E + M E + M E + M [54] 
M M    [55] 
 
Hapgood et al. performed a critical study of understanding of nucleation and wetting rate 
processes in wet granulation [56]. Of particular note in that study is the proposal for a nucleation 
regime map. The proposed map uses a combination of dimensionless groups: dimensionless drop 
penetration time which accounts for formulation parameters; dimensionless spray flux which accounts 
for process parameters. Similar work was also performed by Iveson & Litster [57], with a dimensionless 
group defined for the maximum pore saturation of agglomerates. This group, combined with an 
increasing deformation number group, was used to construct a regime map for growth of wet 
granulation systems. The use of dimensionless groups here, means the work can be applied to a wide 
variety of different wet granulation systems. This is exceptionally useful for engineers as it provides a 
robust and quick method to easily understand their process. The regime map itself has three separate 
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regimes within it: droplet controlled; intermediate; mechanical dispersion. The proposed map is 
displayed in Figure 2.10.  
Figure 2.10. The proposed nucleation regime map in wet granulation. Reproduced from Hapgood et 
al., [5,56].  
  
 
 If a regime map could be developed in a similar way for spherical agglomeration, as indeed 
there are some analogous mechanisms, although these are yet to be fully explained, then this would 
provide an excellent tool for improving the overall mechanistic understanding of the process. This is 
because relevant process parameters, whose influence is relatively well understood, can be 
incorporated, as well as the specific formulation parameters which may be of interest. This could allow 
distinct regions on the map to be developed for each wetting and nucleation mechanism. In turn, this 
could guide engineers in finding a spherical agglomeration process with the desired final-product 
characteristics.   
 
 The Factors Affecting Spherical Agglomeration 
 For the most part, currently published literature on spherical agglomeration specifically 
investigates the influence of process parameters on the formation of spherical agglomerates. The key 
studies for each of these is discussed in the following sub-sections.  
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 Solvent Composition of the System 
 The use of three solvents and varying crystal properties can create challenges when selecting 
solvents. However, several systems have been identified and used with a variety of different drugs. 
Some general rules have also been proposed to aid in the selection of different solvents and are briefly 
stated in Table 2.3 [58]. Table 2.4 provides an overview of solid-solvent systems which have been 
successfully used in spherical agglomeration processes. Note, that all systems identified within Table 
2.4 fall within Group 2 or Group 3 from Table 2.3, as suggested by Chow & Leung [58]. Here, the bridging 
liquid is not immiscible in the solvent system as described, and thus some bridging liquid will be “lost” 
to the bulk solution. As a result, the volume of the bridging liquid phase to agglomerate the particles is 
unknown. This is discussed in more detail in Section 2.4.2. 
Table 2.3. The four suggested groups for spherical crystallisation solvent selection by Chow & Leung 
[58].  
Group Drug Solubility1 Bridging Liquid Anti-Solvent 
1 Water 
Salt solutions of high 
concentration 





Organic solvents  
e.g. chloroform. 
Water-miscible organic 









Not sufficiently soluble in 
the above solvents: binding 
agent required, e.g. PEG 
Salt solutions of high 
concentration 




1 Drug solubility refers to the good solvent which is used to dissolve the particles of interest. Note - 
relative quantities of solvents are listed in the publication. 
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Table 2.4. A selection of spherical agglomeration systems within the literature. 
Solid 
Solvent System 
Bridging Liquid Immisciblea Ref 
Solvent Anti-Solvent 
Aspartic acid Water Ethyl acetate Chloroform x [59] 
Aceclofenac Acetone Water Dichloromethane x [60] 
Aminophylline Ethanol Chloroform Water x [61] 
Benzoic acid Ethanol Water Toluene x [62] 
Carbamazepine Ethanol Water Chloroform x [63] 
Celecoxib Acetone Water Chloroform x [64] 
Cycloserine Water 1-Butanol Ethyl acetate x [65] 
Fenbufen THFb Water Isopropyl acetate x [66] 
Flurbiprofen Acetone Water Hexane x [67] 
Glibenclamide Dichloromethane Water Benzene x [68] 
Glipizide Benzene Toluene Chloroform x [69] 
Indomethacin DMFc Water Chloroform x [70] 
Nabumetone Ethanol Water Cyclohexane x [71] 
Naproxen Ethanol/acetone Water Chloroform x [72] 
Propyphenazone Ethanol Water Isopropyl acetate x [73] 
Salicylic acid Ethanol Water Chloroform x [74] 
Tranilast Ethanol Acetone Water x [75] 
a Immiscibility data from CRC [76]. b Tetrahydrofuran. c Dimethylformamide.  
 Other studies have taken a more theoretical approach, including evaluating the influence of 
Lifshitz-van der Waals forces and Lewis acid-base interactions in combination [77]. The authors noted 
the superiority of both this and ternary phase diagram approaches in developing spherical 
agglomeration processes [77,78]. The latter of these is discussed in more detail in Section 2.4.1.1. The 
authors summarised that both approaches were useful in selecting which three solvents to utilise, 
whereas evaluation of solubility of the drug of interest can promote the use of binary systems. A 
proposed framework for solvent selection also produced successful ternary solvent systems for the 
agglomeration of cefotaxime sodium particles (see Figure 2.11). Unfortunately, the authors did require 
a verification step in their work, which involved conducting a spherical agglomeration experiment. 
Thus, full prediction of a ternary solvent system without experimental work was not possible.  
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Figure 2.11. A proposed framework for identifying ternary solvent systems. The framework accounts 
for the influence of Lifshitz-van der Waals and Lewis acid-base parameters. Reproduced from Chen et 
al., [77]. 
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 Ternary Phase Diagrams 
 The solvent system for spherical agglomeration has a direct influence on the level of 
crystallisation which can be achieved, as well as the extent of agglomeration. This is a result of the level 
of supersaturation, discussed previously, and the agglomeration kinetics.   
 To aid in the selection of solvent concentrations for each of the three solvents, ternary phase 
diagrams can be utilised, an example of which is shown in Figure 2.12. Each axis represents the relative 
fraction of that component within the solution identified. Here, component X is the anti-solvent, 
component Y is the solvent, and component Z is the bridging liquid.  
Figure 2.12. An example of a ternary phase diagram for a spherical agglomeration system. Tie-lines are 
shown as dashed blue lines. The line of miscibility is indicated by a solid blue line. Component X 
represents the anti-solvent, Component Y the solvent, and Component Z the bridging liquid.  
 
 Crucially, there is a boundary line of equilibrium. This line separates the miscible and immiscible 
regions. Tie-lines on the diagram also show lines of equilibrium and can be used to calculate the 
compositions of each immiscible phase. Along a single tie-line, the immiscible phase compositions 
remain the same, only the mass fraction of each phase changes.  
 The first documented use of this was in 1982 [10]. A ternary phase diagram for the solubility of 
an ethanol-water-chloroform system was used for the spherical agglomeration of salicylic acid. A 
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recent study has also utilised this method prior to the agglomeration of the drug etodolac [79]. A 
variety of other crystals have been agglomerated through the determination of ternary phase 
diagrams, including tolbutamide, acebutolol hydrochloride, fenbufen and  ketoprofen [9,46,66,80,81]. 
Generally, these studies have encouraged the use of the ternary phase diagram as it allows 
identification of a system where agglomeration can be optimised within the immiscible region.  
 The ternary phase diagram has been used previously by several studies to identify a region of 
operation for agglomeration processes [46,66,79,80,82]. Such regions are always within the immiscible 
region of the diagram, where two distinct liquid phases are present. In these studies, the solubility of 
bridging liquid in the bulk solution is exceeded to allow formation of a distinct bridging liquid phase. 
However, no studies have evaluated the influence of solvent system miscibility, nor the influence of 
this phenomenon on the bridging liquid volume available to agglomerate the particles of interest. As 
such, the traditional BSR value only provides an indication of the volume of bridging liquid available to 
agglomerate particles.  
 Different approaches have been used to select the solvents for spherical agglomeration. For 
instance, the relative solubilities of the crystals of interest can be evaluated in a variety of different 
solvents [83]. The authors also investigated miscibility, partitioning, and the vapour pressures of the 
solvents in an initial screening. Interestingly, this study reports the co-crystallisation of two different 
crystal species. The level of supersaturation, which is dictated by the solvent composition of the 
system, was found to directly influence which polymorph formed [83]. These considerations must be 
accounted for when designing spherical agglomeration systems. The choice of selecting a bridging 
liquid is detailed in Section 2.4.2.1.    
 The solvent addition method will directly affect the level of supersaturation within the system. 
The first study to investigate this process parameter used continuous spherical agglomeration for the 
agglomeration of sulfamethoxale crystals [84]. The study found that increasing the feed rate of the 
bridging liquid led to an exponential increase in the average diameter of agglomerates [84]. This is to 
be expected, as increasing the amount of bridging liquid increases the level of agglomeration. 
Conversely, increasing the feed rate of the suspension, containing all other solvents and the dissolved 
crystals, led to a decrease in the average diameter of agglomerates, as shown in Figure 2.13 [84].  
 The suspension feed rate results were later verified by another study. Here, increasing the 
addition rate of the solution of benzoic acid, solvent and bridging liquid to the anti-solvent yielded 
agglomerates with a smaller size [46]. The authors did, however, note that the strength of these smaller 
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agglomerates was higher than when the bridging liquid was added alone. This was identified through 
measurements of the fracture stress [46].  
Figure 2.13. The influence of feeding rate on the benzoic acid agglomerate size distribution. 
Reproduced from Thati & Rasmuson, [46].  
 
 The Bridging Liquid 
 The bridging liquid solvent is perhaps one of the single most important parameters to consider 
when designing spherical agglomeration experiments [7]. Crucially, it must be immiscible in the anti-
solvent. The properties of the liquid itself, as well as how much bridging liquid is added, has a major 
influence on the product properties. Thus, there are several considerations which must be made when 
considering bridging liquid addition methods.  
 Choice of Bridging Liquid 
 The choice of the bridging liquid will directly influence the amount of agglomeration and, 
therefore, influence the morphology and mechanical properties of agglomerates. Several studies have 
investigated a variety of different solvents as the bridging liquid. One of these studies evaluated the 
wettability of the drug  particles by different solvents [21]. This was achieved through the Washburn’s 
test, which relies upon capillary action. The Washburn’s equation is given as: 








𝑐𝑜𝑠𝜃 Equation 2.1 
 where ℎ is the covered distance in time 𝑡, 𝛾 is the interfacial tension, 𝜂 the viscosity of the 
liquid, ?̅? the mean of constant radius, 𝜏 tortuosity and 𝜃 the wetting angle of the liquid [85]. The authors 
measured changes in the weight variation of a bed of lobenzarit disodium particles. To do this, the 
weight of the liquid within the bed was related to the liquid front height: 
 𝑚 = 𝜙𝜌𝑆𝑖𝑛𝑛𝑒𝑟ℎ Equation 2.2 
 where 𝑚 is the mass, 𝜙 the porosity of the packed powder bed, 𝜌 the density of the fluid and 
𝑆𝑖𝑛𝑛𝑒𝑟 is the inner section of the bed. Finally, Equation 2.1 and Equation 2.2 are combined to measure 










𝜏?̅?𝑐𝑜𝑠𝜃 Equation 2.3 
 The study also compared a ‘perfect’ wetting agent, where they assumed the contact angle to 
be zero, to the bridging liquid solvent to be tested which had an unknown contact angle. The bridging 
liquids were then tested experimentally [21]. The solvent with the highest wettability of lobenzarit 
disodium, n-hexane, was found to have the lowest contact angle and, indeed, produced agglomerates 
which were denser, larger and had high sphericity [21]. These results suggest the Washburn’s test may 
be a suitable method for the selection of a bridging liquid.   
 A similar study has been performed more recently, although the wettability data of different 
bridging liquid solvents was not provided [86]. The authors used the sessile drop-method to calculate 
the wettability of these solvents to aid selection of an appropriate bridging liquid. The study did 
highlight that the bridging liquid solvent has a pivotal role in producing the desired agglomerates. The 
authors concluded that the different solvents can directly influence the yield of agglomerates as well 
as their strength. Morphological changes were also observed: size, size distribution and sphericity [86]. 
The interfacial tension of the bridging liquid in water can provide insights into how suitable a 
solvent is for agglomeration procedures. It has been suggested that the interfacial tension between 
the bridging liquid and the anti-solvent should also be high, although the authors fail to provide 
quantitative data for this [86]. Bridging liquids with higher interfacial tensions in water provide a larger 
immiscible region to work with; that is, immiscible systems form with lower quantities of bridging 
liquid. In effect, this provides a wider range of experimental systems which may be used when 
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designing agglomeration procedures.   
 Previously, the interfacial tension has been considered as an important parameter in the 
displacement of a non-wetting liquid (i.e. mother solution) by a wetting fluid (i.e. bridging liquid) within 
a thin capillary. The velocity profile of a wetting fluid can be expressed as follows:  






|) (𝑅2 − 𝑟2) Equation 2.4 
 where 𝑅 represents the radius of a cylindrical pipe,  𝑟 is the radial co-ordinate, 𝜇𝑑 is the viscosity 
of the liquid, and |
𝑑𝑃
𝑑𝑧
| is the pressure gradient for the flow. The flow rate 𝑞 can thus be expressed as 
follows, which then allows the average flux of the flow, 𝑄 to be calculated:   






|) 𝑅4 Equation 2.5 










|) 𝑅2 Equation 2.6 
 From here, the authors calculated the rate of displacement of a non-wetting liquid, such as the 
mother solution, by a wetting liquid, such as the bridging liquid. A schematic of this is shown in Figure 
2.14. The authors used these calculations as a basis for two separate models for the immersion 
mechanism. These are discussed in more detail in Section 2.5.  
 
 
Figure 2.14. Displacement of a non-wetting liquid, or bulk solution, by a wetting liquid, or the bridging 
liquid, in a thin capillary. Reproduced from Arjmandi-Tash et al., [12]. 
 
𝓁 (t) 
θ wetting liquid  non-wetting liquid  
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 Bridging Liquid-Solid Ratio (BSR) 
 The bridging liquid-solid ratio is defined as the ratio between the volume of bridging liquid (VZ) 




 Equation 2.7 
 The ratio is critical to the agglomeration rate. Many studies are in agreement in that if the ratio 
is too low, there is an insufficient level of agglomeration, whereas if the ratio is too high, a paste-like 
product is formed [21,45,46]. Many of these studies recognise a ‘critical range’ in which the ratio is 
suitable for agglomeration. Increasing the ratio from the lower to the upper limit, promotes an 
increasing agglomerate size [50,86]. The critical range has been previously determined for select 
salicylic acid (0.35 – 0.47) and benzoic acid (0.47 – 1.16) systems [50,86].   
 The effect of BSR may be described in further detail. When the BSR is below the critical range, 
agglomerates may form, but crystals will remain in solution. Increasing the BSR in the critical range 
increases the agglomerate size, as the remaining crystals in solution become agglomerated [50,86]. 
Above the critical range, a bridging liquid layer forms around the agglomerates and, above this, the 
layer grows to its maximum level. Residual bridging liquid remains as droplets within the suspension 
before subsequent increases promote the formation of soft, paste-like agglomerates as previously 
discussed [50,86]. These relationships are detailed in Figure 2.15 through to Figure 2.20 for various 
levels of bridging liquid, for both the distribution and immersion mechanisms, as shown in Figure 2.7 
and Figure 2.8 respectively.   
 In Figure 2.15 and Figure 2.16, the level of bridging liquid is too low. In the immersion 
mechanism, not all crystals can enter droplets, due to the lack of bridging liquid. In the distribution 
mechanism, not all crystals will be wetted by the bridging liquid droplets. Growth and consolidation 
occurs as usual, but many crystals may be left in solution due to not being wetted. Agglomerates 
formed tend to have weak mechanical properties, making them more prone to breakage and attrition.  
 In Figure 2.17 and Figure 2.18, the level of bridging liquid is ideal. In the distribution mechanism 
all crystals are sufficiently wetted by the bridging liquid droplets. In the immersion mechanism the 
droplets are effectively ‘saturated’ with crystals.  Compaction occurs as usual and all nuclei begin to 
form agglomerates, which densify over time. The resultant agglomerates are highly spherical and have 
the desired mechanical properties.   
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Figure 2.15. The influence of a BSR value below the critical range on the distribution mechanism in 
spherical agglomeration. Adapted from Petela [87] and Peña & Nagy, [32].  
 
Figure 2.16. The influence of a BSR value below the critical range on the immersion mechanism in 
spherical agglomeration. Adapted from Petela [87] and Peña & Nagy, [32]. 
 
Figure 2.17. The influence of a BSR value within the critical range on the distribution mechanism in 
spherical agglomeration. Adapted from Petela [87] and Peña & Nagy, [32]. 
 
 
Figure 2.18. The influence of a BSR value within a critical range on the immersion mechanism in 
spherical agglomeration. Adapted from Petela [87] and Peña & Nagy, [32].  
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Figure 2.19. The influence of a BSR value above the critical range on the distribution mechanism in 
spherical agglomeration. Adapted from Petela [87] and Peña & Nagy, [32].   
 
Figure 2.20. The influence of a BSR value above the critical range on the immersion mechanism in 
spherical agglomeration. Adapted from Petela [87] and Peña & Nagy, [32]. 
 In Figure 2.19 and Figure 2.20, the level of bridging liquid is too high. In the immersion 
mechanism, not all droplets will contain crystals, and the volume of crystals will vary. In the distribution 
mechanism, the excess bridging liquid causes excess wetting of crystals.  The final agglomerates form 
a paste-like material, which has poor mechanical properties. Over time, agglomerates begin to form 
through compaction and consolidation with the excess bridging liquid. 
It has been suggested that increasing the BSR within the critical range leads to an increase in 
the deformability of agglomerates, which means there is an increased amount of energy dissipation. 
This, in turn, leads to an improvement in the efficiency of agglomeration and an increase in 
agglomerate size. Other studies have recognised that increasing the BSR within the critical range also 
leads to a reduction in the size distribution of agglomerates [42,48].  
 Furthermore, there are a lack of studies which have compared different crystals of interest 
within the same solvent system. In these instances, it remains unclear whether the critical range 
identified is consistent across compounds. Studies have shown that changes in one of three solvents 
used causes changes in the critical range value, as highlighted within Table 2.5 [21,45,46,86]. In 
practice, the solvent species changed is almost always the bridging liquid. However, process 
optimisation may require one of the other two solvents to be changed, for example, to improve the 
crystallisation yield of the product. Such studies have currently not been performed in the context of 
SA. Table 2.5 shows that the critical range for BSR is strongly system dependent.  There is no general 
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method for determining the correct range of BSR a priori, only by extensive experimental studies for 
each new system. Thus, predictive design of spherical agglomeration is, at present, impossible. These 
issues create complex challenges for engineers, hampering process development and industrial 
adoption, as the critical range is crucial for accurate control of the process. 
Table 2.5. A summary of the bridging liquid to solid ratio critical range for a variety of different 








Sulfuric Acid/-* Chloroform Salicylic acid 0.35 – 0.50 [45] 
Water/Ethanol Chloroform Salicylic Acid 0.72 [10] 
Water/Ethanol Chloroform Benzoic Acid 0.47 – 1.16 [88] 
Water/Acetone Hexane Benzoic Acid 1.08 – 1.43 [21] 
Water/Ethanol Heptane Benzoic Acid 0.72 – 1.23 [86] 
Water/Ethanol Toluene Benzoic Acid 0.47 – 1.16 [46] 
Water/Ethanol Toluene Benzoic Acid 0.80 [89] 
Water/Acetone DCM Aceclofenac 0.88 [23] 
* N.B. binary system used. 
  
 The influence of BSR could be compared to the influence of the binder-solid ratio parameter in 
granulation. The observations noted are much the same: inadequate levels of binder results in a lack 
of granulation, whilst excessive levels lead to the formation of a slurry. Within this critical range, 
increases also lead to increases in the binder level, as with spherical agglomeration. The pore saturation 
is an imperative factor in this manner [90]. This factor represents the level of intra-granular voids filled 
with binder liquid. Figure 2.21 shows the calcium hydrogen phosphate growth rates with a variety of 
different binders – all of which collapse onto a single curve, regardless of the binder used.  
 Figure 2.22 shows similar trends for the growth in agglomerate size as a function of BSR within 
the critical range for a variety of different spherical agglomeration systems. All these curves, though 
qualitatively similar, are quantitatively different and, therefore, prevent a major obstacle in predictive 
design. Here, the relationship between agglomerate size and BSR cannot be established for a given 
system. The data does follow a similar exponential trend as identified in Figure 2.21, suggesting that it 
may be in fact possible to collapse the data onto a single line. For this to be achieved, standardisation 
across the BSR value should be achieved, along with other experimental parameters. This could be 
achieved using dimensionless parameters or groups, like those well established for wet granulation. 
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Figure 2.21. The effect of liquid saturation on the mean granule size for different binders. 




Figure 2.22. Agglomerate size as a function of BSR for different agglomerate systems: ○ CaCO3-
kerosene; △ salicylic acid-chloroform; x benzoic acid-toluene; ⬦ lobenzarit-hexane; + atorvastatin 
calcium-dichloromethane [21,45,46,91,92].  
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There is one respect in which predicting BSR in spherical agglomeration is more complex than 
predicting liquid to solid ratio for wet granulation. In wet granulation, the continuous fluid is air and 
there is complete immiscibility between the air and the liquid binder.  For spherical agglomeration, 
however, the continuous fluid is a solvent and there is partial miscibility between the continuous phase 
solvent, and dispersed phase bridging liquid. Furthermore, the extent of miscibility is not constant, but 
depends on the operating position on the ternary phase diagram (Figure 2.12). By using the actual 
bridging liquid volume accounting for partial miscibility, it may be possible collapse data from many 
systems onto a single curve. In this instance, it may be possible to predict both the mean size of 
agglomerates, and thus infer the level of fines in solution, when considering a different bridging liquid 
volume quantification method.  This approach uses the “true bridging liquid to solid ratio” (TBSR) rather 
than the BSR.  This approach has not previously been proposed or tested in the literature. 
 
 Bridging Liquid Addition Method 
 A key study has investigated the influence of two different addition methods on the formation 
of spherical agglomerates of salicylic acid [35]. In the first method, an ethanol solution containing 
salicylic acid was placed in the reactor prior to the addition of water, the anti-solvent, to crystallise 
salicylic acid particles [35]. The bridging liquid, chloroform, was added last. In the second method, the 
reverse process occurred – the bridging liquid and water were added to the reactor, before the ethanol 
solution was added [35]. The agglomerates formed through the latter method were found to be both 
more compact  and spherical, although an explanation was not proposed for this observation [35]. 
 A later study reported an increase in the number of spherical agglomerates when the bridging 
liquid is initially mixed into the solvent system prior to precipitation, as opposed to addition after 
precipitation [88]. These results were later verified for atorvastin calcium crystals, where simultaneous 
precipitation and agglomeration occurred when the bridging liquid was initially mixed into the solution 
[92]. The authors also noted the improved flowability and compressibility of agglomerates formed in 
this way, as opposed to adding the bridging liquid post-precipitation [92]. This could be due to 
immediate agglomeration, which reduced the likelihood of polymorph transformation. Injecting the 
same level of bridging liquid over a shorter period of time has been found to decrease the overall 
agglomerate size [42]. The authors state that this is due to increased dispersion of bridging liquid into 
many more, smaller droplets, which subsequently increases the number of agglomerate nuclei.   
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 Bridging Liquid Droplet Size: Immersion vs Distribution Mechanism 
 As previously noted in Section 2.3.1, the size ratio between the bridging liquid droplets and the 
particles of interest dictates which wetting mechanism occurs. This subsequently affects agglomerate 
growth and consolidation and may also influence the degree of breakage. This is due to the generally 
higher friability of agglomerate nuclei formed by the distribution mechanism. The bridging liquid 
droplet size is almost always overlooked. There are many practical difficulties in observing, tracking, 
and characterising bridging liquid droplets within stirred tank reactors. This means it is difficult to 
understand the balance of droplet coalescence and breakage processes, as well as their influence upon 
agglomerate size distributions.  
 Only one study to date has looked at both droplet and particle size control parameters together 
[42].  The authors visualised the in-situ wetting of salicylic acid particles. This involved creating a droplet 
of the bridging liquid (chloroform) of approximately 240 μm using a microcapillary. A suspension of 
salicylic acid was pumped through the visualisation zone. This allowed the authors to visualise the initial 
interactions between the bridging liquid droplet and the particles of interest. In this study, the particle 
size was controlled and found to be approximately 30 μm; thus, the initial wetting occurs by the 
immersion mechanism. This can be seen in Figure 2.23.  
.  
Figure 2.23. In-situ visualisation of chloroform-salicylic acid initial interactions. Scale bar is the same 
for all images. Reproduced from Subero-Couroyer et al., [42].  
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 The authors also noted the contrast in the immersion mechanism as previously identified by 
Madec et al., [93]. In this study, the authors noted that a particle shell formed around the bridging 
liquid droplet, and through shear, particles began to migrate towards the core of the droplet over time. 
This frees up bridging liquid at the droplet surface for further particles to interact, as shown in Figure 
2.24. Madec et al., also noted that immersion in this manner prevented droplet coalescence. This 
suggests that pre-nucleation (i.e. allowing a “protective layer” of droplets to form), could be 
advantageous as a method of controlling bridging liquid droplet sizes.   
Figure 2.24. a) The initial formation of a particle shell around a bridging liquid droplet, b) prior to their 
movement into the droplet itself. Reproduced from Madec et al., [93].   
 
 Indeed, the prior study also managed to observe wetting and nucleation in-situ of a stirred 
agglomeration vessel. It can be seen from the images obtained by the authors that the wetting & 
nucleation, and growth & consolidation, were consistent with the distribution mechanism. These 
results are shown in Figure 2.25. Whilst the qualitative results of the mechanism are sufficient, the 
quantitative results which underpin the mechanism need further study. This secondary result from the 
same study highlights the need for accurate control of the bridging liquid droplet sizes. It is unclear 
whether the authors achieved this during the agglomeration process and, if so, how it was achieved. 
The control of initial particle size is challenging but possible through the use of techniques such as 
recrystallisation, milling etc. However, the control of bridging liquid droplets is much more difficult. 
This could be achieved through microfluidic systems, which would provide droplets at a pre-
determined size. Whether these droplets coalesce or break during agglomeration process remains 
unclear but could be investigated using a stabilisation method as described by Madec et al., [93]. 
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Figure 2.25. (a-d) The evolution of salicylic acid flocs during the injection of chloroform as a bridging 
liquid. Note the compaction of flocs during this process across an unknown time period. Reproduced 
from Subero-Couroyer et al., [42].  
 
 Building on these works, the mean size of spherical agglomerates has also been directly 
controlled through the bridging liquid droplet size [94]. Here, the authors used variations in the 
bridging liquid droplet size and investigated how this affected the mean agglomerate size. The bridging 
liquid (toluene) was infused into the suspension at a controlled flow rate using a microfluidic capillary. 
Whilst direct visualisation and measurement of the droplets was not feasible, the droplet size was 
estimated using mathematical relationships rooted in the forces acting upon forming droplets at the 
capillary tip. These were estimated at between 750 and 1000 µm depending upon the experimental 
conditions, i.e. impeller speed, capillary geometries. The benzoic acid primary particles had a mean size 
of approximately 12 µm. This ensured the immersion mechanism of wetting occurred. The authors 
found that the final agglomerate size was approximately one and a half times that of the initial droplet 
size. This study highlights the possibility of tuning bridging liquid droplet sizes to control the final size 
of agglomerates, and the importance of their size on agglomerate wetting & nucleation and growth & 
consolidation.  
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 Prediction of Bridging Liquid Volume Requirements 
 PA modelling study has investigated the influence of the critical packing volume during 
immersion nucleation driven, spherical agglomeration processes [12]. There, a new definition of the 
true bridging liquid solid ratio was introduced (TBSR), although the supporting theory and validation of 
this was not provided. This definition accounts for miscibility of the bridging liquid in other solvents. 
The authors also used a bridging liquid which was completely immiscible in the one-component 
suspension and, thus, remained as a distinct phase within their simulations. In such scenarios, the TBSR 
and BSR are considered to be mathematically equal as there is no solvent miscibility. The authors were 
able to predict the TBSR optimal range from estimations of the critical packing volume, as shown in 
Equation 2.8: 
 𝑇𝐵𝑆𝑅𝑜𝑝𝑡 = 
𝜑𝑐𝑝
1 − 𝜑𝑐𝑝
 Equation 2.8 
 where 𝜑𝑐𝑝 is the critical packing liquid volume fraction within the agglomerate nuclei. This 
parameter quantifies the amount of bridging liquid contained within an agglomerate nucleus. When 
𝜑𝑐𝑝 = 1, the nucleus is filled with bridging liquid and no crystals are present. Conversely, if 𝜑𝑐𝑝 = 0, 
the nuclei are filled with crystals and no bridging liquid is present. Eventually, the bridging liquid droplet 
is occupied by a maximum fraction of particles, i.e. the critical packing volume is reached.  A schematic 
of this is shown in Figure 2.26.  
 However, in practice, most particulates suited to the spherical agglomeration process are not 
perfectly spherical. As a result, the critical packing may be considerably different and, thus, the 
calculations used within this study would produce undesirable results. DEM studies have previously 
demonstrated the significant influence of aspect ratio and particle size on the critical packing of 
particles [95]. In practice, identifying the value in-situ during experiments may be incredibly difficult, 
especially if crystallisation steps are included. This is due to the potential breakage of primary particles, 
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Figure 2.26. The quantification of critical packing volume (ϕcp) of a unit cell in spherical agglomeration 
processes. Adapted from Arjmandi-Tash et al., [12]. 
 
 Bridging Liquid Miscibility 
Within spherical agglomeration literature, a critical range for BSR is often recognised. Below 
the critical range, the volume of bridging liquid added to the system is too low to form agglomerates 
suitable for direct compression. This is usually indicated by the presence of un-agglomerated crystals 
within the bulk solution and low agglomerate yields. Many studies have found such agglomerates to 
have poor mechanical properties namely, high friability and porosity. This condition is shown for the 
distribution and immersion mechanisms below (Figure 2.27a and Figure 2.28a respectively).  
Immersion Mechanism of Wetting & 
Nucleation 
Φ = Φcp 
Bridging Liquid Droplet Surface 
Bridging Liquid Droplet Core 
Φ = 1 
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The second of these conditions considers a system with a BSR above that of the critical range, 
where the volume of bridging liquid added to the system is too high. In these processes, agglomerates 
often form a paste which is impossible to recover and characterise. This condition is shown for the 
distribution and immersion mechanisms below (Figure 2.27c and Figure 2.28c respectively).  
 The final condition is a spherical agglomerate process which operates within the critical range. 
Here, enough bridging liquid is available to incorporate a high percentage of primary crystals, without 
the formation of a paste. As such, agglomerates are good candidates for direct compression due to 
their mechanical robustness. This condition is shown for the distribution and immersion mechanisms 
below (Figure 2.27b and Figure 2.28b respectively).  
Figure 2.27. A bridging liquid-solid ratio a) below the critical range, b) within the critical range, and c) 
above the critical range, for the distribution mechanism of spherical agglomeration.  
 
Figure 2.28. A bridging liquid-solid ratio a) below the critical range, b) within the critical range, and c) 
above the critical range, for the immersion mechanism of spherical agglomeration. 
 
 All spherical agglomeration processes should, ideally, operate within the critical range as this 
maximises product recovery and drastically enhances the likelihood of improvements in the 
micromeritic properties of bulk crystal powders, which ultimately controls the likelihood of successful 
tablet formation. This range has previously been identified for a variety of solvent-crystal systems, but 
there is not a clear methodology for determining this a priori [21,45,46,86]. All these studies have relied 
upon time and cost intensive trial and error experimental work. In the case of developing the process 
for a newly discovered compound, often, only small quantities are available, meaning such trial-and-
error experimental determination is likely to be impossible to complete.  
a) b) c) 
a) b) c) 
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 Figure 2.22 shows that the best range of BSR for any given system is very narrow but also very 
system dependent. This is indicated by a range varying from 0.1 to 1.6 for the six systems shown in 
Figure 2.22.  By contrast, for an analogous wet granulation process the optimum range of binder to 
solid ratio is largely system independent when expressed as the liquid saturation of the granules (Figure 
2.21).  If the BSR for spherical agglomeration is correctly defined, it too should be largely system 
independent as well. 
 The current BSR definition is based upon the volumes of both the bridging liquid and solid of 
interest introduced to the process. As such, two assumptions are made: a) that there is no solubility of 
the solid within the system; b) there is complete immiscibility between the bridging liquid and the other 
two solvents utilised. These assumptions have separate ramifications: a) all crystals are available to be 
agglomerated; b) all the bridging liquid is available to agglomerate the crystals.  
 The first assumption is acceptable as, most often, crystals are precipitated through an anti-
solvent crystallisation. As such, under the same process conditions, the volume of crystals available to 
be agglomerated should remain constant across different runs. However, the true volume of bridging 
liquid available ultimately depends upon the other two solvents used. Most often in pharmaceutical 
applications, water is used as an anti-solvent, and an organic compound as the solvent, for example 
acetone or ethanol [10,46,79,86,96]. These solvents are completely miscible to allow precipitation of 
the crystals of interest. Ideally, the bridging liquid exists as a distinct phase within the agglomeration 
process as this promotes the immersion mechanism and therefore greater control. For this to occur, 
either the bridging liquid must be completely immiscible with the bulk solution or the bridging liquid 
solubility in the bulk solution must be exceeded. The former of these conditions is often impractical to 
achieve. Here, the ternary phase diagram is imperative to identifying the relative solubility of the 
bridging liquid in the bulk solution (see Figure 2.12). 
 Although the relative compositions of each immiscible phase differ significantly, they still 
contain all three solvent components. The variation in the compositions of these phases is attributed 
to two phenomena: the transfer of some of the bridging liquid to the bulk solution phase and the 
transfer of some of the bulk solution to the bridging liquid phase. The bulk solution phase can be 
referred to as bridging liquid poor as the bridging liquid only forms a small percentage of the phase. 
The bridging liquid phase can be referred to as bridging liquid rich as, here, the bridging liquid forms 
the vast majority of the phase, with small quantities of bulk solution present. This is shown in.  
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 Shear Force through Agitation 
 The agitation speed can directly affect the magnitude of hydrodynamic forces within the 
agglomeration vessel, especially the shear force. As a result, an increase in agitation speed leads to an 
increase in the frequency of particle-particle collisions and particle-equipment collisions, which may 
induce the breakage of particles or agglomerates. However, mixing must be sufficient to promote the 
formation of a flow profile which allows for adequate liquid-particle collisions. Most studies report an 
increased particle size with agitation rate. This could be attributed to increased levels of agglomerate 
nuclei coalescence at higher agitation rates. Further increases in the speed reduce the agglomerate 
size as high agitation rates have the potential to fragment weaker agglomerates that have already 
formed  [88,97]. This has been reported within a wide range of studies [6,10,23,45,98].   
 Increases in the size of agglomerates has been reported across a range of low agitation speeds 
[97]. Similarly, the size distribution of agglomerates becomes larger, whilst a reduction of fines can be 
observed, as shown in Figure 2.29 [99]. This could be attributed to a shorter contact time between 
particles and the bridging liquid, meaning agglomerates do not grow uniformly. The average size was 
found to decrease from 96 µm at 500 rpm to 64 µm at 800 rpm.  
Figure 2.29. The influence of agitation speed on the size distribution of spherical agglomerates of 
cefotaxime sodium. Adapted from Zhang et al., [99].  
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 The speed of agitation directly influences the nucleation and subsequent crystal growth of 
primary particles, with increasing speeds promoting nucleation and, thus, decreases in crystal size 
[100]. Furthermore, the agitation speed also affects the dispersion of the bridging liquid. This has been 
documented through a reduction in the lower limit of the BSR at higher agitation speeds as the liquid 
becomes more well-distributed within the system [92]. Higher agitation speeds also favour smaller 
particles and a faster rate of agglomeration [42]. Agglomeration should be easier at a higher speed, as 
the likelihood of bridging liquid-primary particle collisions is increased.   
 The influence of the agitation rate on the mechanical properties of agglomerates has also been 
reported. The porosity of agglomerates was found to decrease with agitation speed, yielding 
agglomerates which were more dense and, thus, had a higher compressive strength [45]. These 
agglomerates were also found to have improved sphericity and flowability [23]. This has been 
previously attributed to the increased shear forces causing agglomerates to become more compact 
during growth [6]. These trends have been recognised to lead to reductions in the size of agglomerates 
[99].   
 Unfortunately, most studies provide the degree of shear rates as a revolution per minute value 
only. Whilst this is adequate for a quick comparison between different systems, the unit fails to account 
for variations in impeller diameters and suspensions volumes. A standardised definition, such as the 
energy dissipation rate (m-2 s-3), could be used to help alleviate this issue and allow instant comparison 
across different systems. This parameter is defined as follows: 
 = 0.6 𝐷𝑖𝑚𝑝 ×
𝑁3
𝑉𝑠𝑢𝑠𝑝
 Equation 2.9 
 where  is the energy dissipation rate, 𝐷𝑖𝑚𝑝 is the diameter of the impeller, 𝑁 is the speed of 
the impeller in revolutions per minute, and 𝑉𝑠𝑢𝑠𝑝 is the suspension volume. A definition such as this 
therefore allows comparisons of different reactors on different scales, and is common in mixing studies 
as a result, and is thus recommended for the future work in the area. The shear rate clearly affects 
agglomerate size and size distribution to a degree, although the overall influence of this parameter 
seems low. Crucially, enough shear must be provided to ensure that particles are adequately 
suspended, and that the system as a whole remains well-mixed.   
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 Residence Time 
 The residence time, or the duration of agitation, of particles can also have significant effects on 
the properties of agglomerates. This is assumed to be as a result of increasing the relative portion of 
time for processes such as growth and consolidation. Ultimately, a steady-state equilibrium is reached 
between the rate of both agglomerate growth and breakage. As this equilibrium time is ultimately 
dictated by other process parameters, it is important to identify when this occurs. The size of the 
agglomerates produced by spherical agglomeration can be effectively controlled through variations in 
the residence time of agglomerates. For example, aminophylline agglomerates were found to increase 
in size over longer residence times, from a mean of approximately 200 µm at 1 hour to 250 µm at 4 
hours, until the equilibrium point was reached (approximately 500 µm) [101]. This supports previous 
studies performed by the same group [18]. This growth can be attributed to the growth rate processes 
being much higher than the breakage processes initially before the two processes become 
approximately equal, i.e. steady-state is reached.   
 The size distribution profile of salicylic acid agglomerates has also been shown to be affected 
over a variety of residence times [35]. The authors found that increases in the residence time created 
a wider overall size distribution. As more primary particles are incorporated into agglomerates, the size 
distribution should theoretically narrow. This result was obtained, in contrast, by a theoretical study 
using population balance models [102]. Some of these are discussed in more detail in Section 2.5. 
Experimental studies have also reported these findings more recently and attributed these increases 
as a result of the continued coalescence of particles within the system [47].   
 Other studies have found that increased residence times also encourage the integration of a 
higher level of primary particles into spherical agglomerates [98]. This was also found to be directly 
related to the median diameter of spherical agglomerates of a steroid compound. The same trends 
were found regardless of the other process parameters which were changed, including temperature 
and agitation speed. The authors did, however, find that lower residence times are needed when 
higher speeds are employed. These findings were supported by increases in the weight of agglomerates 
over time.  
 The intrinsic mechanical properties of agglomerates are also reported to change with the 
residence time. One of the first studies to investigate the influence of residence time found that 
agglomerate porosity decreased with increasing experimental time, even up to a period of two hours 
[18]. This was attributed to an increased time for the consolidation of agglomerates, resulting in 
decreasing associated porosity.   
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  One study has investigated such properties in high detail. The authors found a direct 
relationship between increases in the size and density of spherical agglomerates as the residence time 
was increased [47]. The same authors also reported that the friability of agglomerates decreases with 
an increasing residence time, as shown in Figure 2.30. This was also supported by an increase in the 
crushing strength of agglomerates, as reported elsewhere in the literature [45,86]. Agglomerates 
formed over two hours were approximately twice as strong as those formed over one hour and four 
times stronger than those formed over thirty minutes. Interestingly, this relationship is relatively linear 
over a wide range of particle sizes, suggesting the agglomerate formation was relatively uniform.   
 
Figure 2.30. The relationship between friability of bucillamine agglomerates and the residence time of 
agglomerates: (○) 30 minutes; (△) 60 minutes; (□) 120 minutes. Here, X represents the pulverised 
fraction of agglomerates. Reproduced from Morishima et al., [47]. 
 Residence time of agglomerates is shown to directly influence the end product properties 
obtained and should be considered as a means of optimising the performance of spherical 
agglomeration processes. The kinetics associated with the residence time, such as wetting and growth, 
are intrinsically linked to the agglomerate properties, and thus should be studied in further detail as a 
means of understanding and developing these relationships further. This is emphasised by a lack of 
studies which track agglomerate populations and their properties over a range of residence times. 
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 Current Modelling in Spherical Agglomeration 
 Models of Agglomeration in Suspension Systems 
 The modelling of spherical agglomeration is complex, especially without a full understanding of 
the mechanisms which drive the process. Some modelling work has been undertaken, however. A 
population balance model (PBM) was developed to predict any changes in the agglomerate size 
distribution [49]. This work included terms for both coalescence and breakage as well as growth. The 
model was found to be useful for predicting the agglomerate size distribution at steady state. The study 
did not focus on the nucleation and growth of crystals but purely their agglomeration.  
 Initially this was solved using an agglomeration rate kernel which could account for additional 
factors, including particle concentrations, supersaturation and crystal size, amongst others [53]. A 
multi-layer agglomeration model was then developed which accounted for the efficiency of 
agglomeration based upon the collision mechanisms, Brownian 𝑏𝑟𝑜𝑤, laminar 𝑙𝑎𝑚, or turbulent 𝑡𝑢𝑟𝑏 
[103,104]. These are represented respectively in Equation 2.10 through to Equation 2.12. As the 
particle size increases through agglomeration, the collision mechanism changes from Brownian to 
laminar, and finally to turbulent. 




 Equation 2.10 
   








 Equation 2.11 
   











) Equation 2.12 
where 𝑘𝐴 is the agglomeration rate constant, 𝐺𝑎𝑔𝑔 is the growth rate of agglomerates, 𝑆𝑖 and 
𝑆𝑗 refer to the size of particles 𝑖 and 𝑗, 𝑃 is the dissipated power per unit mass, 𝜈 is the kinematic 
viscosity, 𝑀 is Marchal’s relative size function, 𝑁 is the agitation speed, 𝐷 is particle diffusivity and 𝜆𝑐 
is the Taylor microscale.   
 It is worth noting that these kernels apply directly to crystallisation processes in which 
agglomeration arises, not agglomeration in suspension systems. However, the effects of 
hydrodynamics, particle size and concentration have been verified experimentally as relevant to both 
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(see Figure 2.31)[49]. The kernels developed incorporated the supersaturation level and temperature 
of the system within the growth rate term; supersaturation increases promote strengthening of the 
liquid bridges, which, in turn, increases the efficiency of the process [105]. 
 
 
Figure 2.31. The relationship between experimental growth curves as a function of a) particle 
concentration and b) agitation speed during bridging liquid injection. Reproduced from Bemer [49]. 
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 Other work has investigated the Monte Carlo approach to solve multi-dimensional kernels 
designed for agglomeration in suspension [102]. The bridging liquid composition was included in these 
kernels. The bridging liquid is a critical parameter in forming spherical agglomerates. 
 𝛽 = 𝛽0(𝑆𝑖
3 + 𝑆𝑗









 Equation 2.13 
   
 𝑐𝑖 =
volume of liquid
volume of the agglomerate
× 100 Equation 2.14 
   
 𝛿 = (
1 − 𝑐𝑜𝑝𝑡
𝑐𝑜𝑝𝑡
)𝛿𝑙 Equation 2.15 
 where 𝑐𝑖 is the volume percentage of the binding agent, defined in Equation 2.14, 𝛿 is the 
weight coefficient of solid particles and 𝛿𝑙 is the weight coefficient of liquid particles. This composition 
function, Equation 2.14, is derived to account for the level of bridging liquid present within 
agglomerates; those with too much bridging liquid, or not enough, will not form agglomerates. 
Equation 2.15 accounts for both the amount of bridging liquid and the weight coefficients of both solids 
and droplets, ensuring that agglomeration cannot occur without sufficient wetting. This serves as an 
efficiency term by which the agglomeration processes reach an equilibrium. These kernels could more 
accurately predict the agglomeration size distribution, improving upon the previous work [49].    
 Other work has also looked into the modelling of the growth period of agglomerates [45,50]. A 
combination of experimental and modelling work was performed once the most significant 
characteristics of the process were identified, building on previous work [49]. The authors concluded 
that four mechanisms are present during the agglomeration process [45]: 
i. Bridging liquid droplets form and engulf solid particles; agglomerate nuclei form within 
these droplets. 
ii. The collisions of droplets cause a decrease in the size of agglomerate nuclei through a 
compaction mechanism. 
iii. The process conditions dictate the level of growth and consolidation of agglomerates, i.e. 
agitation speed, amount of bridging liquid. 
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iv. Compaction mechanism no longer occurs; agglomeration ends and there is no further 
growth in size. 
 The authors found the relative relationship between the bridging liquid-solid ratio, particle solid 
concentration and agitation rate of the system studied, Equation 2.16. Through experimental 
observations, a ‘growth only’ agglomeration model was then established, Equation 2.17: 
 𝑆𝑓𝑖𝑛𝑎𝑙 = 𝐴𝑝 ⋅ 𝐶𝑆
0.3 ⋅ 𝑁−0.6 ⋅ 𝐵𝑆𝑅2.1 Equation 2.16 




= 𝑅𝐴(𝑆, 𝑡) Equation 2.17 
 where 𝑆𝑓𝑖𝑛𝑎𝑙 is the final agglomerate size, 𝐴𝑝 is a proportionality constant, 𝐶𝑆 is the solid 
concentration of particles and 𝐵𝑆𝑅 is as defined previously in Equation 2.7. In Equation 2.17, 𝜓 is the 
number density function, 𝑡 is the agglomeration time and 𝑅𝐴 is the agglomeration rate distribution. 
This final parameter can be separated into the agglomeration rate of rank 𝑟𝑎𝑔𝑔(𝑙, 𝑡), agglomeration 
kernel 𝐾, the probability of two particles meeting 𝑓, and the efficiency of agglomeration, 𝑒𝑓𝑓, as shown 
in Equation 2.18 through to Equation 2.21 respectively: 
 𝑟𝑎𝑔𝑔(𝑙, 𝑡) = 𝐾(𝑖, 𝑗, 𝑡) 𝑁𝑖(𝑡) 𝑁𝑗(𝑡) Equation 2.18 
   
 𝐾(𝑖, 𝑗, 𝑡) = 𝑓(𝑖, 𝑗, 𝑡) eff(𝑖, 𝑗, 𝑡) Equation 2.19 
   
 𝑓(𝑖, 𝑗, 𝑡) = 𝐶𝑐𝑜𝑙𝑙𝛼(𝑖, 𝑗, 𝑡) (
𝜋
4
) (𝑆𝑖 + 𝑆𝑗)
2
[𝑢(𝑆𝑖)2̅̅ ̅̅ ̅̅ ̅̅ + 𝑢(𝑆𝑗)
2̅̅ ̅̅ ̅̅ ̅̅
]
0.5




 eff(𝑖, 𝑗, 𝑡) =
𝑓𝑎𝑑ℎ(𝑖, 𝑗, 𝑡)
𝑓𝑠𝑒𝑝(𝑖, 𝑗, 𝑡)
− 1              𝑖𝑓 𝑓𝑎𝑑ℎ(𝑖, 𝑗, 𝑡) ≥ 𝑓𝑠𝑒𝑝(𝑖, 𝑗, 𝑡)
eff(𝑖, 𝑗, 𝑡) = 0                                                                      𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒  
 Equation 2.21 
   
 The target efficiency, 𝛼(𝑖, 𝑗, 𝑡), accounts for the densities of both agglomerates and fluids, as 
well as the fluid viscosity. Collision velocities are calculated from the relative velocity of particles and 
fluids as a function of energy dissipation. The agglomeration efficiency is the ratio of adhesive forces 
to disruptive forces. The former, 𝐹𝑎𝑑ℎ(𝑖, 𝑗, 𝑡), accounts for deformation energies and collision energies. 
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The deformation energy is related to the strength of agglomerates and is influenced by porosity and 
BSR. The adhesion forces equation is given in Equation 2.22. The collision energies are related to the 
particle size as well as its interfacial energy and binding force. The latter, 𝐹𝑠𝑒𝑝(𝑖, 𝑗, 𝑡), is a function of 
shear stress and dissipation energies. The separation force is given in Equation 2.23. The notation for 
Equation 2.18 to Equation 2.23 is displayed in Table 2.6.  











3) Equation 2.22 
   
 𝐹𝑠𝑒𝑝(𝑖, 𝑗, 𝑡) ∝ 𝜌𝑠𝑢𝑠𝑝[ (𝑆𝑖 + 𝑆𝑗)]
2
3 ⋅ (𝑆𝑖)
2            (𝑆𝑖 < 𝑆𝑗) 
Equation 2.23 
 All the previously discussed models agreed with the experimental data, as shown in Figure 2.32. 
The key difference between these two papers is that the latter ignores breakage and fragmentation 
due to the experimental observations of deformation and compaction during collisions [49,50]. The 
work to date on modelling has used experimental results and observations to improve the models 
which describe the critical mechanisms of the agglomeration process. Different growth regimes in the 
formation of agglomerates were observed and a model developed to combine coalescence and 
breakage to aid the prediction of these [49].  
 Differences in agglomeration with fluid flow regimes and particle sizes allowed the 
development of models with multilayer agglomeration kernels [103]. These models were improved 
upon further through the addition of terms which account for the bridging liquid composition [45]. 
Finally, the most comprehensive model to date has been established, which accounts for both 
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Figure 2.32. The comparison between experimental and modelling results for a) mean diameter and 
porosity, and the number particle size distribution at agglomeration times of b) 200 secs, c) 2880 secs 
and d) 11390 secs. Reproduced from Blandin et al., [50]. 
 
Table 2.6. Nomenclature for Equation 2.18 through to Equation 2.23 [50]. 
Nomenclature Definition Units 
𝑟𝑎𝑔𝑔(𝑙, 𝑡)  Agglomeration rate of rank 𝑙 = 𝑙(𝑖, 𝑗) at time 𝑡 nb m-3 s-1 
𝐾(𝑖, 𝑗, 𝑡)  Agglomeration kernel, function of time and particles 𝑖 and 𝑗 - 
𝑁𝑖(𝑡); 𝑁𝑗(𝑡)  Concentration of agglomerating particles, 𝑖 and 𝑗 with time nb m-3 
𝑓(𝑖, 𝑗, 𝑡)  Product of the meeting probability - 
eff(𝑖, 𝑗, 𝑡)  Agglomeration efficiency - 
𝐶𝑐𝑜𝑙𝑙  Kinetic parameter; matched on agglomeration experiments - 
𝛼(𝑖, 𝑗, 𝑡)  Target efficiency of the process - 
𝑆𝑖 ; 𝑆𝑗  Size of agglomerates under consideration m 
𝑢  Collision velocity of particles m s-2 
𝐹𝑎𝑑ℎ(𝑖, 𝑗, 𝑡)  Adhesion force N 
𝐹𝑠𝑒𝑝(𝑖, 𝑗, 𝑡)  Shear-induced disruptive force N 
 𝑑𝑒𝑓𝑚𝑎𝑥 Contact surface radius m 
𝐷𝑝  Primary particle diameter m 
𝒫(𝑡)  Mean porosity of the agglomerates - 
𝐹𝑏𝑟𝑖𝑑𝑔𝑒  Force exerted by a liquid bridge between two elementary particles N 
𝜌𝑠𝑢𝑠𝑝  Density of suspension Kg m-3 
  Specific stirring power W kg-1 
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 Models of Simultaneous Crystallisation and Agglomeration Systems 
 Whilst these studies show the progression of models over time, there is still scope for further 
improvements to accurately predict and control spherical agglomeration processes. There has been a 
tendency for studies to separate the agglomeration process, either investigating crystallisation systems 
which exhibit agglomeration [53], or the agglomeration of particles which have been pre-suspended in 
solution [49]. However, some studies have investigated crystallisation and agglomeration in the same 
process [46,86]. Here, the authors investigated whether the addition of bridging liquid was preferential 
during or after crystallization. They concluded that the bridging liquid itself, and thus, the 
agglomeration step, was much more critical in the formation of dense spherical agglomerates, when 
compared to the anti-solvent crystallization. To increase understanding within these processes, it is 
important to use experimental knowledge surrounding the nucleation, growth and agglomeration 
mechanisms which govern the process. The changes of the primary particles themselves should also 
be considered [106], despite the difficulty in this observation. This is reflected in the challenges of 
identifying when rate processes occur, their duration, and their dependence upon one another.   
 Other modelling work has investigated the use of a coupled PBM framework to evaluate the 
agglomeration of needle-like crystals [106]. This framework features a 2D population balance equation 
to describe the two-dimensional growth of crystals. This method allowed a kernel to be developed 
which accounted for both the lengths of crystals during agglomeration, as well as their specific 
orientation.   
 The authors also identified five key issues which are current barriers to filling the knowledge 
gap in the modelling of spherical agglomeration processes [106]. These are as follows: 
1. ‘Experimental tools that allow for the measurement of both shape and degree of 
agglomeration simultaneously.’  
2. ‘Require a suitable modelling framework that enables description of entire crystallisation 
procedures with a high level of accuracy.’ 
3. ‘Obtain a better grasp of the roles of both fluid dynamics and mixing.’ 
4. ‘The use of adequate models to describe the collision frequency and the agglomeration 
efficiency of non-equant crystals, considering their rotational anisotropy.’ 
5. ‘Instructive ways of analysing experiments and comparing them to models, to inform of us 
of shortcomings and to improve predictions.’  
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 The modelling of the process is challenging but ultimately relies upon a key understanding of 
the mechanisms which drive the process. Without considering all these mechanisms, and in sufficient 
detail, models will fail to accurately predict the agglomeration process.   
 
 Further Applications of Spherical Crystallisation 
 The applications of spherical crystallisation are wide and varied, with the process itself being 
applied in a variety of industries which deal with fine particulate materials. As mentioned in Section 
2.1, this includes the agglomeration of graphite, coal and sand in the bulk chemicals industries [14–16]. 
Further to this, there is the application of the technique for the co-agglomeration of particles and 
excipients prior to tabletting, as well as the continuous operation of the process as a whole. Both 
applications are discussed in more detail in Section 2.6.1 and Section 2.6.2 respectively.  
 
 Co-agglomeration of Crystals and Additives  
The co-agglomeration of particles with suitable additives is a further route to vastly improving 
the efficiency of manufacturing processes for solid dosage formats within the pharmaceuticals 
industry. Co-agglomeration potentially allows the removal of downstream blending and formulation 
unit operations, allowing agglomerates to be directly tabletted and packaged. Additives previously 
investigated in spherical crystallisation include polymers to improve the physicomechanical properties 
of the agglomerates themselves, and disintegrants to improve the in vivo dissolution profile of the 
drug. This is possible due to high polymorph stability of compounds [107,108].  
Carbamazepine-saccharine cocrystals have previously been agglomerated with a variety of 
different bridging liquids [6,83]. The role of sodium starch glycolate on agglomerate properties has 
been investigated [6]. The disintegrant was found to vastly improve the dissolution profile of sodium 
starch glycolate agglomerates compared to the pure agglomerates. The authors did note, however, a 
significant reduction in the recovery yield of the cocrystals. Sodium starch glycolate was insoluble other 
than in the dissolving solvent, which led to sedimentation within the system overall. The influence of 
mannitol, a disintegrant, in the co-agglomeration of bovine serum albumin has also been investigated, 
with the dissolution profile of the drug also significantly improved [20].  
The influence of polymers on spherical agglomerate properties has also been investigated. An 
improved dissolution rate has been found for agglomerates of mefenamic acid which were co-
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agglomerated with hydroxypropyl methyl cellulose (HPMC) [71]. The inclusion of a surfactant in 
tolbutamide spherical agglomerates found similar results, with the dissolution rate improvements 
being attributed to the increased wettability of the agglomerates [80].  
In a separate study, the incorporation of HPMC into aceclofenac agglomerates led to an 
increase in agglomerate size [23]. The authors also noted that increasing concentrations of HPMC led 
to subsequent increases in the agglomerate size. This was attributed to an increased level of particle-
particles interactions during agglomerate formation, which promoted bridging liquid “squeezing out”. 
As a result, more bridging liquid was available for agglomerate growth. Whilst the aceclofenac-HPMC 
agglomerates had a higher porosity compared to agglomerates formed without HPMC, increasing 
concentrations of HPMC were found to decrease their porosity. This could be explained by an increase 
in the layering mechanism of growth and, thus, a subsequent decrease in the degree of consolidation.  
Two studies by Kawashima et al., investigated the influence of the addition of polyethylene 
glycol (PEG) into agglomerates of phenytoin [109,110].  The authors discovered that the co-
agglomeration of phenytoin with PEG led to dramatic improvements in the mechanical strength of 
agglomerates compared to pure agglomerates of phenytoin. Upon further characterisation of 
agglomerate structure, it was noted that the PEG was able to form solid bridges between phenytoin 
crystals, which promoted the observed strength increase. Furthermore, the authors noted the 
significantly smoother surface of agglomerates. In one of these studies, PEG was found to increase the 
rate of dissolution of the agglomerates in water, most likely as a result of the hydrophobic tendency of 
PEG [109]. In the second study, increasing the concentration of PEG during the co-agglomeration 
procedure led to a decrease in the overall mean size of agglomerates [110]. The authors also stipulated 
that the introduction of PEG led to an overall reduction in the cohesive force necessary for particles to 
agglomerate, through a reduction in the interfacial tension and wettability of the bridging liquid.  
As the physicomechanical properties of agglomerates can be altered through the incorporation 
of additives, it is feasible that such properties could be directly tailored through a combination of 
polymer additions, including hydroxypropyl cellulose (HPC). This has been successfully achieved in one 
study, where the sphericity and dissolution profiles of agglomerates could be accurately tailored [79]. 
The authors noted that co-agglomerating etodolac with a specific polymer blend (HPMC-PEG-HPC) 
resulted in a superior product with improved flowability and dissolution.  
 Co-agglomeration could provide a viable option for simplifying the manufacturing process, 
specifically formulation and blending unit operations, required for oral solid dosages prior to tabletting. 
Whilst the product quality of agglomerates can be improved directly in this nature, care must be taken 
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to ensure no adverse effects persist. This includes whether the addition of polymers affects the solvent 
system itself, namely the solubility of components in each other, the overall viscosity of the system, 
and the interfacial tensions of the system components themselves. Ultimately, this can disturb and 
disrupt the overall agglomeration process.  
 
 Continuous Spherical Crystallisation 
As previously discussed, spherical agglomeration can drastically improve the micromeritic 
properties of crystal particles, especially those with a naturally acicular morphology. The enhancement 
in the size and shape of particles is mirrored in their dynamic powder properties, namely their 
flowability and tabletability. As a result, the downstream processing of such particles is significantly 
simplified through the reduction in the required number of unit operations. A stream-lined process 
such as this not only decreases the equipment costs of manufacturing but further benefits in terms of 
energy and time intensity. This in turn increases throughput, which would allow comparably more 
product to be delivered to market in the same period of time.  
Continuous manufacturing processes can further improve product quality and process 
efficiency, all whilst retaining robust and predictable performance [3]. The transition from batch to 
continuous manufacturing processes has already been successful in a variety of different chemical 
engineering sectors: petrochemicals and fine chemicals [111]; pharmaceuticals [112]; foods [113]. The 
benefits of continuous manufacturing have been highlighted in a plethora of peer-reviewed papers. 
These include reductions in the energy and cost requirements as well as a reduction in the quantity of 
waste produced [3]. Whilst regulatory issues have previously been a cause for concern, especially for 
governing and executive bodies, improvements to in-line monitoring using process analytical tools 
(PAT) have allowed the Food & Drug Administration (FDA) to approve continuous manufacturing 
processes [114].   
The earliest recorded work for continuous operation of spherical agglomeration was performed 
in 1982, observing the preparation of sulfamethoxazole wax matrices [84]. A single-stage continuous 
mixed suspension mixed product removal (MSMPR) crystalliser was used to investigate agglomeration 
mechanisms. The authors, along with others, have noted the presence of different mechanisms in the 
size enlargement regime when compared to batch spherical agglomeration [91]. 
In continuous spherical agglomeration, a fast growth period persists prior to a decrease in the 
overall mean size of agglomerates. There is some residual growth in the system before finally, the mean 
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size plateaus at a relatively constant value [91]. In contrast, batch systems usually follow a period of 
zero growth in agglomerate size, succeeded by a fast growth period prior to the mean size plateau 
[49,91]. The initial fast growth period in continuous spherical agglomeration has previously been 
attributed to a reduced slurry density and poor bridging liquid dispersion. Both factors occur due to 
the MSMPR not reaching continuous steady state prior to the addition of crystalline particles. As both 
the bridging liquid droplets and crystalline particles are not evenly distributed throughout the MSMPR, 
flocculation tends to dominate rather than agglomeration. As these flocs compact, larger than normal 
agglomerates are produced. As the MSMPR reaches continuous steady state, the slurry density 
increases, and the dispersion of bridging liquid and crystalline particles becomes almost uniform. As a 
result, agglomerate nuclei form more evenly throughout the reactor and are more uniform in size but 
critically, smaller than the agglomerates produced prior to continuous steady state (size reduction 
period). It is worth noting however, that between both batch and continuous processes, the same 
overall trends can be drawn between the final physicochemical properties of agglomerates as a 
function of operating conditions. The role of operational conditions is discussed in more detail in 
Section 2.5. 
The work by Kawashima et al., and Bos & Zuiderweg was extended by using a two-stage 
continuous MSMPR [32]. The use of a two-stage system allowed the authors to isolate the 
crystallisation and agglomeration phenomena, permitting a more in-depth study of the mechanisms of 
each: first stage for crystal nucleation and subsequent growth of individual crystals and the second 
stage for crystal agglomeration. In the first stage, the crystals are dissolved in a solvent and then 
precipitated with an anti-solvent. The crystal population could be controlled through the solvent to 
anti-solvent ratio (SASR), the amount of shear applied to particles and their residence time within the 
crystalliser. In the second stage, the solution of crystals is infused along with the bridging liquid, 
promoting the agglomeration of crystals. As before, the shear rates and residence time could be 
accurately controlled, as well as the bridging liquid to solid ratio (BSR). Because the operational 
parameters of both stages can be controlled independently, it is possible to directly tailor both the 
crystallisation and agglomeration stages to produce spherical agglomerates with the desired final 
properties.   
The authors went on to extend their work further through the use of an oscillatory baffled 
crystalliser (OBC) [115]. This plug-flow configuration crystalliser has many benefits over a traditional 
crystalliser. For instance, both the primary particle and agglomeration size distributions can be 
accurately controlled through the process parameters. Due to the nature of the reactor, the 
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temperature profile through the crystalliser could be controlled accurately, as well as the as solvent 
streams, crystal solution and bridging liquid solution. As a result, the crystallisation and agglomeration 
mechanisms can be separated and studied independently despite the process occurring in a single-
stage. The authors noted the high level of autonomy of the system and improved consistency over their 
prior work. Their work highlighted how continuous spherical agglomeration can produce spherical 
agglomerates with the desired properties through fine control of the system process.  
Other studies have investigated the influence of continuous operation of emulsion solvent 
diffusion (ESD) [116]. In their study, a single-stage continuous MSMPR crystalliser was used. Whilst ESD 
does differ from spherical agglomeration, the authors did find trends in the operating parameters and 
final agglomerate properties. These trends align with those for batch systems, which are discussed in 
more detail in Section 2.5. The authors also made use of a reservoir in the experimental set-up, which 
allowed solvent to be recycled back into the reactor. Subsequently, crystalline particles have more 
bridging liquid available for the formation of agglomerate nuclei, leading to an improved yield overall. 
This system could be incorporated into spherical agglomeration systems which utilise a single-stage 
continuous MSMPR crystallisers. It is worth noting however, that continuous MSMPRs only operate at 
a single point in the ternary phase diagram which reduces the overall yield of agglomerates.  
 
 Critical Summary 
 The available literature surrounding spherical crystallisation, generally, is wide and varied. 
Many studies have concentrated on spherical agglomeration, specifically investigating the process 
using drug compounds such as salicylic acid, an active metabolite of aspirin. Most of these studies have 
offered major insights into the influence of process parameters on the agglomeration process itself, 
and the agglomerates produced. This has included the influence of temperature, agitation speed and 
solid loading, amongst others. These studies have been successful and provide general relationships 
between process parameters and the critical quality attributes of drug molecules, including size, 
porosity, and mechanical strength. Some of these studies are summarised in Table 2.7. 
 Additionally, the spherical agglomeration modelling is currently under-developed. There are a 
limited amount of studies which directly address modelling the entirety of the process. Also, there is a 
lack of studies which attempt to clearly define the rate processes which govern spherical 
agglomeration. Whilst some models have been developed for the process, and their performance has 
been verified experimentally for the model system used, it remains to be seen whether these models 
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can be applied universally. Finally, a full model which incorporates all rate processes is not currently 
available. This is primarily due to studies focussing on different elements of spherical agglomeration, 
with some models failing to account for other influential rate processes as discussed.  
 The vast majority of the literature covers spherical agglomeration in batch operation only. For 
the continuous operation of oral solid dosages to be successful, from initial molecule synthesis through 
to the end-stage packaging, all processes must be fully modelled in a way which offers predictable 
performance. This performance must persist, regardless of the operational parameters, or indeed the 
drug molecule itself. The development of such models would vastly improve both the macro-scale 
production of final formulations, as well as the micro-scale production of new research and 
development molecules.  
 From the presented literature, a key gap in the currently available knowledge has been 
identified. The relationships identified between process parameters and product properties should be 
underpinned directly by relevant rate parameters, which should also be validated experimentally. 
Here, the analogies between spherical agglomeration and wet granulation have been qualitatively 
recognised within the literature. 
 However, the quantitative approaches for wet granulation, including key dimensionless groups 
and regime maps for engineering design, have not been applied to spherical agglomeration. 
Additionally, there are a lack of mechanistic studies which investigate the role of the bridging liquid-
solid ratio on the rate processes of spherical agglomeration, despite its recognition as a key process 
parameter. This makes current prediction difficult, with the impact of miscibility between the binder 
and solvent not being fully recognised. Here, approaches from wet granulation can be used, but the 
impact of bridging liquid miscibility, which is not an issue in wet granulation, must be included. Hence, 
a new definition is required to evaluate the effect of bridging liquid miscibility on overall agglomerate 
properties. Such parameters are key to the success of developing robust models which can address the 
industrial challenges discussed. As such, there is the potential to rapidly intensify the production of 
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Good solvent with crystal of interest added to poor solvent-bridging liquid 
mixture found to produce more compact and spherical agglomerates [38] 
Rate of bridging liquid infusion produces unclear effects [42,84] 
Simultaneous precipitation and agglomeration produces more agglomerates, 
improved flowability and compressibility [88,92] 
Bridging Liquid 
High wettability leads to large, dense spherical agglomerates [21] 
High vapor pressure of bridging liquid drives supersaturation [83] 
Original BSR 
Value 
Must be in the critical range for successful agglomeration, with increases in 
this range producing larger agglomerates [45,86] 
Too low – little, if any, agglomeration [21,46] 
Too high – paste product forms with poor flowability [21,46] 
Temperature 
Initial increases in temperature decrease agglomerate size. Further increases 
lead to larger agglomerates being formed [38] 
Bulk density and sphericity found to decrease with increases [6] 
Constituent crystal size increases [38] 
Agitation Speed 
Low speed increases promotes increases in agglomerate size [97] 
High speeds decreases the agglomerate size [6,23,45]  
Agglomerate size distribution was also found to broaden at higher speeds [99]  
Increases can reduce level of bridging liquid required [92] 
Porosity increases with speed, whilst strength, sphericity and flowability 
decrease [23,45] 
Residence Time 
Increased agglomerate size with residence time [101] 
Sphericity and strength increase also [45,86] 
Porosity decreases / agglomerate density increases [45,47] 
 
 Research Objectives 
 This thesis aims to develop and further the mechanistic understanding of spherical 
agglomeration processes in order to aid in the development of robust and predictive models. This 
research will specifically identify and investigate parameters which influence wetting and nucleation 
rate processes as ultimately these dictate the subsequent rate processes and the overall unit 
operation. Here, a combination of theoretical, simulation and experimental elements are combined. 
Within the literature, no studies account for the role of solvent miscibility, especially that of the 
bridging liquid. Furthermore, it is not clear whether studies have focussed on the operation within the 
immiscible region of ternary solvent systems, where process control is much greater. The main 
objectives of this thesis are to: 
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1. Identify and quantify the influence of bridging liquid miscibility on the binder liquid volume 
available in spherical agglomeration processes, including the effects of different bridging liquids, 
solid loading levels and bulk solution compositions. 
2. Experimentally validate this theory, with the aim of standardising bridging liquid volume 
reporting within future literature.  
3. Investigate the immersion nucleation mechanism and associated kinetics using a model 
compound, comparing the results with mathematical models previously developed.  
 MATERIALS & 
METHODS 
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 Introduction 
 This chapter outlines the materials and methodologies used within this research. Figure 3.1 
displays a workflow of the described methodologies undertaken. First, titration experiments and Aspen 
simulations used for ternary phase diagram construction are described. An analysis was performed in 
which further examination of the bridging liquid-solid ratio, allowed the true bridging liquid-solid ratio 
to be defined. The results are presented within Chapter 4. The experimental validation of the definition 
is then described, including agglomeration and characterisation methodologies. These results are 
presented within Chapter 5. Finally, the methods are described for a study into the agglomeration 
kinetics of paracetamol, with results presented within Chapter 6.   
Figure 3.1. An overview of the methodologies conducted within this research and their order within 




The following solvents were purchased from Sigma-Aldrich (UK) for use as a bridging liquid: 
chloroform (99+ %), heptane (99 %), toluene (99.8 %). The following solvents were purchased from 
Acros Organics (UK) for use as a bridging liquid: 4-methylpentan-2-one (MIBK, 99 %), butyl-acetate (99+ 
%). Acetone (≥ 99.8 %) was used as a solvent and purchased from Sigma-Aldrich. Distilled water was 
used in all experimental work. The properties of these solvents are given in Table 3.1. Salicylic acid was 
purchased from Sigma-Aldrich. Paracetamol was kindly prepared and provided by Dr N Rajoub of the 
University of Strathclyde. Table 3.2 provides common properties of these solids.   
Table 3.1. Standard properties of solvents used at 1 atmosphere and 25 oC [76].     
Chemical Species Molecular Formula 
Molecular Weight Density 
(g mol-1) (g cm-3) 
Acetone C3H6O 58.079 0.7845 
Chloroform CHCl3 119.378 1.4788 
Heptane C7H16 100.202 0.6795 
MIBK C6H12O 100.158 0.7965 
n-Butyl acetate C6H12O2 116.158 0.8825a 
Toluene C7H8 92.139 0.8668a 
Water H2O 18.015 0.9970 
a Values at 20 oC 
Table 3.2. Standard properties of solids used at 1 atmosphere and 20 oC [76].     
Chemical Species Molecular Formula 
Molecular Weight Density 
(g mol-1) (g cm-3) 
Paracetamol C8H9NO2 151.163 1.2930 
Salicylic Acid C7H6O3 138.121 1.4430 
For the determination of ternary phase diagrams, the following solvents were used: 
water/acetone mixtures as a bulk solution; and chloroform, heptane, MIBK, n-butyl acetate or toluene 
as a bridging liquid. In addition, bridging liquid/acetone mixtures were used as a bulk solution, with 
water as a third solvent. For the TBSR validation, water/acetone mixtures were used as a bulk solution. 
Chloroform, MIBK or n-butyl acetate were used as bridging liquids. Salicylic acid was used as the solid. 
For the kinetic study, water was used as a bridging liquid, heptane was used as the suspending liquid 
and paracetamol is used as a solid.  
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 Characterisation of Materials 
 Salicylic Acid Size Distributions 
 Salicylic acid particles were sieved at an amplitude of 2.25 mm for 10 minutes on a 45 µm sieve 
and pan to encourage breakage (Retsch AS200 Sieve Shaker). The sample within the pan was retained 
and used in subsequent experiments. These samples are referred to as prepared from hereon in, with 
commercial samples referring to off the shelf product as purchased. The particle size distribution of 
samples was measured with a Malvern MasterSizer 3000 (Malvern Instruments Ltd, Malvern, UK). The 
dry cell was attached and used to feed samples through the instrument. Particles pass through an 
emitted laser beam, and the beam is scattered, allowing particles between of 0.01 μm and 3500 μm to 
be measured. During measurements, both the air pressure and feed rate were adjusted as necessary 
to ensure an obscuration percentage of 1-6 %. This is the recommended region for obtaining reliable 
measurements. The sample was fed until fifteen separate measurements were obtained. Figure 3.2 
shows the averaged results for commercial and prepared salicylic acid.  
Figure 3.2. The particle size distributions of commercial salicylic acid and prepared, sub 45 µm salicylic 
acid particles.   



























 Static Contact Angles of Bridging Liquid-Solid 
 The static contact angles of a bridging liquid on the solid were measured using a goniometer 
(FTÅ200, First Ten Ångstrom, Sweden). Here, the sessile-drop method was used to determine the 
contact angle of the liquid at the solid-liquid interface in air. The set-up is shown in Figure 3.3. A custom 
die produced in-house was used to form tablets of the required solid. The die had an internal diameter 
of 2 cm (see Figure 3.4). The die was partially filled with the solid before pressure being applied by 
hand for one minute. The tablet was recovered and mounted on a slide for further analysis.  
Figure 3.3. The experimental set-up of the goniometer system used for contact angle measurements.  
Figure 3.4. The die and press used to form tablets for contact angle analysis.  
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 A syringe with needle tip was positioned directly above the tablet. A droplet of the required 
solution was allowed to form at the needle tip and dropped directly onto the powder bed. The 
experiment was recorded using an integrated camera. The video was analysed in FTÅ-32 software (First 
Ten Ångstrom, Sweden). A minimum of five droplets were observed for each system. The results are 
displayed in Figure 3.5 through to Figure 3.8. Here, frames are taken one thirtieth of a second apart, 
the maximum frame rate possible (30 fps). The contact angle was measured as 0, or perfectly wetting, 
for chloroform and n-butyl acetate. MIBK had a contact angle of approximately 33o after 0.033 of a 
second. It should be noted that the following frame (0.067 secs) showed a contact angle of 0o, 
indicating perfect wetting, albeit on a slower scale. This is shown in Figure 3.6. 
Figure 3.5. The contact angle measurements of chloroform on a salicylic acid tablet, with a) chloroform 
droplet prior to measurement and b) the next frame showing perfect wetting. 
 
Figure 3.6. The contact angle measurements of MIBK on a salicylic acid tablet, with a) MIBK droplet 
prior to measurement, b) the next frame with a contact angle of 33 degrees and c) the subsequent 
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Figure 3.7. The contact angle measurements of n-butyl acetate on a salicylic acid tablet, with a) n-butyl 
acetate droplet prior to measurement and b) the next frame showing perfect wetting. 
 
 Contact angles measurements were performed using two different liquids on a hand-pressed 
tablet of paracetamol. This tablet was formed using the method as described previously. The 
measurements were performed as per the method described previously. The results are displayed in 
Figure 3.8.  
Figure 3.8. Contact angle of water, approximately 42o, on a micronised paracetamol tablet.   
 
 Hypothesis of the True Bridging Liquid-Solid Ratio 
 As the crystals of interest are preferentially wet by the bridging liquid, only the bridging liquid 
rich phase is available to agglomerate the crystals of interest. Thus, the volume of this bridging liquid-
rich phase should be accurately quantified and reported. 
 As shown in Figure 3.10, the anti-solvent is denoted X, the solvent Y and the bridging liquid Z. X 
and Y are fully miscible, whilst Z is selected for its immiscibility with the X-Y mixture. If we plot the X-Y-
Z ternary phase diagram, a significant two-phase region exists. Here, a solvent rich continuous phase 
a) b) 
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and a bridging liquid rich discrete phase form. The definition of the bridging liquid-solid ratio is given 
as: 
 








 Equation 3.1  
 where the mass of solid within the system is 𝑀𝑆, and the mass of three liquid components in 
the system, on a solids free basis, is 𝑀𝑋, 𝑀𝑌 and 𝑀𝑍 respectively. The true density of the bridging liquid 
and solid are represented as 𝜌𝑍 and 𝜌𝑆 respectively. Provided that the masses of each liquid component 
given, the ternary phase diagram can be used to identify the system conditions. If the system lies within 
the immiscible two-phase region, the tie-lines can be interpolated to give the composition of the 
discrete phase and the continuous phase. These can be given as 𝑥𝑋 , 𝑥𝑌, 𝑥𝑍 and 𝑦𝑋 , 𝑦𝑌, 𝑦𝑍 respectively. 
A mass balance on any of the three liquid components allows the mass fraction of the bridging liquid-
rich phase to be calculated: 
 𝑀𝑍 = 𝑥𝑍𝑀𝐷 + 𝑦𝑍(𝑀𝑇 −𝑀𝐷) Equation 3.2  
 where 𝑀𝐷 represents the mass fraction of the dispersed or bridging liquid-rich phase. 𝑀𝑇  
represents the total system mass: 
 𝑀𝑇 = 𝑀𝑋 +𝑀𝑌 +𝑀𝑍 Equation 3.3  
 The well-known inverse lever rule can be obtained if we rearrange Equation 3.2, where 𝑀𝐷 is 
the true amount of the bridging liquid rich phase available to agglomerate the solid (see Equation 





 Equation 3.4  










 Equation 3.5  
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Here, 𝑀𝑍 describes the amount of bridging liquid which is lost to the continuous phase, 𝑀𝐶. This 
relationship is primarily influenced by the interfacial tension, which is in turn, governed by a variety of 
thermodynamic properties.  
 𝑀𝐷 = 𝑀𝑍 −𝑀𝐶  Equation 3.6  
 







Equation 3.7  
 
Figure 3.9. An example of a ternary phase diagram where X is the anti-solvent, Y is the solvent and Z 
is the bridging liquid. The cross represents a system of interest, and the circles the immiscible phase 
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 Determination of Ternary Phase Diagrams 
  This section details both experimental and simulation approaches for the determination of the 
ternary phase diagrams. The results are presented and discussed within Chapter 4. The interfacial 
tensions values of different bridging liquids in water are listed in Table 3.3. These values provide an 
indication of bridging liquid miscibility, that is, the degree of bridging liquid available to agglomerate 
the particles of interest. 
Table 3.3. A review of experimental data for the interfacial tension (dyne cm-1) of bridging liquids in 
water. 






Water at 25 oC  
(dyne cm-1) 
30.8 50.1 10.4 - 35.4 [117] 
31.6 50.2 - 14.5 36.1 [118] 
32.8a 50.2 10.1 14.5 36.1 [119] 
31.6 50.2 10.1 14.5 36.1 [120] 
31.1 50.1 - - 35.8 [121] 
- - -  15.0b 35.8b [122] 
a Values at 20 oC; b Values at 17 oC.  
 Experimental Approach & Methodology 
 The following methodologies describe the titrations used to obtain the binodal curve for ternary 
phase diagrams. All experiments were conducted within a fume cupboard at 19.5 oC (± 0.5 oC). The 
bridging liquids used were those identified in Table 3.3. A solution of one of these bridging liquids and 
acetone was prepared in varying compositions as identified in Table 3.4. The solutions were made to a 
mass of 20 g in a 50 ml conical flask.   
 Whilst under vigorous agitation by hand, distilled water was added to the solution dropwise 
from a burette. Upon the formation of a two-phase solution, the boundary between miscible and 
immiscible regions is reached. The change is identified visually by a cloudy solution being formed or 
droplets within the solution forming after agitation is stopped. The mass of water added to reach this 
state was noted. Two further repeats were also performed. The nineteen conditions specified in Table 
3.4 produced fifty-seven data points of the first half of the binodal curve.   
 The second half of the binodal curve was determined using solutions of water and acetone in 
varying compositions (see Table 3.5). These solutions were also made to a mass of 20 g in 50 ml conical 
flasks. The bridging liquid required was titrated dropwise from a burette, recording the mass added at 
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the onset of two immiscible phases being formed, as per the method described above. Across nine 
conditions, triplicates produced a further eighteen data points for the binodal curve. Each triplicate 
data point was considered individually, and no averages were taken.  
 
Table 3.4. Water titrations into various bridging liquid-acetone solutions for experimental 
determination of the binodal curves. 
Initial Solution Composition (% w/w) 





















Table 3.5. Bridging liquid titrations into various water-acetone solutions for experimental 
determination of the binodal curves. 









 The mass of each solvent was known at the end point of each titration, which allowed the final 
composition (% w/w) of the solution to be calculated. For each bridging liquid, the ternary phase 
diagram is plotted using Origin Pro.  
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 Simulation Approach & Methodology 
 The following section describes the methodology to obtain ternary phase diagrams in Aspen 
software. Tie-lines are lines of equilibrium within the immiscible region of a ternary phase diagram. 
Provided that the system composition is known, the relative composition of each immiscible phase can 
be calculated from the tie-lines. The system location along this line also provides the relative mass of 
each immiscible phase. As such, the full masses of all three components, in both immiscible phases, 
can be calculated from the tie-lines.   
 To evaluate the tie-lines of each ternary phase diagram, Aspen Plus was used (v8.4, Aspen 
Technologies). Here, several thermodynamic models commonly used in liquid-liquid extraction models 
were used, which incorporate activity coefficients, and the results compared [123]: the Universal 
Quasi-Chemical, or UNIQUAC, model; the Universal Quasi-Chemical Functional-group Activity 
Coefficient (UNIFAC) model; the Universal Functional-group Liquid-Liquid (UNIF-LL) model; and the 
Universal Quasi-Chemical Redlich-Kwong (UNIQ-RK) model. The conditions of the experimental 
titrations were replicated within Aspen, i.e. 19.5 oC and 1.01325 bar. The maximum number of tie-lines 
was obtained each time(twenty-five). The maximum number of iterations was set to five thousand, 
with a mole fraction error tolerance of 1 x 10-5. The data for binodal curves and tie-line values produced 
in the previous section were analysed in Origin Pro. Using the molecular weights identified in Table 3.1, 
the mole fractions were converted to masses, and then mass fractions (see Appendix A for details). 
These values were then plotted. 
 
 TBSR Validation Methodologies 
 This section describes the methodologies for validating the TBSR definition. The results 
obtained from these procedures are detailed in Chapter 5. Here, a 1 L agglomerator and Rushton 
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Table 3.6. Geometry of reactor and impeller used within validation experiments. 
Geometry Distance (mm) 
Agglomerator inner diameter 90 
Agglomerator outer diameter 100 
Impeller shaft diameter 8 
Impeller diameter 30 
Impeller blade height 6 
Impeller blade width 7.5 
Impeller height from agglomerator floor 30 
 
 Agglomeration Methodology 
 For the agglomeration experiments, salicylic acid saturated mother solutions were prepared at 
the following solvent compositions: 95 % w/w water, 5 % w/w acetone, 90 % w/w water, 10 % w/w 
acetone; 85 % w/w water, 15 % w/w acetone..   
 12 g of the sieved salicylic acid was suspended in the saturated mother solution (388 g). This 
corresponds to a 3 % w/w loading, not accounting for the mass of bridging liquid to be added. The 
system was agitated for one minute at 750 rpm to disperse the solid within the saturated solution in a 
1 L agglomerator, as shown in Figure 3.10. The bridging liquid was then manually added from a 
measuring cylinder through a funnel in the top of the reactor, corresponding to an infusion time of 
approximately one second. The funnel was replaced with parafilm to ensure the system remained 
closed and evaporation was limited. 
Figure 3.10. Agglomerator set-up.  
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 Characterisation of Agglomerates 
 To analyse the percentage of crystals agglomerated, the agglomeration suspensions were 
filtered after 45 minutes, using glass microfibre filter papers with a pore size of 1.2 μm. Agglomerates 
were washed with distilled water. The retentate was allowed to dry overnight at room temperature. 
The sample was then sieved using a variety of different sieve meshes on the sieve shaker at an 
amplitude of 0.40 mm for 30 seconds. The smallest mesh used was 300 μm and the largest mesh used 
was 8 mm. The agglomerate mass retained in each sieve was noted and a particle size distribution 
determined for each experiment. Particles which passed through all sieve meshes were recovered from 
the pan (< 300 μm) and were considered un-agglomerated. These results were used as the basis for a 
comparison between different agglomeration systems in validation of the TBSR definition. 
  
 Kinetic Study of Spherical Agglomeration Processes 
 Experimental Methodology 
 All experiments were conducted at 21 oC (± 0.5 oC). There are several common elements across 
both residence time and TBSR studies undertaken in this work. These are described here, with 
differences highlighted in the following subsections. Here, a 150 ml agglomerator and three blade-
pitched impeller are used for spherical agglomeration, the geometries of which are displayed in Table 
3.7. 
Table 3.7. Geometry of reactor and impeller used within kinetic experiments. 
Geometry Distance (mm) 
Agglomerator inner diameter 55 
Agglomerator outer diameter 60 
Impeller shaft diameter 65 
Impeller diameter 35 
Impeller height from agglomerator floor 20 
 
 All systems were agitated at a speed of 500 rpm unless otherwise stated. 47.5 g of heptane was 
used to suspend 2.5 g of paracetamol, which corresponded to a solid loading of 5 % w/w, unless 
otherwise stated. Distilled water saturated with paracetamol was used as a bridging liquid in all 
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experiments. It should be noted that heptane and water are completely immiscible; here, the BSR is 
equal to the TBSR.  
 Imaging Methods 
 Samples were imaged using a Navitar 12 x zoom lens (Image Optics, UK) equipped with a dome 
diffuser LED light (Model LGT.19.MF2d, Haishu Honyu Opto-Electro Co., Ltd, Ningbo, PR China). A 
Luminera Infinity 3 camera and Infinity Analyse software was used to capture the images. This is 
displayed in Figure 3.11. Scale bars were added manually using images of a calibration slide at different 
zoom levels. Size measurements were performed by importing the images to Pixelink µScope software. 
Within the software, the software was calibrated to ensure measurements performed corresponded 
to the actual scale of the picture. No further image alteration was performed. 
 
Figure 3.11. The experimental set-up of the Luminera Infinity 3 camera with 12 x zoom lens and LED 
light dome diffuser. 
 
 Process Parameters Study 
 A variety of TBSR values were investigated in the range of 0.2-8. The bridging liquid was added 
from a volumetric pipette into a port in the reactor lid. This corresponds to a bridging liquid addition 
time of approximately 1 second. In some experiments, the bridging liquid was dyed with Acid red IV 
(Sigma Aldrich, UK). This allowed identification of the bridging liquid. Samples were recovered every 
five minutes using a Pasteur pipette. These samples were imaged both before and after drying, as per 
the method discussed in Section 3.6.2. All experiments were repeated using a solid loading of 1 % w/w, 
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and a solid loading of 9 % w/w. Effect of shear rate experiments were performed at a TBSR of 0.75 and 
a solid loading of 5 % w/w. The shear rate was adjusted using impeller speeds of 300 rpm, 500 rpm and 
700 rpm.   
 
 Agglomerate Formation Kinetics 
 The required bridging liquid volume was dispensed from a volumetric pipette through a port 
opening in the reactor lid. The TBSR of 0.75 was used at a 5 % solid loading and shear rate of 500 rpm. 
A second set of experiments used bridging liquid samples dyed with Acid Red IV (Sigma Aldrich) to 
allow visualisation and identification of bridging liquid as a function of time. The solution was sampled 
using a Pasteur pipette to recover agglomerates in solution at various time intervals.  
 
 Percentage Agglomeration 
 Individual experiments were performed for each time point investigated: 10 mins through to 
120 mins in 10-minute intervals. The TBSR of 0.75 was used at a 5 % solid loading and shear rate of 500 
rpm. Once the desired residence time was reached, the experiment was stopped. The solution was 
poured through a 212 µm sieve (Retsch) positioned directly above a Buchner flask with a 0.7 µm pore 
sized filter paper. Heptane was used to wash agglomerates. Agglomerates retained on the sieve were 
dried overnight and weighed. Material retained on the filter paper was also dried overnight and 
weighed to calculate the percentage agglomerated. Triplicates were performed for each time point. 
  
 
 Agglomerate Size & Sphericity 
 Individual experiments were performed for each time point investigated. The TBSR of 0.75 was 
used at a 5 % solid loading and shear rate of 500 rpm. At the desired residence time, the experiment 
was stopped. A sample of the suspension was isolated in a small petri dish. Imaging of the samples 
used the method described in Section 3.6.2. Size measurements were performed by importing the 
images to Pixelink µScope software. The number of agglomerates measured was typically in the range 
of 500 – 750 individual agglomerates per time interval. The experiments were repeated. The aspect 
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ratio of agglomerates was used as an indication of their sphericity. This required measurement of the 
shortest physical dimension and dividing this by the longest physical dimension. This was also 
performed in Pixelink µScope software.  
 
 Agglomerate Density 
 At the required time, a sample of the suspension was removed and placed on a microscope 
slide. Images were immediately taken, as per Section 3.6.2. The samples were dried overnight at room 
temperature. Individual agglomerates were weighed using a microbalance (Mettler Toledo, UMT2). 
Agglomerates were transferred using a small probe or tweezers. Here, only the most spherical 
agglomerates are used to limit error in the volume calculation. The diameter is measured in both the x 
and y dimensions. In the instance a small difference between the values was found, an average of the 
two was taken. This allowed a volume to be estimated and the density calculated, assuming the third 
dimension to be the same value. A minimum of ten agglomerates were measured for each time 
interval. The mean density was then calculated. Triplicates of the experiments were performed.  
 THE TRUE 
BRIDGING LIQUID TO 














 The literature review presented within Chapter 2 provided an overview of the current state of 
the art, with respect to the influence of process parameters and mechanistic understanding of 
spherical agglomeration. Crucially, the bridging liquid-solid ratio (BSR) was found to be one of the most 
critical process parameter (Section 2.4.2) [35,47,83,84,99]. This parameter can be used to control the 
overall agglomerate properties, including size, porosity etc.  The parameter is defined as a 





 Equation 4.1  
where 𝑉𝑧 is the volume of binder liquid added and 𝑉𝑠 is the volume of the solid (crystalline) 
phase in the system. There is consensus in the literature that a critical range of the BSR prevails for all 
agglomeration systems [21,45]. Within Section 2.4.2, the influence of solvent miscibility, including that 
of the bridging liquid, was mentioned and how this is not accounted for within the current literature. 
To address this, the following objectives were developed:  
 
➢ Identify the degree of miscibility within ternary solvent systems, using reproducible and 
robust methods. 
 
➢ Analyse results to account for the full bridging liquid volume added, across both immiscible 
phases.  
 
➢ Highlight the need for a new definition, using a variety of different exemplar systems.  
 
Here, a new definition is developed and discussed: the true bridging liquid-solid ratio (TBSR). 
This definition aims to standardise bridging liquid volume reporting by accounting for solvent miscibility 
of ternary solvent systems. This chapter will highlight the need for the definition by looking at several 
different agglomeration systems.  
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 Agglomeration Systems 
 To evaluate the equations presented, several agglomeration systems were identified. The 
agglomeration systems were based upon the literature presented within Chapter 2. These components 
are commonly used within the context of spherical agglomeration: acetone as the solvent; water as an 
anti-solvent; a partially immiscible bridging liquid. Solid loadings of 1 % w/w, 3 % w/w and 5 % w/w 
were used, as these were found to be common within the literature. These systems were based upon 
the ternary phase diagrams determined through titration and computational methods (see Section 
3.3). Common properties of the solvents used within this section are listed below.  
Table 4.1. Standard properties of solvents used at 1 atmosphere and 25 oC [76]. 
Chemical Species 
Molecular Molecular Weight Density 
Formula (g mol-1) (g cm-3) 
Acetone C3H6O 58.079 0.7845 
Chloroform CHCl3 119.378 1.4788 
Heptane C7H16 100.202 0.6795 
MIBK C6H12O 100.158 0.7965 
n-Butyl acetate C6H12O2 116.158 0.8825a 
Toluene C7H8 92.139 0.8668a 
Water H2O 18.015 0.9970 
a Values at 20 oC. 
 Development of Theoretical Systems 
 For the theoretical systems, a solution of water-acetone was first considered. The first 
composition contained 5 % w/w water and 95 % w/w acetone. A second solution, containing 10 % w/w 
water and 90 % w/w acetone was also investigated. A 5 % w/w increment was used for each 
subsequent composition, the final of which was 95 % w/w water, 5 % w/w acetone. This formed a total 
of nineteen individual, bulk mother solution compositions. Here, an assumption of a 20 g solution was 
made. From this, the mass of both water and acetone components could be calculated, as well as the 
volume, according to the density values given in Table 4.1. It was assumed that salicylic acid particles 
are completely insoluble in all solvents and, thus, were completely available to be agglomerated.  
 The first agglomeration system had an addition of 0.02 ml of the bridging liquid across all bulk 
solutions and bridging liquid variations. The volume and mass fractions of each component, post-
addition, were then calculated. As the volume of bridging liquid is constant, and the solid loading 
remains the same, the BSR is equal across all systems. In this addition, the BSR is approximately 0.05. 
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A second system was then considered, with the bulk solution composition kept constant. The second 
system included a bridging liquid addition of 0.04 ml of the required bridging liquid. This corresponding 
to a BSR of approximately 0.1. The increment of bridging liquid was 0.02 ml for each subsequent 
system, up to a maximum of a 1 ml addition, corresponding to fifty different theoretical agglomeration 
systems. This process was repeated, across all bulk solutions, to form nine-hundred and fifty theoretical 
system across each bridging liquid. The BSRs are equal, regardless of the initial composition or bridging 
liquid used.    
 
 Verification of Acceptable Error 
 One key parameter to check was whether the system of interest developed in this section was, 
in fact, within the immiscible region, as identified previously. To do so, the co-ordinates of the binodal 
curve from Aspen were used first. The co-ordinates closest to the system of interest were identified. 
First, the acetone mass fraction (y-value) was considered. The value of the theoretical system must be 
lower than that of the closest co-ordinate identified. This indicates that the system lies below the 
closest binodal curve co-ordinate. As this does not necessarily indicate that the system is within the 
immiscible region, the water mass fraction (x-value) was also considered. As all the theoretical systems 
lie along the y-component axis initially, and move towards the origin, the x-value must be lower than 
the closest curve co-ordinates, indicating the system lies to the left of the closest co-ordinate. Both 
these conditions must be satisfied for the theoretical system to be considered as within the immiscible 
region. Data within the miscible region was identified and discarded. The accuracy of the calculations 
involving tie-lines were also evaluated.  
 As the relative compositions of each individual immiscible phase were calculated, along with 
the masses of each individual component, further checks could be performed. The total mass of the 
theoretical systems devised in Section 4.3.1 was used here. The calculated values for each individual 
component in each individual phase were summed and compared. The respective densities of each 
individual component, as identified in Table 4.1 are used to calculate the volumes here. The volumes 
can be summed individually, under the assumption that each immiscible phase is an ideal solution 
when considered as a single entity.  
 A maximum allowable error of ± 5 % was implemented, i.e. the volume of each component 
from both phases must be within 5 % of the original theoretical system volumes. As the TBSR relies 
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solely on the bridging liquid rich phase and, indeed, the volume of bridging liquid initially added, a final 
check was performed. The total error in the volume of the bridging liquid was also not permitted to 
exceed ± 5 %. This ensured that TBSR calculations were accurate and based upon the volumes originally 
added in theoretical systems. An example of the calculations utilised in Section 4.2.1 is presented 
within Appendix A.  
 
 Results & Discussion 
 Ternary Phase Diagrams: Experimental Results 
 Chapter 3, Section 3.3.1 provides the methodology for experimental titrations. The 
experimental titration results are shown in Figure 4.1 for water-acetone-bridging liquid systems. The 
onset of turbidity during each titration was easily observed, and this is reflected in the high level of 
reproducibility across all the bridging liquids. The general shape of all systems, regardless of the 
bridging liquid used, follows a smooth, bell-shaped curve with shallow sides. The height of the curve, 
as expected, is dictated by the degree of the miscibility of the three solvents, which can be inferred by 
their interfacial tensions in water (see Table 4.2). Essentially, less miscible bridging liquids can be 
identified by a higher peak in the curve, or a greater immiscible region (see Figure 4.2). For the 
components investigated as bridging liquids, the results were found to also follow the trend of the 
interfacial tension in water, i.e. higher interfacial tensions produce higher curve peaks, and thus, higher 
degrees of immiscibility. Heptane displays the highest peak, followed by toluene, chloroform, butyl-
acetate, and MIBK, which follows the highest interfacial tension through to the lowest.  
Table 4.2. Experimental data for the interfacial tension (dyne cm-1) of bridging liquids in water. 






Water at 25 oC  
(dyne cm-1) 
50.1 35.4 30.8 - 10.4 [117] 
50.2 36.1 31.6 14.5 - [118] 
50.2 36.1 32.8a 14.5 10.1 [119] 
50.2 36.1 31.6 14.5 10.1 [120] 
50.1 35.8 31.1 - - [121] 
-  35.8b -  15.0b - [122] 
a Values at 20 oC; b Values at 17 oC.  
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Figure 4.1 Ternary phase diagrams (% w/w) for water-acetone-bridging liquid systems. Red crosses 
represent experimental data points; a) heptane; b) toluene; c) chloroform; d) n-butyl acetate; e) 
MIBK. 
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 Ternary Phase Diagrams: Modelling Results 
 Five thermodynamic models were compared to experimental results: UNIQUAC, and its 
variations UNIFAC, UNIF-LL, UNIQ-RK. Each model was simulated against all five bridging liquids and 
the results compared. The models with the closest alignment to the experimental results are displayed 
in Figure 4.2.  
 UNIF-LL was shown to best predict water-acetone-chloroform systems, whilst UNIFAC best 
predicted water-acetone-heptane systems. UNIQUAC was found to best predict the behaviour of the 
remaining systems: butyl acetate; MIBK; toluene. For butyl acetate and MIBK, the interfacial tension in 
water is relatively low. Subsequently, there is a much higher degree of miscibility, and therefore there 
are potential difficulties in predicting system behaviour. This could explain why all the models failed to 
accurately predict the peak location of the binodal curve, as this observation was not noted with the 
bridging liquids with higher interfacial tensions in water.  
 
 Comparison of BSR and TBSR for All Systems 
 It is hoped that utilisation of the TBSR, rather than the BSR, will increase the comparability of 
different systems. For the TBSR to be used, the formation of two immiscible phases is required, i.e. the 
solubility of the bridging liquid in the bulk solution must be exceeded. Thus, when the immiscible 
phases do form, this soluble volume is lost to the bulk solution. A result of this behaviour is that the 
TBSR is always initially less than the BSR. Prior to this, the system is considered miscible and, as a result, 
the TBSR is equal to zero, as there is no bridging liquid rich phase but a single homogenous solution. 
Bulk solutions with a higher initial mass fraction of water were shown to have least deviation from the 
BSR equals TBSR relationship. This behaviour is to be expected as all the bridging liquids are much less 
miscible in water compared to acetone.  
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Figure 4.2. Ternary phase diagrams (mass fraction) of water-acetone-bridging liquid systems featuring 
experimental data and Aspen prediction overlays; a) heptane UNIFAC prediction; b) toluene 
UNIQUAC prediction; c) chloroform UNIF-LL prediction; d) n-butyl acetate UNIQUAC prediction; e) 
MIBK UNIQUAC prediction. 
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 As the initial mass fraction of acetone is increased, significant deviation of TBSR from the BSR 
occurs, regardless of the bridging liquid used. As the bridging liquid is more miscible in acetone than 
water, the solubility is much higher. The BSR is calculated as being high in these systems, whereas the 
TBSR is low. In the ternary phase diagram, this is reflected by theoretical systems requiring more 
bridging liquid to cross the binodal curve into the immiscible region of the diagram. Interestingly, and 
according to the literature presented in Chapter 2, most BSR values used are below a value of 1. 
However, the optimum BSR value can vary greatly for different systems (see Figure 2.22). 
Unfortunately, many studies do not provide detailed enough information to calculate the TBSR 
accurately. 
 
Figure 4.3. Agglomerate size for different spherical agglomeration systems: o kerosene/CaCO3 [91]; Δ 
chloroform/salicylic acid [45]; × toluene/benzoic acid [46]; − hexane/lobenzarit disodium [21]; + 
dichloromethane/atorvastatin calcium [92] as a function of a) BSR (Source: Pitt et al. [7]) and b) TBSR. 
Here the TBSR values are for illustrative purposes only.  
a) b) 
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Figure 4.4. True bridging liquid volume available to agglomerate solid particles as a function of BSR, 
for water-acetone-bridging liquid systems a) heptane; b) toluene; c) chloroform; d) MIBK; e)  
n-butyl acetate. 
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 If the fraction of the bridging liquid addition available to agglomerate particles is plotted as a 
function of the BSR, powerful relationships can be established. For the agglomeration systems 
identified, these results are shown in Figure 4.4. For heptane, if a BSR of 1 is considered, approximately 
65 % to 95 % of the bridging liquid is available to agglomerate the particles of interest, dependent upon 
the bulk solution composition (see Figure 4.4a). These comparisons can also be made for the other 
bridging liquids; toluene (see Figure 4.4b): chloroform (see Figure 4.4c): n-butyl acetate (see Figure 
4.4d): MIBK (see Figure 4.4e). Note that as the initial concentration of acetone increases, more bridging 
liquid is lost to the bulk solution. In all cases, this results in the initial immediate volume of bridging 
liquid available to agglomerate particles being reduced. This same relationship is observed for 
increases in the bridging liquid miscibility (with the bulk solution). Note that here, more bridging liquid 
is immediately available for bridging liquids which have a higher interfacial tension in water (i.e., less 
miscible).  
For chloroform, the fraction of MZ available becomes greater than 1.0 at a BSR of around 1.25 
for some bulk solutions. That is, that the TBSR value becomes larger than the BSR value calculated for 
the same bridging liquid volume addition. As higher volumes of bridging liquid are added, a greater 
amount of water and acetone is transferred into the bridging liquid rich phase. As acetone is more 
miscible in the bridging liquid than the water, more acetone is transferred in these instances. It should 
be noted that these systems represent unrealistically high BSR values and indeed TBSR values. At these 
high values, systems are more likely to form pastes upon bridging liquid addition. Note that this only 
occurs for chloroform and should be attributed to the negative gradient of the tie-lines, as observed in 
Figure 4.2.  
  Two further solid loading concentrations were investigated and tested against water-acetone-
chloroform systems, as developed in Section 4.2. The same theoretical agglomeration systems were 
also utilised. Considering a 1 % w/w loading, the initial solid volume is one third that of the system 
originally investigated. As a result, the BSR value traditionally used would be expected to be three times 
higher. This holds true. Additionally, the TBSR values were seen to be approximately three times larger. 
Considering the available volume of MZ to agglomerate particles, at a given BSR, only one third the 
fraction of that calculated for 3 % solid loading systems is available (Figure 4.5a). Investigations using 
a 5 % w/w loading produced results in-line with the above observations, as shown in Figure 4.5b.  
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Figure 4.5. Comparison between a solid loading of a) 1 % w/w and b) 5 % w/w for water-acetone-
chloroform systems.  
  
These results demonstrate that the solid loading of systems should also be considered carefully 
in practice, especially when the solid loading is below 3 % w/w. At 1 % w/w, the influence of bridging 
liquid miscibility within the bulk solution becomes even greater. Increasing the solids content increases 
the amount of binder liquid added and pushes the operating point further into the immiscible region 
(see Figure 4.6). If the operating point is very close to the boundary envelope, then a small drop in 
solids content could cause a dramatic change in performance. The precise value of solids content for 
this will be system specific and depends also on the BSR, the shape of boundary envelope and the 
solvent composition.  However, it is easily calculated for a given system using the approaches described 
in this chapter.   
a) b) 
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Figure 4.6. Increasing the bridging liquid volume addition causes the system to move further into the 
immiscible region, shown here for four exemplar bulk solution conditions.  
 
 Conclusions 
 The traditional bridging liquid to solid ratio (BSR) does not account for the solubility, or 
miscibility, of the bridging liquid in the bulk solution. This, in turn, directly influences the volume of 
bridging liquid available for agglomeration of the particles of interest. If any of the three solvents in 
the process are changed, the amount of available bridging liquid phase changes. This is also true for 
changes in the solid loading.   
 Here, the True BSR (TBSR) has been defined. The results demonstrate that this new parameter 
is a much more accurate measure of the bridging liquid, especially when considering the fraction of the 
initial bridging liquid added available to agglomerate particles of interest. Under some process 
conditions, the TBSR can vary dramatically from the BSR, and thus, the bridging liquid fraction available 
may be exceptionally lower than thought. This is particularly true when the ternary phase diagram 
features a large miscible region. Highly miscible bridging liquids lead to increased levels of deviation in 
the TBSR value, when compared to the BSR. The mother solution must also be considered here as 
increasing the initial acetone mass fraction was shown to produce the same trend. TBSR is generally 
lower than the BSR, especially upon the formation of two immiscible phases. One exception was found 
using chloroform as the bridging liquid, where the TBSR exceeded the BSR value at very high values. 
This is attributed to the negative gradient of the tie-lines within the ternary phase diagram. 
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 Introduction 
 As detailed in Chapter 4, the current bridging liquid to solid ratio definition fails to account for 
solvent miscibility. As such, the amount of bridging liquid available to agglomerate particles of interest 
may be less or, in some cases more, than initially intended. As a result, whilst a critical range for a 
particular solvent-solid system can be identified, within which agglomeration behaviour is predictable 
and efficient, this target critical range may not be achieved. Thus, the subsequent agglomeration 
profile of these systems may be hard to predict and deviation from expected behaviour becomes 
increasingly likely. The definition also fails if a different ternary solvent system is utilised or the solid of 
interest changes. This creates a key challenge for producing robust processes which perform as 
expected.  
 In this chapter, the TBSR definition is experimentally tested. To do so, the results presented in 
the previous chapter are utilised to calculate the required volume of bridging liquid to reach a desired 
TBSR value. The extent of agglomeration is measured at several TBSR values with three different 
bridging liquids: butyl acetate; chloroform; methyl-isobutyl ketone. These will test the hypothesis that 
all systems have similar levels of agglomeration at the same TBSR.  In addition, three different bulk 
liquid compositions are investigated: 95 % w/w water, 5 % w/w acetone; 90 % w/w water, 10 % w/w 
acetone; 85 % w/w water, 15 % w/w acetone. 
 
 Equipment and Methodology Validation 
 Agglomeration experiments were performed using the equipment and methodology described 
in Section 3.4.1.  In these experiments, the fraction of solids agglomerated, and the size distribution of 
the agglomerates were measured in batch agglomeration experiments. A residence time of 45 minutes 
at 750 rpm was used. A Rushton turbine was placed 2.5 cm from the bottom of a sealed 1 L beaker, as 
shown in Figure 5.1. A solid loading of 3 % w/w corresponding to 12 g of mass of solid, was added to 
388 g of saturated bulk solution.     
 Several tests were designed to evaluate the robustness of the experimental equipment and 
methodology. The first of these looked exclusively at whether any solvent within the system would 
evaporate over the 45-minute duration of the experiment. To test the level of evaporation, if any, the 
system was agitated for the full duration. A mass balance was performed both before and after this 
time. The highest acetone percentage initial solution was used: 85 % w/w water, 15 % w/w acetone. A 
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triplicate was performed, and the losses calculated as followed: 0.53 g loss from 400.88 g; 0.29 g loss 
from 401.89 g; 0.30 g loss from 389.89 g. These values correspond to losses of 0.13 %, 0.07 % and 0.08 
% respectively. This reactor design was incorporated into further testing. These results are displayed 
in Figure 5.1a.  
 The dissolution of suspended samples, or precipitation, of crystals from the initial solution was 
considered next. Evaporation was not considered an issue. Thus, the above experiments were repeated 
using a system with both suspended solids and a bridging liquid of interest. The mass balances were 
repeated for 85 % w/w water, 15 % w/w acetone, with a bridging liquid corresponding to a TBSR of 0.5. 
The repeat for chloroform showed a 0.94 g loss from 411.15 g. A second repeat showed a 0.68 g loss 
from 412.39 g, and a third repeat a 0.78 g loss from 412.19 g. These values correspond to 0.23 % w/w, 
0.16 % w/w and 0.19 % w/w respectively (see Figure 5.1b). Assuming that the evaporation of the bulk 
solution remained consistent, only slight increases in losses are present when using a system with 
suspended solid and bridging liquid, compared to without. These losses were deemed reasonable.  
 Dissolution of agglomerates is also possible during the washing procedure. To evaluate this, 
suspended and agitated retentates, with no added binder liquid were washed with either water or 
water saturated with salicylic acid. The recovered samples were left to dry overnight in an oven, with 
samples separated from the filter paper and weighed. The mass balance for both conditions was in the 
order of less than 0.01 % when considering the initial mass suspended.   
 Crystal aggregation, due to the hydrophobicity of salicylic acid, could also be occurring. In these 
scenarios, it is possible that false readings would be obtained for the agglomeration profiles, despite 
no agglomerates actually being formed. To evaluate the influence of this, a TBSR of 0.00 (no added 
bridging liquid) was implemented as a control across all initial solutions. The recovery and 
characterisation followed the procedure described in Section 3.4.2. As no bridging liquid was added, a 
0 % agglomeration profile would be expected, i.e. all aggregates pass through the 300 μm sieve, and 
no agglomerates are present. Triplicates used the 90 % w/w water, 10 % w/w acetone bulk solution. 
The results for the agglomeration profiles showed that agglomeration was less than 1 % of the original 
solid mass. 
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Figure 5.1. Testing of closed reactor experimental set-up for a) evaporation and b) dissolution and 
precipitation during spherical agglomeration experiments. Conditions replicating those of the 
validation experimental methodology were used here.  
 
   
 
 
Evaporation 0.09 % 
Bulk solution 400 g Recovered 99.91% 
 
Evaporation 0.19 % 
Bulk solution 388 g 
Solid 12 g 
Bridging liquid 12 g Recovered 99.81% 
a) 
b) 
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 Experimental Design 
 TBSR values just above zero represent systems in which the bridging liquid miscibility within the 
bulk solution has only just been surpassed – that is, two distinct immiscible phases form spontaneously. 
These systems are of high interest in the spherical agglomeration context, as the distribution and 
immersion mechanisms may be investigated . Providing the relationship between the BSR and TBSR 
has been established, target TBSR values can be reached with ease. This involves examination of the 
system of interest and identifying the corresponding BSR value. This provides the volume of bridging 
liquid which should be added to the system to achieve the TBSR required i.e. the total volume of the 
bridging liquid rich phase. This volume is different if the bulk solution composition or bridging liquid is 
changed.  
 From the results presented in Chapter 4, three bridging liquids were selected which have a wide 
range of interfacial tensions with acetone/water mixtures: butyl acetate; chloroform; methyl-isobutyl 
ketone (MIBK). These bridging liquids have been used extensively within the literature. All these 
bridging liquids were investigated with a bulk solution of 90 % w/w water, 10 % w/w acetone. From 
methodology developed in Section 5.2, a TBSR of 0.5 formed a paste for all systems. Here, a range of 
different TBSR values were used, from 0.025 to 0.150 in increments of 0.025 to avoid the formation of 
a paste. The relationship between TBSR and BSR for the three systems is shown in Figure 5.2. A TBSR 
equal to zero was also investigated as a control. In this condition, there is no bridging liquid rich phase, 
and thus any agglomeration or aggregation of crystals is not a result of the presence of bridging liquid. 
The particles studied were salicylic acid prepared to a sub-45 µm size. A solid loading of 3 % w/w was 
used throughout the calculations and validation experiments. Table 5.1 provides the BSR and TBSR for 
the systems identified, and the relative mass fraction of each of the three solvent components within 
the system (not accounting for solid additions). Examples of the calculations are provided in Appendix 
A.  
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Table 5.1. The bridging liquid addition volumes, BSR, TBSR and compositions (% w/w) of the bulk 
solutions, used in agglomeration validation experiments, prior to solid addition.  
Mother Solution 
(% w/w) 




Water Acetone Chloroform Water Acetone TBSR BSR Chloroform 
95 5 
0.96 94.09 4.95 0.050 0.340 2.824 
1.03 94.02 4.95 0.100 0.388 3.225 
1.11 93.95 4.94 0.150 0.436 3.626 
90 10 
1.23 88.89 9.88 0.025 0.405 3.372 
1.30 88.83 9.87 0.050 0.429 3.569 
1.35 88.78 9.87 0.075 0.446 3.709 
1.40 88.74 9.86 0.100 0.462 3.838 
1.45 88.70 9.86 0.125 0.477 3.968 
1.51 88.64 9.85 0.150 0.499 4.148 
85 15 
1.44 83.77 14.78 0.025 0.477 3.965 
1.51 83.72 14.77 0.050 0.499 4.151 
1.58 83.66 14.76 0.075 0.522 4.337 
1.62 83.62 14.76 0.100 0.539 4.480 
1.67 83.58 14.75 0.125 0.553 4.600 
1.72 83.54 14.74 0.150 0.568 4.720 
Water Acetone MIBK Water Acetone TBSR BSR MIBK 
95 5 
2.76 92.38 4.86 0.050 1.664 14.262 
2.84 92.30 4.86 0.100 1.713 14.684 
2.92 92.23 4.85 0.150 1.762 15.105 
90 10 
3.05 87.26 9.70 0.025 1.841 15.786 
3.09 87.22 9.69 0.050 1.866 15.996 
3.13 87.19 9.69 0.075 1.890 16.205 
3.17 87.15 9.68 0.100 1.915 16.415 
3.20 87.12 9.68 0.125 1.939 16.625 








0.81 94.23 4.96 0.050 0.432 3.699 
0.90 94.14 4.95 0.100 0.481 4.120 
0.99 94.06 4.95 0.150 0.530 4.541 
90 10 
0.89 89.20 9.91 0.025 0.476 4.081 
0.94 89.16 9.91 0.050 0.500 4.290 
0.98 89.12 9.90 0.075 0.525 4.498 
1.03 89.07 9.90 0.100 0.549 4.707 
1.07 89.03 9.89 0.125 0.573 4.916 
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Figure 5.2. The identified agglomeration systems for three different bridging liquids with the same 
initial bulk solution composition (90 % w/w water, 10 % w/w acetone).  
 
 
Figure 5.3. The identified agglomeration systems for three different bridging liquids with the same 
initial bulk solution composition (95 % w/w water, 5 % w/w acetone). 
 
 Three individual bulk solutions were also investigated for one bridging liquid, chloroform (95 % 
w/w water, 5 % w/w acetone; 90 % w/w water, 10 % w/w acetone; 85 % w/w water, 15 % w/w 
acetone). Bulk solutions with higher acetone mass fractions produce further deviation in the TBSR 
value from the BSR value. It should also be noted that, often, these systems failed to form two 
immiscible phases as the binodal curve of equilibrium was not reached. These systems represent a 
TBSR equal to zero and are not considered within this work.  
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 As before, a range of different TBSR values were used, from TBSR equal to 0.025 through to 
TBSR equals 0.150 in increments of 0.025. These selections were chosen to investigate conditions 
below, within and above the proposed optimal range. A TBSR equal to zero was also investigated as a 
control. All these systems are displayed in Figure 5.2 to Figure 5.4.   
 




 Results & Discussion 
 The TBSR as a Comparison Tool 
 The rate processes of spherical agglomeration are sometimes considered as analogous to wet 
granulation systems. Figure 4.2a demonstrated that for a variety of wet granulation systems, regardless 
of the binder used, if the mean granule size is plotted against liquid pore saturation, the data collapses 
on to one smooth curve [90]. The bridging liquid volume (𝜑) was developed in a previous publication 






 Equation 5.1 
 This parameter considers the volume of crystals within the nuclei, compared to the volume of 
the bridging liquid. Crystals which pack in the agglomerate nuclei effectively have a higher solids 










 BSR = TBSR
 95% W 5% A
 90% W 10% A
 85% W 15% A
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fraction in the agglomerate, and thus 𝜑 becomes lower. For any system, the liquid volume fraction 
when the crystal are at their maximum solids fraction is called the critical packing liquid volume fraction 
𝜑𝑐𝑝. Thus, Equation 5.1 with 𝜑 = 𝜑𝑐𝑝 should represent the minimum TBSR required for complete 
agglomeration. This relationship is shown in Figure 5.5 [12]. The strongly non-linear nature of the 
function demonstrates that care must be taken when estimating the optimal TBSR range.  
 If the results for percentage un-agglomerated (i.e. the normalised mass retained within the pan 
after sieving) are plotted for each different system as a function of the BSR, a wide variation is shown. 
However, plotting the same results against the TBSR of the system causes the systems to align much 
more closely together (see Figure 5.6 and Figure 5.7). This demonstrates that solvent miscibility is an 
important factor which must be considered when designing spherical agglomeration systems as, 
ultimately, the volume of the bridging liquid rich phase will dictate whether any agglomeration occurs. 
The systems could fall on a single curve, providing other factors were accounted for, namely the 
wettability of the bridging liquids. Previously, studies have highlighted the influence of having a high 
wetting bridging liquid for produced robust spherical agglomerates, as discussed in Section 2.4.3. 
Bridging liquids with lower contact angles, i.e. increased wetting, produce agglomerates which were 
larger and stronger [21]. 
Figure 5.5. The relationship between critical packing bridging liquid volume (𝜑𝑐𝑝) and the predicted 
minimum TBSR value, as developed by Arjmandi-Tash et al., [12]. 
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Figure 5.6. The relationship between the BSR and the percentage of fines observed for the systems 
investigated, including different bulk solutions, and bridging liquids.  
Figure 5.7. The relationship between the TBSR and the percentage of fines observed for the systems 
investigated, including different bulk solutions, and bridging liquids. 
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 Effect of Bridging Liquid on Agglomerate Size Distribution 
 The mean agglomerate size from experimental validation of the TBSR is displayed in Figure 5.8 
and Figure 5.9 for the BSR and TBSR definition respectively. Associated parameters are also provided 
in Appendix B. Regardless of the bridging liquid used, the same trend can be identified: increasing the 
TBSR leads to increases in the agglomerate size. This is shown for both the BSR and TBSR. This is 
identified by a shift of the size distributions to the right. Regardless of the TBSR, a high level of 
suspended solid was incorporated into the agglomerates.  
If Figure 5.9, and indeed Figure 5.7, is considered alongside the earlier presented results of 
Chapter 4, key relationships can be identified. As the BSR increases, the fraction of bridging liquid 
added available to agglomerate particles increases (see Figure 4.4). This in turn, leads to a direct 
increase in the average size of agglomerates, as well as a reduction in the number of fines left in 
solution. Note, that this latter reduction produces larger than expected gains in the agglomerate mean 
size. This indicates, although not directly measured, that the agglomerates form at higher BSR, and 
indeed TBSRs, tend to be less dense and more porous. This porosity arises due to a bridging liquid rich 
nuclei core, which upon drying, remains hollow.  
 For both chloroform and n-butyl acetate, increasing the TBSR results in a reduction in the 
percentage unagglomerated fraction, regardless of the bulk solution used. This trend is expected, as 
increasing the volume of available bridging liquid leads to the incorporation of a higher percentage of 
solids. MIBK does not follow this trend, and a much larger margin of error was calculated. For all 
bridging liquids, the TBSR required is much smaller than anticipated. If we assume that the particles 
are perfectly spherical, the physically closest packing can be achieved, which is approximately 64 %. 
From Equation 5.1, a TBSR value of approximately 0.54 is required for this degree of packing. Thus, the 
expected TBSR value for these non-spherical particles should be higher than 0.54, and much higher 
than the observed behaviour.  
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Figure 5.8. The relationship between the BSR and the agglomerate mean size for different bridging 
liquids and bulk solutions.  
 
Figure 5.9. The relationship between the TBSR and the agglomerate mean size for different bridging 
liquids and bulk solutions.  
 
There are several potential reasons for the observed behaviour. As Section 5.2 details, the 
evaporation of solvent in-situ is unlikely. In a fully loaded system, the mass lost through evaporation 
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increases because of bridging liquid volatility. However, it is impossible to directly measure the degree 
of dissolution and precipitation that occurs through mass balance alone. Thus, it may be possible that 
salicylic acid is dissolving to a much greater degree than originally thought, especially when combined 
with a pre-saturated bulk solution. In this instance, the volume of the solid decreases, and thus the 
TBSR increases. This is a plausible explanation for the agglomeration behaviour observed, at what is 
thought to be an extremely low TBSR value. If the solubility of solid in the bridging liquid is known, this 
too could be incorporated into future TBSR calculations.   
Differences in the agglomerate size distributions were observed across the different bridging 
liquids investigated, and this is mirrored by the changes seen in the mean size of agglomerates. These 
differences could be due to variations in the wettability of the solid by the bridging liquid, as the 
influence of bridging liquid miscibility is accounted for. Generally, chloroform and n-butyl acetate 
systems produced more mono-sized agglomerates of a much larger size. MIBK produced agglomerates 
with a high average size for one of the bulk solution compositions. However, it should be noted that 
there was a high level of fines left in solution. Figure 5.10 displays the size distribution data for the 
three bridging liquids at the 90 % w/w water, 10 % w/w acetone bulk solution. The size distributions 
for the other conditions can be found in Appendix B.  
 Figure 5.10a displays the size distribution data for chloroform. Here, increases in the TBSR 
produce clear increases in the agglomerate size, whilst also reductions in the cumulative agglomerate 
frequency, i.e. the level of fines unincorporated into agglomerates. These trends are expected from 
the literature described within Chapter 2. Similar trends to chloroform were observed for n-butyl 
acetate, although the differences between TBSR values were much smaller (see Figure 5.10c).  
MIBK was noted for almost no variation in agglomeration profiles, regardless of the volume of 
bridging liquid added (see Figure 5.10b). MIBK has the highest miscibility in both water and acetone, 
and n-butyl acetate the second highest miscibility, out of the three bridging liquids investigated here. 
As such, the volume available to agglomerate particles is more likely to change with only minor 
variations in solvent composition. Bulk solutions not being completely homogenised may be a reason 
for variations in bulk composition. If the composition is different to the one upon which calculations 
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Figure 5.10. Agglomerate size distribution for salicylic acid-bridging liquid systems, a) chloroform, b) 
MIBK and c) n-butyl acetate, with an initial bulk solution of 90 % w/w water and 10 % w/w acetone. 
Error bars represent standard error of a least three repeats.  
  
Generally, bridging liquids are accepted within the literature as being immiscible or slightly 
miscible. A relatively large degree of standard error was calculated for each condition, which reflects 
the high level of variability across repeats and, thus, the unsuitability of MIBK as a bridging liquid for 
salicylic acid. Whilst this does not explain the observed behaviour, these findings do further support 






 Bulk Solution Compositions 
 The experimental validation agglomeration profiles are displayed in Figure 5.11 for chloroform 
for the three different bulk solution compositions. Results for MIBK and n-butyl acetate can be found 
in Appendix B. Associated parameters are also provided in Appendix B.  
 For two of the water-acetone-chloroform systems with different initial solution compositions, 
there were some experiments with equal BSR values (see Table 5.1). For a BSR of 0.477, the TBSR is 
equal to 0.125 for 90 % w/w water, 10 % w/w acetone bulk solutions. The same BSR, however, equates 
to a TBSR of 0.025 for 85 % w/w water, 15 % w/w acetone bulk solutions. The traditional BSR definition 
would suggest that these systems produce roughly equal behaviour. Traditionally, it would be expected 
that the agglomerate size distribution is also relatively similar as the BSR is equal. 
 However, the TBSR definition demonstrates that the actual volume of bridging liquid available 
is different for both these systems. The experimental validation of the definition also shows very 
different agglomerate size distributions (see Figure 5.11). Similar observations were also found at a 
BSR of 0.499 in two further systems at 90 % w/w water, 10 % w/w acetone, and 85 % w/w water, 15 % 
w/w acetone composition (see Table 5.1).  
If the new TBSR definition holds, it would also be expected to observe relatively similar 
agglomeration profiles. However, all three bridging liquids at this composition demonstrate different 
behaviour. Together, these results highlight that the TBSR definition is only partially validated within 
this work. Future works must be undertaken to further analyse the role of solid solubility within the 
bridging liquid, as well as the influence of changing the bulk solution composition.  This further 
highlights the need for consideration of solvent system miscibility in spherical agglomeration 
processes. 
 Conclusions 
 For the first time, the influence of bridging liquid miscibility within the bulk solution has 
been accurately quantified. In this chapter, the definition of the True BSR proposed previously has also 
been partially validated experimentally. The agglomeration profiles of systems can be compared much 
more easily if the TBSR definition is used, rather than the BSR. Additional to this, key relationships 
between the fraction of bridging liquid available, compared to the added volume, the agglomerate 
mean size, and the agglomerate size distribution, have all been identified. This further exemplifies the 
necessity of the definition as a method of standardising bridging liquid volume reporting within 
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spherical agglomeration processes, as well as providing the basis for a regime map or dimensionless 
group.   
 The results from experimental validation of the TBSR definition has shown, largely, 
reproducible, and predictable spherical agglomeration processes, providing this definition is used 
rather than its traditional counterpart. Additionally, the TBSR has shown promise as an instant 
comparison tool across different bridging liquids and different bulk solution compositions. This has 
been achieved through the utilisation of the results presented in Chapter 4.  
Figure 5.11. Agglomerate size distribution for salicylic acid-chloroform systems with an initial bulk 
solution of a) 85 % w/w water and 15 % w/w acetone, and b) 95 % w/w water and 5 % w/w acetone. 
Error bars represent standard error of a least three repeats.  
 
 Whilst evaluation of solvent miscibility allows prediction of process performance in spherical 
agglomeration, there is a need for other parameters to be considered. For example, within immersion 
nucleation, the volume of solid which can be packed into a defined bridging liquid droplet volume will 
ultimately dictate the amount of bridging liquid required. As a result, it is possible that the critical range 
may shift for particulate material with different morphologies. Additional to this, further tests should 
be undertaken which aim to identify the influence of solid solubility in the bridging liquid and, 
potentially, the bulk solutions utilised. This factor appears to have a much larger influence on the TBSR 
than initially thought. 
a) b) 
 A KINETIC 
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 Introduction 
 The true bridging liquid-solid ratio (TBSR) was defined and partially validated in Chapter 4 and 
Chapter 5 respectively, as a means of quantifying and standardising bridging liquid volume reporting. 
TBSR has also shown promise as a process design tool. In this chapter, the definition is used to further 
mechanistic understanding within spherical agglomeration through a kinetic study which aims to 
identify relationships between rate processes and product outputs i.e. size, size distribution and 
density. 
 Within this chapter, results of paracetamol mechanistic studies are reported. This study was 
performed as part of a CMAC CORE Project (SPA 99) in collaboration with Dr Kate Pitt.  While we worked 
as a team, Dr Pitt was primarily responsible for method development and experimental measurements, 
and I was primarily responsible for the data analysis and interpretation presented in Section 6.2.  
 Paracetamol was used as the solid of interest. A robust system with good product outputs was 
initially identified. The influence of operating parameters on these product attributes was investigated, 
with the aim of elucidating the balance of mechanisms which arise in a ‘perfect’ agglomeration system, 
i.e. all solids are incorporated and the time for paste formation is exceptionally long. The kinetics of 
these systems, where successful agglomeration occurs, is also studied within this section. The kinetics 
are evaluated as a means of identifying robust spherical agglomeration process performance. Systems 
such as these improve the likelihood of successful implementation. Paracetamol was chosen as it is 
one of the most widely available active pharmaceutical ingredients. Heptane was chosen as an anti-
solvent to suspend the paracetamol, as paracetamol is almost insoluble in heptane. Water is used as a 
bridging liquid due to its immiscibility with heptane. Full materials and methods can be found in Section 
3.5.  
 Additionally, these results are compared to a previously developed mathematical model. This 
serves as the initial foundation for model validation, as well as furthering understanding of the 
mechanistic processes of spherical agglomeration. The kinetics have a large influence on the spherical 
agglomeration processes and should be adequately described through rate process understanding. 
Specifically, the immersion nucleation mechanism is isolated here in a novel methodology. A sensitivity 
analysis for the effect of TBSR, shear and solid loading is performed and compared to the experimental 
results.  
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 Results & Discussion 
 Agglomerates formed through the immersion mechanism have been shown to be superior to 
those formed via the distribution mechanism. To aid comparison against immersion nucleation 
mathematical models, it was imperative to ensure the immersion mechanism occurred within the 
system of interest. To identify the dispersion of bridging liquid droplets and their initial interactions 
with paracetamol, water dyed with acid red IV was used. This allowed observation of the immersion 
mechanism in situ, as per the methods described in Section 3.5. The experiment was performed at 
TBSR of 0.75 and a solids loading of 5 % w/w. Figure 6.1 displays the agglomerates formed at different 
time points within the experiment. Here, agglomerate nuclei are clearly seen as red droplets with a 
surface covering of paracetamol. Flocs of paracetamol are also present although these are still white. 
This indicates these particles have not been wetted by the bridging liquid and the distribution 
mechanism is not occurring. 
Figure 6.1. Agglomerates sampled at a) 20 minutes, b) 40 minutes, c) 60 minutes and d) 80 minutes 
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 Influence of True Bridging Liquid-Solid Ratio 
 Incorporation of all material into spherical agglomerates is preferential as it promotes cost-
efficiency and there is a reduced requirement for product recycling. Here, the role of the true bridging 
liquid-solid ratio and the time to paste is considered, as a means of further understanding the balance 
of mechanistic rate processes in spherical agglomeration. An optimum region where all solid material 
is incorporated without the formation of a paste is preferred.   
 It was expected that increasing the available bridging liquid volume will lead to the 
agglomeration of all solid particles in a shorter amount of time. As such, the time for a paste to form 
will be reduced compared to lower bridging liquid volumes. In some instances, this could lead to an 
immediate formation of a paste. Conversely, if the volume of bridging liquid available is less, then the 
time for all particles to be agglomerated would be longer. Here, the influence of the critical packing 
liquid volume fraction, 𝜑𝑐𝑝, becomes important. As this parameter quantifies the relationship of solid 
packing within a bridging liquid droplet, its value ultimately dictates the volume of bridging liquid 
necessary to agglomerate all particles (see Section 5.4).  
 The full method is described in Section 3.5. A solid loading of 5 % w/w at 500 rpm was used. 
Values of TBSR over the range of 0.2 to 8 were investigated. For a TBSR value of 0.2, agglomerates 
formed slowly and not all suspended material was incorporated into agglomerates. The remaining 
material remains as flocs within the suspension. The solutions were left agitating for a total of four 
hours, but no significant changes in the agglomeration profile were observed (see Figure 6.2). These 
observations were mirrored for a TBSR value of 0.5, as shown in Figure 6.3. 
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Figure 6.2. TBSR 0.2 produced agglomerates sampled at a) 60 minutes, b) 120 minutes, c) 180 
minutes and d) 240 minutes. 
 
Figure 6.3. TBSR 0.5 produced agglomerates sampled at a) 60 minutes, b) 120 minutes, c) 180 
minutes and d) 240 minutes. 
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 At a TBSR of 0.7 and 0.8, in contrast to the behaviour of TBSRs of 0.2 and 0.5, agglomerates 
which are spherical and dense do form, with the recovery and drying of agglomerates found to be 
exceptionally quick. Importantly, agglomerates did not form a paste, even after prolonged periods of 
time under agitation. Here, the balance between the bridging liquid volume and the available solid is 
reached. These results are shown in Figure 6.4 and Figure 6.5.  
  A TBSR of 1.0 produced spherical agglomerates, which appear to be slightly weaker than those 
formed at lower TBSR values (Figure 6.6). Recovery and drying were possible. The time for complete 
agglomeration was 56 minutes, with the agglomerates remaining stable before forming a paste at 59 
minutes. A TBSR of 1.5 produced agglomerates which also incorporated all of the suspended 
paracetamol. The agglomerates were spherical and fairly dense, and therefore able to survive filtration 
and drying (Figure 6.7). The time for formation of a paste was 39 minutes after the addition of bridging 
liquid, around one minute after all the solid had been incorporated into agglomerates.   
 
Figure 6.4. Agglomerates at 75 minutes after bridging liquid addition (TBSR = 0.7) with a) and b) 
isolated from the reactor and c) and d) filtered and dried. 
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Figure 6.5. Agglomerates at 75 minutes after bridging liquid addition (TBSR = 0.8) with a) and b) 
isolated from the reactor and c) and d) filtered and dried. 
 
 
Figure 6.6. Agglomerates at 56 minutes after bridging liquid addition (TBSR = 1.0) with a) and b) 
isolated from the reactor and c) and d) filtered and dried. 
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Figure 6.7. Agglomerates at 35 minutes after bridging liquid addition (TBSR = 1.5) with a) and b) 
isolated from the reactor and c) and d) filtered and dried. 
 
 At a TBSR of 2.0, another change in the agglomeration profile was observed. As before, 100 % 
agglomeration occurred, albeit on a much shorter timescale of approximately twenty-five minutes, 
with a paste forming soon after. Some agglomerates were spherical, but these were found to be weak 
and broke up during filtration and drying (Figure 6.8). A TBSR of 3.0 produces a paste at approximately 
fifteen minutes, with the recovery of preserved agglomerates being impossible. Upon filtration and 
drying, these agglomerates instantly form a brittle cake (Figure 6.9). Results for TBSR values of 0.9, 4, 
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Figure 6.8. Agglomerates at 25 minutes after bridging liquid addition (TBSR = 2) with a) and b) 
isolated from the reactor and c) and d) filtered and dried. 
 
Figure 6.9. Agglomerates at 15 minutes after bridging liquid addition (TBSR = 3) with a) and b) 
isolated from the reactor and c) and d) filtered and dried. 
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 Increasing TBSR reduced the time to paste overall. Additionally, agglomerates that did form 
were less dense. This would suggest that the increased number of bridging liquid droplets allowed a 
higher number of agglomerate shell nuclei to form. This rapid usage of the free material meant that 
densification of existing nuclei became impossible, explaining the low-density agglomerates observed 
here. If the time taken for paste formation is plotted against each TBSR value, the results follow a 
power law, as shown in Figure 6.10. Five distinct agglomeration zones are observed, where each 
produces a different agglomeration profile.   
 These distinct zones provide an idea into the suitable operating region of the system under 
consideration. Zone E can immediately be discounted due to the instantaneous formation of a paste. 
Zone D produces agglomerates which are weak and do not survive filtration and drying. As such, these 
agglomerates are unsuitable for tabletting as they are unlikely to be able to withstand the mechanical 
pressures involved. Zone A presents the converse: strong, robust agglomerates are formed but the 
yield of spherical agglomerates is low and primary particles remain in suspension; full agglomeration is 
never attained. This is generally undesirable in batch processes but could be beneficial in a continuous 
process, where the starting material can be recycled. Zone C represents the formation of strong, robust 
agglomerates, with a very high proportion of solid material incorporated, ideal for batch processes. 
These agglomerates are good candidates for downstream processing. As these conditions are time 
sensitive, it is important to recover the agglomerates as it is still possible to form a paste if the 
suspension is agitated for too long.   
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Figure 6.10. The influence of the TBSR value on the time required for paste formation in paracetamol-
heptane-water spherical agglomeration experiments. 
 
 Zone B is the desired area of operation. Here, all the suspended product is incorporated which 
eliminates the need for product recycling. Additionally, there is an exceptionally long time required for 
the system to form a paste, which provides greater operational flexibility and stability: it may be 
possible to achieve adequate particle dispersion at low impeller speeds too. The agglomerates 
produced are also highly spherical and dense as desired. There is the potential for changes in the solid 
loading to have an influence on the agglomerate size distribution, which further enhances the 
desirability of operating within this region.   
   
 Influence of Solid Loading 
 Within spherical agglomeration literature, the influence and effect of solid loading is usually 
overlooked, with only two studies identified to date investigating this process parameter. Here, the 
authors found a decrease in porosity with increased loading, as well as an increase in agglomerate 
mean size [45,88]. Most studies reviewed in Chapter 2 operate within 3 % w/w to 6 % w/w solid 
loading. Within the context of the pharmaceutical industry, higher solid loadings allow an increase 
product throughput and, therefore, a reduction in time to market of the finished product. Here, two 
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further solid loadings of 1 % w/w and 9 % w/w are investigated.  
 Interestingly, results from these experiments showed a degree of similarity for the time for 
paste formation, at different TBSR values as before, but there are some differences. These results are 
shown in Figure 6.11. The associated data is presented within Appendix C.  
Figure 6.11. The influence of the TBSR value on the time required for paste formation in different 
solid loading conditions.  
 
 The results for agglomeration profiles are consistent across all solid loading conditions. The five 
demarcated zones previously identified are also still present, each with distinct product properties. The 
zones are separated at approximately the same TBSR value, regardless of the solid concentration used 
within the agglomeration vessel. Figure 6.11 shows an overlay of all three conditions, and the time to 
paste. At a TBSR of approximately 1.3, the three solid loading levels intersect. Below this TBSR, and 
above the optimal range, higher solid loadings take a longer time to form a paste. Above this TBSR, 
higher solid loadings take less time to form a paste. These results suggest that for TBSR values between 
0.8 and 1.3, the agglomerate formation is limited by the volume of the bridging liquid available. As a 
result, it takes longer for all solid material to be incorporate into the fewer agglomerates formed. 
Conversely, above a value of 1.3, the process is not limited by this phenomenon. The bridging liquid is 
in excess, indicating particles are rapidly wetted and agglomerate growth begins almost 
instantaneously. This quick depletion of available solid results in agglomerate nuclei coalescence and 
the onset of paste formation.  
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 The mean size of agglomerates was found to decrease with an increased solid loading, as shown 
in Figure 6.12. This also correlates with an overall decrease in agglomerate porosity (see Figure 6.13 
and Equation 6.3). As the solid loading is increased, the available bridging liquid increases too, leading 
to an overall decrease in bridging liquid droplet sizes. This subsequently leads to a reduction in the 
agglomerate nuclei size and, eventually, the agglomerate size distribution. A larger number of collisions 
are also possible, which increases the compaction and consolidation of agglomerates. This is reflected 
by the noted increase in their density (reduction in their porosity).  
Figure 6.12. The mean size (a) and size distribution (b) of agglomerates as a function of solid loading, 
at a TBSR of 0.7. The recovery times are 100 mins for 1 % w/w loading, 160 mins for 5 % w/w loading 
and 320 mins for 9 % w/w loading. 
 
Figure 6.13. Agglomerate porosity as a function of solid loading. Error bars represent standard error 
of 20 measurements.  
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 Influence of Impeller Speed  
 The investigation into the effect of shear rate was carried out in the optimum zone (TBSR = 
0.75). Three different impeller speeds were used:  300 rpm, 500 rpm and 700 rpm. The energy 





 Equation 6.1 
Here, 𝑃 is the power number, 𝐷𝑖𝑚𝑝 is the impeller diameter, 𝑁 the speed of agitation, and 𝑉𝑠𝑢𝑠𝑝 the 




5 Equation 6.2 
 
Table 6.1 shows the energy dissipation rates for this system (𝑃 = 0.36; 𝐷𝑖𝑚𝑝 = 0.055 m)[124]. 
Table 6.1. Calculated energy dissipations rates. 





 Higher impeller speeds were shown to produce smaller agglomerates. The mean size of 
recovered agglomerates was 499 µm at an agitation speed of 700 rpm. At 500 rpm, this mean size 
increased to 723 µm. A speed of 300 rpm yields the largest agglomerates, with an average agglomerate 
size of 1182 µm. Figure 6.14 shows the recovered agglomerates, and Figure 6.15 shows the 
agglomerate size distribution, as measured through image analysis. This trend is expected as increasing 
the agitation speed reduces the size of bridging liquid droplets during infusion. It also promotes 
increased levels of consolidation through increased agglomerate-agglomerate and agglomerate-
equipment collisions. The porosity of agglomerates can be calculated from the agglomerate density 
and the true density of paracetamol, as per Equation 6.3: 
 𝑃𝑜𝑟𝑜𝑠𝑖𝑡𝑦 = 1 −
𝜌𝑎𝑔𝑔
𝜌𝑡𝑟𝑢𝑒
 Equation 6.3 
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 This finding is supported by a decrease in the porosity of agglomerates, as shown in Figure 6.16.  
Smoother, more spherical agglomerates were obtained at higher impeller speeds. It has been noted 
within the literature that these higher impeller speeds may promote breakage, which was also noted 
within the results here  [6,23,45].  
 
Figure 6.14. The influence of impeller speed on agglomerate size and morphology, at a TBSR of 0.75 
with a 5 % solid loading. Conditions at a) 300 rpm, b) 500 rpm and c) 700 rpm. 
 
 
Figure 6.15. The influence of impeller speed on agglomerate size distribution at a TBSR of 0.75 with a 
5 % solid loading.  
 
 
a) b) c) 
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Figure 6.16. The influence of impeller speed on agglomerate porosity at a TBSR of 0.75 with a 5 % 
solid loading.   
 
 Agglomerate Structure Development 
 Agglomerate structure development was studied at TBSR = 0.75 with 5 % w/w solid loading. 
Here, the agglomeration profile remains within Zone B, where all material becomes fully incorporated 
without formation of a paste (see Figure 6.4 and Figure 6.5). Samples were taken at increasing time 
intervals from 10 min to 120 min after bridging liquid addition. Samples at 10 mins, 30 mins, 50 mins, 
70 mins and 90 mins are shown in Appendix C. These results are displayed in Figure 6.17 to Figure 6.21. 
Figure 6.17. Observations of spherical agglomerate nuclei and paracetamol flocs 20 minutes after 
bridging liquid addition. 
 
a) c) b) 
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Figure 6.18. Observations of spherical agglomerates, nuclei and paracetamol flocs formed 40 minutes 
after bridging liquid addition. 
 
 
Figure 6.19. Observations of spherical agglomerates, and paracetamol flocs formed 60 minutes after 
bridging liquid addition. 
 
 
Figure 6.20. Observations of spherical agglomerates and fragments formed 80 minutes after bridging 
liquid addition. 
a) c) b) 
a) c) b) 
a) c) b) 
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Figure 6.22. Observations of spherical agglomerates and fragments formed 120 minutes after bridging 
liquid addition. 
 
 Over time, through compaction and consolidation, solid particles are pushed into the droplet 
which allows the nuclei to become much denser. This is reflected by the number of primary particles 
in solution reducing gradually over time, until all fines are incorporated at 80 minutes. This is mirrored 
by an increase in the number of distinct agglomerates formed, as well as agglomerates becoming 
smoother and more spherical with time.   
 There is some breakage or fragmentation of agglomerates at 80 minutes, as indicated in  Figure 
6.20. However, this does not appear to lead to significant changes in the overall mean size of 
agglomerates. This suggests that the breakage which does occur happens at a rate equal to that of 
incorporation of material back into the agglomerate population. There appears, visually, to be a slight 
decrease in agglomerate sphericity and potentially a slight increase in agglomerate size. Fragments are 
still detected at 100 minutes, which suggests these rate processes are still occurring (Figure 6.21). After 
a) c) b) 
a) c) b) 
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120 minutes, highly spherical agglomerates are formed with only a very small amount of fragmented 
material remaining (see Figure 6.22). As identified in Section 6.2.1, there is no agglomerate 
coalescence at a TBSR of 0.75. Once all solid has been incorporated, there appears to be little to no 
free bridging liquid available. This absence of free bridging liquid is also a barrier to agglomerate 
coalescence.   
 The mean size of agglomerates was found to decreases within the first 30 minutes of the 
spherical agglomeration process. This is most likely due to consolidation and compaction, where young 
agglomerate nuclei become much more densified over time, as well as the breakage of large, weaker 
agglomerates. The finding is also supported by the increase in the percentage of solids agglomerated 
during spherical agglomeration experiments (see  
Figure 6.23). The particle size distribution is also much wider at these earlier stages in the experiment 
(see Figure 6.24). These findings are mirrored in an immersion nucleation mathematical model of 
interest, where agglomeration processes limited by the collision rate of the particles and bridging 
liquid, showed an approximately linear growth of dimensionless agglomerate volume. This model is 
discussed in more detail in subsequent sections. 
Figure 6.23. The influence of residence time on the percentage of initial solid incorporated into 
agglomerates. A BSR of 0.75, 5 % w/w solid loading, and 500 rpm shear rate was used. Error bars 
represent standard error of three measurements.  
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Figure 6.24. The influence of residence time on the agglomerate size distribution. A BSR of 0.75, 5 % 
w/w solid loading, and 500 rpm shear rate was used.   
 
 Figure 6.25 shows the relationship between agglomerate size and sphericity as a function of 
residence time. Critically, three distinct regions can be identified from the data and qualitative image 
analysis. Region A represents the formation of low-density agglomerates initially, which densify causing 
a decrease in their size. A sharp increase in sphericity mirrors a decrease in the average agglomerate 
size. Region B defines the formation of stronger and denser agglomerates, which are less susceptible 
to breakage. The sphericity increases slightly as agglomerates consolidate and become more well-
formed. No significant change in the agglomerate size is detected, probably as a result of consolidation 
& growth and breakage & attrition rate processes being approximately equal. Finally, Region C 
represents dense agglomerates which are incorporating breakage fragments. This leads to zero change 
in density, but a decrease in sphericity. Through further shear force and consolidation, this decrease in 
sphericity is reversed as agglomerates become more rounded and smoother.  

























y = 1.0993 x
R = 0.9963
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Figure 6.25. The influence of residence time on the agglomerate mean size and sphericity. Standard 
error bars represent standard deviation of two experiments.     
 
 
 Figure 6.26 shows that the agglomerate density increases with an increasing residence time. 
The relationship is linear until around a 100 minute residence time is reached. After this point, the 
density and porosity of agglomerates roughly remains constant. This time corresponds to complete 
agglomeration, as per percentage agglomeration plots (see  
Figure 6.23). This agrees with visual observations of agglomerate formation, as all fines have been 
incorporated and a balance between breakage and consolidation is reached (Figure 6.21). This also 
aligns with  
Figure 6.23, where, over multiple runs, all solid was deemed to have agglomerated just after 100 
minutes. The final recorded density is 0.75 g cm-3 which corresponds to a final porosity of 
approximately 0.48. This aligns with results obtained for results in Section 6.2.2 and Section 6.2.3.  
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Figure 6.26. The influence of residence time on the agglomerate density. A BSR of 0.75, 5 % w/w solid 
loading and 500 rpm shear rate was used here. and  
 
 Mathematical Theory 
 Next a previously developed mathematical model is applied to further mechanistic 
understanding of the agglomerate nucleation kinetics of the immersion mechanism in the spherical 
agglomeration of paracetamol. This utilises observations made in the previous sections and should 
inform the direction of future studies into immersion nucleation.   
 The model provided a way of expressing the optimal TBSR range, providing that the critical 
packing liquid volume fraction of agglomerates is known. It should be noted that if the TBSR utilised is 
larger than 𝑇𝐵𝑆𝑅𝑜𝑝𝑡, there are not enough crystals within the bulk solution to reach a packing of 𝜑𝑐𝑝 
within bridging liquid droplets. Additionally, 𝜑𝑐𝑝 may be difficult to calculate or estimate. From Section 
6.2, the optimal range for the TBSR of water-heptane-paracetamol system is between 0.70 and 0.80. 
Using these values produces 𝜑𝑐𝑝 values of 0.412 and 0.444, respectively.   
 The mathematical model also identifies two key limiting regimes for the kinetics of agglomerate 
nucleation in the immersion mechanism. Both regimes consider conditions in which the particles are 
more wettable by the bridging liquid than the bulk solution. Here, the particles are able to penetrate 
and enter into the bridging liquid droplets through compressive forces, as opposed to the collision 
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velocities and surface tension forces involved. These forces only limit the kinetics of the immersion 
rate.  
 The immersion rate limited regime defines scenarios in which it is assumes a packed layer of 
particles is always available at the surface of the bridging liquid droplet [12]. Thus, the rate of 
agglomerate nucleation is controlled by the wetting action only, i.e. the rate at which particles can be 
incorporated into the young agglomerate nuclei. The collision rate limited regime assumes that 
nucleation is limited by the collision rate of particles and bridging liquid droplets, i.e. the availability of 
particles at the surface of the droplet. As such, this second regime occurs on a much faster timescale 
than the first. The agglomeration nucleation number is used to define these regions and is defined as 
the ratio between the timescales required for full agglomeration nucleation, limited by the immersion 



























 In the case of the immersion rate limited model (𝐴𝑔𝑁𝑢 > 100), the timescale for completion 







3  Equation 6.5 
 where 𝜇𝑑 is the viscosity of the bridging liquid, 𝐷𝑑 is the bridging liquid droplet diameter, 𝛹 is 
the sphericity factor, 𝐷𝑝 the particle diameter, 𝛾 the interfacial tension of the bridging liquid in the 
suspension liquid, and 𝜃 the contact angle of the bridging liquid on the solid at the bulk solution-
bridging liquid-solid interface. In the case of a collision rate limited regime (𝐴𝑔𝑁𝑢 < 1), the timescale 
























 Equation 6.6 
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 where 𝛼 is the target efficiency, the target efficiency here defines the fraction of particles within 
the fluid volume displaced by the bridging liquid droplet, which successfully interact. Additionally, 
𝑢(𝐷𝑝) and 𝑢(𝐷𝑑) represent the velocities of the particles and droplets, respectively. Instances during 
the immersion mechanism can occur, in which the system is limited by a combination of both the 
immersion rate limited regime and collision rate limited regime i.e., when the predicted agglomeration 
nucleation number is close to 1. This can be thought of as the immersion rate limited and collision rate 
limited timescales being approximately equal. This scenario is probable during several conditions, 
including a lack of crystal particles within the bulk solution. To assess the volume fraction of particles 
in the bulk mother solution over time for an immersion rate limited regime, the following equation can 
be used:  









) Equation 6.7 
 where 𝜑𝑃𝑏0 is the initial concentration of solid within the bulk solution. If we consider the 
kinetics of the time for paste formation of paracetamol (see Section 6.2), it can be assumed that the 
time for a paste to form is equal to when the solid concentration within the bulk solution is equal to 
zero (𝜑𝑃𝑏 = 0). Using these parameters, the concentration of the solid within the solution at a given 
time 𝑡, can be calculated as follows: 













  Equation 6.8 
 The velocities of the particle-mother solution and droplet-mother solution can be calculated 
according to Equation 6.9 and Equation 6.10 respectively, and the target efficiency to Equation 6.11. 
This is shown in Figure 6.27.  
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Figure 6.27. Bridging liquid droplet and particle interaction which defines the target efficiency. 
Reproduced from Arjmandi-Tash et al., [12]. 
















































 where 𝜌 is density, 𝜇 is viscosity, 𝐷 is diameter for the particles (𝑝) and liquid (𝑙).  
 
 Model Parameters & Assumptions 
 To evaluate the effect of TBSR on the concentration of paracetamol particles in the bulk solution 
during nucleation, the parameters use both known and assumed values. Table 6.2 displays the value 
for each of the parameters used in Equation 6.1 to Equation 6.11, for the experimental system used in 
Section 6.2. A TBSR of 0.75 is used, which represents a condition within the optimal region (see Figure 
6.11). A value of 0.425 for 𝜑𝑐𝑝 is calculated from this TBSR value. The sphericity 𝛹, is assumed to be 
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0.5, and the bridging liquid droplet diameter 𝐷𝑑, is assumed to be 100 µm. Remaining parameters are 
calculated from the values shown in Table 6.2.  
Table 6.2. Summary of parameters and values used for sensitivity analysis of a mechanistic model. 
Parameter Units Value 
𝐷𝑝 m 2.1 x 10
-5 
𝐷𝑑 m 1 x 10
-4 
𝜇𝑑 Pa s 8.9 x 10
-4 
𝜇𝐿 Pa s 3.76 x 10
-4 
𝛾 N m-1 0.051 







 m2 s-3 2.097 
𝜔 - 0.5 
𝜑𝑐𝑝 - 0.425 
𝜑𝑃𝑏 - 0.05 
𝑇𝐵𝑆𝑅 - 0.75 





𝑡𝑖𝑚𝑚 s  
𝑡𝑐𝑜𝑙𝑙 s  
  
 The following assumptions are also made, regardless of which regime the system falls in: crystal 
particles are assumed to be much more wettable by the bridging liquid, compared to the bulk solution 
of the system; immersion of particles into the bridging liquid droplet core occurs due to capillary force; 
a growing agglomerate nucleus contains a bridging liquid core and particle shell with liquid volume 
fractions of 1 and 𝜑𝑐𝑝 respectively; a two-dimensional, planar geometry is used.   
 For the immersion rate limited regime only: a packed layer of particles is always available at the 
surface of bridging liquid droplets; the rate of nucleation is limited by the immersion of particles inside 
the bridging liquid droplets; the immersion rate is given by the rate of imbibition of bridging liquid in 
the packed layer through Darcy’s law; permeability of the packed layer of particles is given by the 
Kozeny-Carman equation.  
 For the collision rate limited regime only: the immersion of particles inside the bridging liquid 
droplets is extremely fast; the rate of nucleation is limited by the collision rate between particles and 
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bridging liquid droplets; both the bridging liquid droplets and solid particles are larger than the 
Kolmogorov turbulent microscale; there is negligible change of the relative velocity of the bridging 
liquid droplet-bulk solution (𝑢(𝐷𝑑)) throughout the full nucleation time. 
 
 Model Prediction: Analysis & Discussion 
 Here, an insight into the relationship between the TBSR and the kinetics of agglomeration is 
provided. To do so, it can be assumed that the time required for the onset of paste formation is equal 
to when the solid concentration within the bulk solution is equal to zero. Experimentally, many systems 
formed a paste quickly (within a few minutes of all solids being incorporated into agglomerates), and 
therefore this assumption seems reasonable. Note that within the model, the onset time for nucleation 
is the parameter of most interest and is the one calculated, not the time for a paste to be formed. This 
nucleation time describes the time taken for droplets to ‘capture’ the particles of interest. 
 Effect of TBSR 
 If the immersion rate limited regime is first considered, using the appropriate values from Table 
6.2,  Figure 6.28 shows the results for various TBSR values. 𝑡𝑖𝑚𝑚 (Equation 6.5) was calculated to be a 
value of 0.00054 s. This corresponds to the complete filling of the droplets and depletion of solid within 
the bulk solution. For a TBSR of 0.7, the solid concentration within the bulk solution reaches zero to 
𝑡𝑖𝑚𝑚. This indicates there are not enough particles within the bulk solution to fill bridging liquid 
droplets to a value of 1 − 𝜑𝑐𝑝. This model result was observed experimentally, with the disappearance 
fines for a TBSR of 0.7 after a certain period (see Figure 6.20). To reach the value of 1 − 𝜑𝑐𝑝, the 
available solid would need to be increased. This indicates that the full packing was not reached. The 
model predictions for a TBSR of 0.4 and below show that 𝑡𝑖𝑚𝑚 is reached prior to the bulk solid 
concentration reaching zero. Here, there are enough particles for solids to reach 1 − 𝜑𝑐𝑝. 
Experimentally, this is shown by particles remaining within solution (see Figure 6.2 and Figure 6.3).  It 
is unclear whether individual particles break off the agglomerates, whilst others are incorporated due 
to the shear forces.   
 If the collision rate limited regime is considered, again using appropriate values from Table 6.2, 
Figure 6.29 shows the results for various TBSR values. Here, the 1 − 𝜑𝑐𝑝 condition of agglomerate 
formation is reached prior to the solids concentration within the solution reaching zero. This indicates 
CHAPTER 6: A KINETIC STUDY OF SPHERICAL AGGLOMERATION PROCESSES 
136 
that there is an ample volume of solid available for the 1 − 𝜑𝑐𝑝 to be met. Experimentally, it would be 
expected that a large volume of fines are left in solution at a TBSR of 0.7, as the 1 − 𝜑𝑐𝑝 condition is 
satisfied. However, this was not observed experimentally, with all solid being incorporated into the 
agglomerates formed. 
Figure 6.28. The time evolution of solid fraction within the bulk solution for the immersion rate 
limited regime, with variations in TBSR shown.  
Figure 6.29. The time evolution of solid fraction within the bulk solution for the collision rate limited 
regime, with variations in TBSR shown. 
 
 Effect of Solid Loading 
 The influence of solid loading on the immersion rate and collision rate limited regimes was also 
considered through analysis of the 𝜑𝑐𝑝 profiles. The solid loading, at 1 % w/w, 5 % w/w and 9 % w/w 
produced results contrasting to those when investigating varied TBSR values.  In the immersion rate 
limited regime, changes in the solid loading of the system have no influence on the time taken for the 
bulk solids concentration to reach zero. This is shown in Figure 6.30, and occurs as the solid loading is 
not included in this parameter (see Equation 6.5). However, and as noted in Section 6.2.4 the solid 
loading does, in fact, play a role in the immersion nucleation kinetics. 
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Figure 6.30. The time evolution of solid fraction within the bulk solution for the immersion rate 
limited regime, with variations in solid loading shown.  
 
 
 The collision rate limited regime predicts rapid decreases in the bulk solution solid 
concentration for systems with an increased level of solid loading. Systems with a 1 % w/w solid loading 
exhibited change over a much longer time frame (see Figure 6.31). There also appears to be cross-over 
point between all three solid loadings, although often the time 𝑡𝑖𝑚𝑚 is reached first. If present, this is 
a similar trend to that observed in Figure 6.11. Mechanistically, this result suggests that for higher solid 
loadings, particles are often wetted and incorporated into agglomerate nuclei exceptionally quickly, as 
more particle-nuclei collisions occur. As the particle concentration in the bulk solution decreases, the 
rate of collisions decreases, hence the slower rate seen later on. At higher solid loadings, the nuclei 
size becomes larger quicker. This is represented by the rate of reduction of the bulk solids 
concentration being higher in these conditions. For example, in Figure 6.31, at 0.2 seconds the rate of 
reduction in the bulk solids concentration is higher at 9 % loading, than both 5 % and 1 % conditions. 
As such, the time for a paste to form would expected to be lower at solids loadings of 9 %.  
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Figure 6.31. The time evolution of solid fraction within the bulk solution for the collision rate limited 
regime, with variations in solid loading shown. 
 
 Experimental vs Modelling Observations 
 In all model predictions, the predicted agglomeration times are several orders of magnitude 
different to those observed experimentally. This can be attributed to the direct result of the model 
considering the time for nucleation only, and not the time for the formation of a paste itself. Here, the 
time for nucleation describes the time required for particles to be captured by the bridging liquid 
droplet. Thus, the time taken for compaction and rearrangement of constituent crystals within an 
agglomerate nuclei is not considered. This process would allow further bridging liquid to become 
available at the nuclei surface, either to incorporate fines or un-agglomerated material from within the 
suspension or promote coalescence of individual agglomerate nuclei. Once the former of these 
processes has finished, then only agglomerate coalescence can occur, and thus, depending on the 
available bridging liquid at the surface of the nuclei, a paste is then formed.  It should be noted that 
the time for the rearrangement and densification of nuclei takes a much longer time than anticipated 
in the case of paracetamol, most likely due to the needle-like morphology of primary particles.   
 However, the overall trends predicted by the model were observed experimentally. This 
indicates that the core theory of the model is correct and that, in the case of the paracetamol-heptane-
water system, agglomeration is limited by the immersion rate of the solid inside bridging liquid 
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droplets. There are several possible reasons why the timescale for this rate process are experimentally 
different to the model prediction. The mathematical model here assumes that the solution is mono-
dispersed – something which was not achieved experimentally. This was supported by the high degree 
of flocculation of paracetamol observed prior to the addition of bridging liquid. Additionally, the 
contact angle of water on paracetamol was found to be approximately 45o, much higher than literature 
values for other bridging liquid-solid systems. This is also much lower than the values measured for 
bridging liquids on salicylic acid, as used within Chapter 5.  
 
  Conclusions 
 Paracetamol-heptane-water systems have been used to observe the immersion nucleation 
mechanism in-situ as a means of further developing mechanistic understanding. This includes the 
formation of agglomerate nuclei and their evolution into dense, spherical agglomerates. Here, a critical 
range of a TBSR of 0.7 – 0.8 was identified. This aligns with previously identified works, in which the 
optimal TBSR range and critical packing liquid volume fraction are directly related. This serves as an 
initial validation of the theory.  
 Four other distinct zones of operation were identified. These zones are separated by significant 
changes in the agglomerate properties, including their size, size distribution, porosity, and sphericity. 
These zones are also characterised by whether a paste forms and the time required for the onset of 
paste formation. Zone A represents systems where the TBSR is below the optimal range and is 
characterised by a high level of fines in solution (TBSR < 0.7). Here, the bridging liquid available is rapidly 
depleted and, thus, the formation of a paste was not observed, even at long residence times of 300 
mins. Zone B represents the optimal range in which all particles are incorporated into spherical 
agglomerates. Here, agglomerates are more well-formed, reflected in their larger size, high sphericity, 
and density. When TBSR is higher than in Zone B, the agglomerate quality begins to decrease. A paste 
also forms providing the residence time is long enough.  
 Interestingly, these demarcated zones are still present and hold for changes in the solid loading 
of the system of interest. Slight differences in the time to paste were observed. At a TBSR of 
approximately 1.3, the time to paste curves intersect which provides further insights into the 
agglomeration kinetics of this study: between TBSR of 0.8 and 1.3, agglomeration is limited by the 
bridging liquid volume available; above this range, excess bridging liquid promotes nuclei coalescence 
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and the onset of a paste. Higher solid loading values were shown to reduce the average size of 
agglomerates from approximately 1050 µm to 700 µm, whilst increasing the density from 
approximately 0.63 g cm-3 to 0.82 g cm-3. An increase in the shear of experiments was also found to 
promote similar changes in agglomerate characteristics.  
 A previously developed mathematical model was also used to evaluate the system of interest 
and draw comparison between the predicted and observed behaviours. Here, the general trends are 
the same for both, which serves as an initial validation of the model. However, the timescales predicted 
by the model are several magnitudes of order quicker. This can be attributed to the model only 
accounting for the nucleation time, and not the time for the compaction and rearrangement of 
constituent particles within agglomerate nuclei. Ultimately, the rate of this densification process will 
dictate the speed at which bridging liquid becomes available at the agglomerate surface, and thus, the 
time required for the formation of a paste. Further work characterising agglomerate nuclei at different 
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 Conclusions 
Within this thesis, the influence of bridging liquid miscibility on the bridging liquid volume in 
spherical agglomeration processes has been identified. This influence has been quantitatively analysed 
through the use of simulations and experimental procedures. To account for this, a new process 
parameter, the true bridging liquid-solid ratio, has been developed and proposed. This definition is 
quantified as the total volume of the bridging liquid rich phase, which may be calculated by analysing 
solvent miscibility through ternary phase diagrams. As such, different bridging liquids and bulk solution 
compositions have no effect on this new process parameter, as their influence is accounted for within 
the calculations. This also extends to the solid loading concentration of the spherical agglomeration 
process under consideration.  
As such, this new definition provides an instant comparison tool across different processes, 
regardless of these three aforementioned operating parameters. As the definition combines these 
three parameters together, and is indeed a dimensionless parameter, it should be used in subsequent 
future works as the beginnings of a regime map. The rationale of the definition has been supported 
through subsequent validation procedures within this body of work. The ease at which different 
systems can be compared has been demonstrated. Further results and analysis of the fraction of 
available bridging liquid, as a proportion of that originally added, has also been considered alongside 
agglomerate properties and size distributions. This provides further power in using the definition as a 
method of benchmarking spherical agglomeration processes.  
 The immersion nucleation mechanism has also been investigated within this thesis, using 
paracetamol as a model compound. From this investigation, a critical TBSR range was identified. 
Additional to this, distinct operating regimes were identified, all of which produced unique end 
agglomerate properties. The underlying mechanisms which govern these processes has been 
elucidated through identifying agglomeration formation, densification, and breakage over time. These 
kinetic results have been established through a novel sampling technique using aliquots and bridging 
liquid dyes. The results have also been compared to a mathematical model previously developed, 
which highlights that there is still much to learn. Whilst the model accurately predicts the overall trends 
occurring in immersion nucleation only spherical agglomeration processes, the timescales of such 
trends were found to be several orders of magnitudes slower than predicted by the model. This has 
identified a current limitation of this model, in which the time for the compaction and rearrangement 
of constituent particles within agglomerate nuclei is not accounted for.  
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 Future Work 
The recommendations for future work are as follows: 
➢ Undertake experimental investigations for further ternary solvent systems and other 
particulates as means of further validating the TBSR definition proposed in this thesis. 
 
➢ Investigate relaxing some of the assumptions in the TBSR definition to incorporate the degree 
of solid solubility within the bridging liquid rich phase during the spherical agglomeration 
processes.  
  
➢ Further develop novel techniques, such as dyed bridging liquid, to promote and image the 
immersion mechanism in-situ to improve mechanistic understanding of wetting and 
nucleation in spherical agglomeration. Ideally, such studies should incorporate both bridging 
liquid droplet and particulate size control concurrently to ensure immersion nucleation.    
 
➢ Study the timescales for the incorporation of crystalline particles into bridging liquid droplets 
and the compaction and rearrangement of constituent particles, paying particular attention to 
the influence of the solvent properties, for example, interfacial tension, wettability etc. 
There are further areas within spherical agglomeration which also require further research. Whilst all 
studies may provide beneficial findings in spherical agglomeration as a whole, studies surrounding 
wetting and nucleation should be given priority. Ultimately, accurate control of this rate process will 
dictate how agglomerates form, grow and break, which determine the agglomerate properties 
themselves. Thus, wetting and nucleation may provide a crucial stepping-stone for the engineering of 
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This part of Appendix A corresponds to Section 4.3.1 in Chapter 4. The full results from titrations are 
presented in the following tables, bridging liquid by bridging liquid.  














0.760 1.060 20.000 21.820 0.035 0.049 0.917 
0.140 1.070 18.850 20.060 0.007 0.053 0.940 
0.240 1.090 19.010 20.340 0.012 0.054 0.935 
0.450 1.980 18.220 20.650 0.022 0.096 0.882 
0.280 2.010 18.040 20.330 0.014 0.099 0.887 
0.340 1.990 18.420 20.750 0.016 0.096 0.888 
0.410 2.920 18.380 21.710 0.019 0.135 0.847 
0.540 3.010 17.690 21.240 0.025 0.142 0.833 
0.410 2.960 18.780 22.150 0.019 0.134 0.848 
0.350 4.000 16.380 20.730 0.017 0.193 0.790 
0.280 4.020 16.880 21.180 0.013 0.190 0.797 
0.350 4.000 15.920 20.270 0.017 0.197 0.785 
0.460 5.340 15.790 21.590 0.021 0.247 0.731 
0.410 5.130 15.120 20.660 0.020 0.248 0.732 
0.420 5.010 16.820 22.250 0.019 0.225 0.756 
0.290 6.000 14.410 20.700 0.014 0.290 0.696 
0.380 6.130 14.100 20.610 0.018 0.297 0.684 
0.480 6.180 14.250 20.910 0.023 0.296 0.681 
0.550 7.100 13.150 20.800 0.026 0.341 0.632 
0.590 7.130 13.490 21.210 0.028 0.336 0.636 
0.690 7.030 13.390 21.110 0.033 0.333 0.634 
0.760 8.070 12.380 21.210 0.036 0.380 0.584 
0.790 8.100 12.730 21.620 0.037 0.375 0.589 
0.560 7.950 12.130 20.640 0.027 0.385 0.588 
0.860 8.920 11.550 21.330 0.040 0.418 0.541 
0.850 9.340 11.020 21.210 0.040 0.440 0.520 
0.770 9.030 11.810 21.610 0.036 0.418 0.547 
1.370 10.240 10.270 21.880 0.063 0.468 0.469 
1.140 10.230 10.200 21.570 0.053 0.474 0.473 
0.990 10.060 10.010 21.060 0.047 0.478 0.475 
1.310 11.230 9.080 21.620 0.061 0.519 0.420 
1.260 11.050 9.010 21.320 0.059 0.518 0.423 
1.240 11.150 9.550 21.940 0.057 0.508 0.435 
1.800 11.990 8.720 22.510 0.080 0.533 0.387 
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1.760 11.970 8.020 21.750 0.081 0.550 0.369 
1.800 11.990 8.720 22.510 0.080 0.533 0.387 
1.770 12.090 8.220 22.080 0.080 0.548 0.372 
2.150 13.050 7.210 22.410 0.096 0.582 0.322 
2.130 12.970 7.090 22.190 0.096 0.584 0.320 
1.860 12.990 7.750 22.600 0.082 0.575 0.343 
2.980 14.050 6.100 23.130 0.129 0.607 0.264 
2.780 14.250 6.870 23.900 0.116 0.596 0.287 
3.100 14.020 6.380 23.500 0.132 0.597 0.271 
4.850 14.990 4.930 24.770 0.196 0.605 0.199 
4.100 15.070 5.720 24.890 0.165 0.605 0.230 
4.820 15.080 5.170 25.070 0.192 0.602 0.206 
6.430 16.000 4.500 26.930 0.239 0.594 0.167 
7.620 16.280 3.990 27.890 0.273 0.584 0.143 
7.130 15.860 4.130 27.120 0.263 0.585 0.152 
10.660 16.950 3.150 30.760 0.347 0.551 0.102 
11.080 17.090 3.050 31.220 0.355 0.547 0.098 
10.570 16.920 3.100 30.590 0.346 0.553 0.101 
16.570 17.940 2.000 36.510 0.454 0.491 0.055 
17.540 17.960 1.990 37.490 0.468 0.479 0.053 
13.200 17.980 2.780 33.960 0.389 0.529 0.082 
32.480 19.070 1.080 52.630 0.617 0.362 0.021 
30.230 18.940 1.110 50.280 0.601 0.377 0.022 
27.400 18.930 1.040 47.370 0.578 0.400 0.022 
8.370 11.690 2.610 22.670 0.369 0.516 0.115 
8.280 12.090 2.860 23.230 0.356 0.520 0.123 
9.360 11.970 1.930 23.260 0.402 0.515 0.083 
10.180 10.380 1.210 21.770 0.468 0.477 0.056 
9.710 10.360 1.090 21.160 0.459 0.490 0.052 
10.020 10.140 1.310 21.470 0.467 0.472 0.061 
11.730 8.530 0.950 21.210 0.553 0.402 0.045 
12.920 7.730 0.890 21.540 0.600 0.359 0.041 
12.150 7.740 0.720 20.610 0.590 0.376 0.035 
13.890 6.000 0.660 20.550 0.676 0.292 0.032 
15.870 6.400 0.650 22.920 0.692 0.279 0.028 
14.550 6.280 0.550 21.380 0.681 0.294 0.026 
16.320 4.200 0.720 21.240 0.768 0.198 0.034 
16.000 4.450 0.380 20.830 0.768 0.214 0.018 
16.230 4.140 0.490 20.860 0.778 0.198 0.023 
19.120 2.060 0.520 21.700 0.881 0.095 0.024 
18.180 1.550 0.510 20.240 0.898 0.077 0.025 


















1.390 1.200 19.040 21.630 0.06 0.06 0.88 
0.361 0.990 19.630 20.981 0.02 0.05 0.94 
1.370 1.060 18.790 21.220 0.06 0.05 0.89 
0.540 2.020 18.380 20.940 0.03 0.10 0.88 
1.000 1.940 18.560 21.500 0.05 0.09 0.86 
1.180 2.000 17.950 21.130 0.06 0.09 0.85 
0.670 3.030 17.010 20.710 0.03 0.15 0.82 
0.570 3.210 17.050 20.830 0.03 0.15 0.82 
0.480 3.010 17.050 20.540 0.02 0.15 0.83 
0.490 3.960 14.020 18.470 0.03 0.21 0.76 
0.890 4.040 15.910 20.840 0.04 0.19 0.76 
0.420 4.140 15.900 20.460 0.02 0.20 0.78 
1.030 5.050 14.960 21.040 0.05 0.24 0.71 
0.600 5.050 14.950 20.600 0.03 0.25 0.73 
0.520 5.050 15.000 20.570 0.03 0.25 0.73 
0.500 6.360 14.780 21.640 0.02 0.29 0.68 
0.260 6.030 13.870 20.160 0.01 0.30 0.69 
0.250 6.150 14.010 20.410 0.01 0.30 0.69 
0.270 7.350 12.930 20.550 0.01 0.36 0.63 
0.410 6.920 12.930 20.260 0.02 0.34 0.64 
0.210 7.060 12.960 20.230 0.01 0.35 0.64 
0.330 8.056 12.410 20.796 0.02 0.39 0.60 
0.260 8.000 12.200 20.460 0.01 0.39 0.60 
0.300 8.430 12.050 20.780 0.01 0.41 0.58 
0.360 9.170 11.180 20.710 0.02 0.44 0.54 
0.370 8.980 11.370 20.720 0.02 0.43 0.55 
0.430 9.330 11.030 20.790 0.02 0.45 0.53 
0.460 9.970 10.000 20.430 0.02 0.49 0.49 
0.430 10.460 10.370 21.260 0.02 0.49 0.49 
0.490 10.030 9.920 20.440 0.02 0.49 0.49 
0.470 11.020 9.010 20.500 0.02 0.54 0.44 
0.930 11.330 8.940 21.200 0.04 0.53 0.42 
0.963 11.320 9.000 21.283 0.05 0.53 0.42 
0.900 12.900 7.210 21.010 0.04 0.61 0.34 
0.840 12.220 7.930 20.990 0.04 0.58 0.38 
0.700 12.060 8.080 20.840 0.03 0.58 0.39 
0.880 13.260 7.190 21.330 0.04 0.62 0.34 
0.860 13.240 7.290 21.390 0.04 0.62 0.34 
0.900 12.900 7.210 21.010 0.04 0.61 0.34 
0.980 14.130 6.340 21.450 0.05 0.66 0.30 
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1.240 14.010 6.050 21.300 0.06 0.66 0.28 
1.070 14.000 5.950 21.020 0.05 0.67 0.28 
1.480 15.380 5.000 21.860 0.07 0.70 0.23 
1.420 15.330 4.980 21.730 0.07 0.71 0.23 
1.320 14.780 4.990 21.090 0.06 0.70 0.24 
1.770 15.970 4.170 21.910 0.08 0.73 0.19 
1.880 15.990 3.840 21.710 0.09 0.74 0.18 
2.080 16.370 4.060 22.510 0.09 0.73 0.18 
2.540 17.070 3.060 22.670 0.11 0.75 0.13 
2.800 17.000 3.030 22.830 0.12 0.74 0.13 
2.680 17.360 3.170 23.210 0.12 0.75 0.14 
7.230 18.160 1.550 26.940 0.27 0.67 0.06 
4.730 18.260 1.940 24.930 0.19 0.73 0.08 
4.790 18.090 1.880 24.760 0.19 0.73 0.08 
10.320 19.120 0.880 30.320 0.34 0.63 0.03 
6.520 19.130 1.310 26.960 0.24 0.71 0.05 
9.340 19.480 1.130 29.950 0.31 0.65 0.04 
8.490 12.310 0.860 21.660 0.39 0.57 0.04 
8.730 11.550 0.530 20.810 0.42 0.56 0.03 
8.400 12.370 0.590 21.360 0.39 0.58 0.03 
10.490 10.200 0.550 21.240 0.49 0.48 0.03 
9.840 10.390 0.670 20.900 0.47 0.50 0.03 
10.400 10.220 0.470 21.090 0.49 0.48 0.02 
12.160 7.860 0.450 20.470 0.59 0.38 0.02 
13.170 8.310 0.590 22.070 0.60 0.38 0.03 
12.080 7.960 0.590 20.630 0.59 0.39 0.03 
14.210 5.980 0.450 20.640 0.69 0.29 0.02 
14.740 6.480 0.370 21.590 0.68 0.30 0.02 
14.360 6.190 0.340 20.890 0.69 0.30 0.02 
16.330 3.960 0.330 20.620 0.79 0.19 0.02 
16.530 4.010 0.370 20.910 0.79 0.19 0.02 
16.640 4.060 0.410 21.110 0.79 0.19 0.02 
18.460 1.880 0.510 20.850 0.89 0.09 0.02 
18.320 2.160 0.350 20.830 0.88 0.10 0.02 



















0.750 1.030 19.220 21.000 0.04 0.05 0.92 
0.570 1.010 18.870 20.450 0.03 0.05 0.92 
0.890 1.120 19.070 21.080 0.04 0.05 0.90 
0.910 2.050 18.010 20.970 0.04 0.10 0.86 
0.870 2.180 18.140 21.190 0.04 0.10 0.86 
0.950 2.130 17.930 21.010 0.05 0.10 0.85 
0.710 3.100 17.020 20.830 0.03 0.15 0.82 
0.470 3.010 18.340 21.820 0.02 0.14 0.84 
0.530 3.010 17.080 20.620 0.03 0.15 0.83 
0.730 3.920 16.540 21.190 0.03 0.18 0.78 
0.860 0.960 16.450 18.270 0.05 0.05 0.90 
0.630 4.020 16.460 21.110 0.03 0.19 0.78 
0.960 5.290 15.090 21.340 0.04 0.25 0.71 
0.940 4.960 15.010 20.910 0.04 0.24 0.72 
0.940 5.090 15.120 21.150 0.04 0.24 0.71 
1.400 6.080 14.040 21.520 0.07 0.28 0.65 
1.000 6.050 14.100 21.150 0.05 0.29 0.67 
1.020 6.150 14.030 21.200 0.05 0.29 0.66 
1.190 7.150 13.230 21.570 0.06 0.33 0.61 
1.570 7.510 13.000 22.080 0.07 0.34 0.59 
1.690 7.080 13.150 21.920 0.08 0.32 0.60 
1.540 8.380 12.320 22.240 0.07 0.38 0.55 
1.690 8.070 12.300 22.060 0.08 0.37 0.56 
1.410 8.150 12.020 21.580 0.07 0.38 0.56 
1.760 8.930 10.960 21.650 0.08 0.41 0.51 
2.100 9.260 11.330 22.690 0.09 0.41 0.50 
1.880 9.530 10.980 22.390 0.08 0.43 0.49 
2.270 9.990 10.130 22.390 0.10 0.45 0.45 
2.140 9.990 10.910 23.040 0.09 0.43 0.47 
2.650 10.150 9.860 22.660 0.12 0.45 0.44 
3.910 11.370 9.240 24.520 0.16 0.46 0.38 
3.170 11.050 9.030 23.250 0.14 0.48 0.39 
3.020 10.910 8.930 22.860 0.13 0.48 0.39 
3.490 12.390 10.120 26.000 0.13 0.48 0.39 
4.560 11.900 8.320 24.780 0.18 0.48 0.34 
4.460 12.030 7.930 24.420 0.18 0.49 0.32 
5.950 12.940 7.150 26.040 0.23 0.50 0.27 
6.100 13.130 7.280 26.510 0.23 0.50 0.27 
6.260 13.030 7.130 26.420 0.24 0.49 0.27 
8.910 14.130 6.180 29.220 0.30 0.48 0.21 
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7.960 14.030 6.690 28.680 0.28 0.49 0.23 
8.600 14.080 6.250 28.930 0.30 0.49 0.22 
13.160 15.250 5.020 33.430 0.39 0.46 0.15 
12.610 15.080 5.040 32.730 0.39 0.46 0.15 
12.610 15.510 5.440 33.560 0.38 0.46 0.16 
18.900 16.220 3.980 39.100 0.48 0.41 0.10 
17.600 15.880 4.120 37.600 0.47 0.42 0.11 
18.320 16.060 4.130 38.510 0.48 0.42 0.11 
29.490 17.370 3.410 50.270 0.59 0.35 0.07 
29.820 17.250 3.160 50.230 0.59 0.34 0.06 
30.520 17.220 3.020 50.760 0.60 0.34 0.06 
7.750 11.810 5.610 25.170 0.31 0.47 0.22 
8.330 12.110 5.250 25.690 0.32 0.47 0.20 
7.930 12.240 5.380 25.550 0.31 0.48 0.21 
10.190 10.120 3.420 23.730 0.43 0.43 0.14 
9.950 9.710 2.980 22.640 0.44 0.43 0.13 
10.000 10.250 3.100 23.350 0.43 0.44 0.13 
12.240 8.170 2.100 22.510 0.54 0.36 0.09 
12.170 7.900 2.040 22.110 0.55 0.36 0.09 
12.170 8.100 1.790 22.060 0.55 0.37 0.08 
14.200 6.400 1.370 21.970 0.65 0.29 0.06 
14.460 6.060 1.100 21.620 0.67 0.28 0.05 
14.180 6.110 1.070 21.360 0.66 0.29 0.05 
15.980 4.110 0.910 21.000 0.76 0.20 0.04 
16.620 4.170 1.140 21.930 0.76 0.19 0.05 
16.370 3.700 0.780 20.850 0.79 0.18 0.04 
18.300 2.100 0.800 21.200 0.86 0.10 0.04 
18.110 2.040 0.930 21.080 0.86 0.10 0.04 
18.440 2.190 1.020 21.650 0.85 0.10 0.05 
16.320 4.200 0.720 21.240 0.77 0.20 0.03 
16.000 4.450 0.380 20.830 0.77 0.21 0.02 
16.230 4.140 0.490 20.860 0.78 0.20 0.02 
19.120 2.060 0.520 21.700 0.88 0.09 0.02 
18.180 1.550 0.510 20.240 0.90 0.08 0.03 


















1.250 1.440 20.900 23.590 0.05 0.06 0.89 
0.490 0.990 19.090 20.570 0.02 0.05 0.93 
0.480 1.200 19.110 20.790 0.02 0.06 0.92 
0.690 2.110 18.320 21.120 0.03 0.10 0.87 
0.240 2.100 18.040 20.380 0.01 0.10 0.89 
0.280 1.950 17.900 20.130 0.01 0.10 0.89 
0.210 3.110 16.900 20.220 0.01 0.15 0.84 
0.390 3.040 17.010 20.440 0.02 0.15 0.83 
0.470 3.180 16.990 20.640 0.02 0.15 0.82 
0.580 3.980 15.980 20.540 0.03 0.19 0.78 
0.660 4.060 16.710 21.430 0.03 0.19 0.78 
0.600 3.960 15.960 20.520 0.03 0.19 0.78 
0.440 5.120 14.960 20.520 0.02 0.25 0.73 
0.630 5.000 15.150 20.780 0.03 0.24 0.73 
0.560 5.190 14.960 20.710 0.03 0.25 0.72 
0.800 6.330 14.130 21.260 0.04 0.30 0.66 
0.970 6.000 14.040 21.010 0.05 0.29 0.67 
0.950 6.010 13.980 20.940 0.05 0.29 0.67 
1.150 7.380 13.120 21.650 0.05 0.34 0.61 
1.160 6.960 13.710 21.830 0.05 0.32 0.63 
0.980 6.980 13.260 21.220 0.05 0.33 0.62 
1.310 8.400 12.250 21.960 0.06 0.38 0.56 
1.370 8.230 12.000 21.600 0.06 0.38 0.56 
1.230 8.110 12.020 21.360 0.06 0.38 0.56 
1.440 8.940 10.980 21.360 0.07 0.42 0.51 
1.640 9.130 10.960 21.730 0.08 0.42 0.50 
1.270 8.990 12.250 22.510 0.06 0.40 0.54 
1.840 10.220 9.940 22.000 0.08 0.46 0.45 
1.950 10.190 9.800 21.940 0.09 0.46 0.45 
2.030 9.940 9.870 21.840 0.09 0.46 0.45 
2.390 11.010 8.900 22.300 0.11 0.49 0.40 
2.320 11.300 9.050 22.670 0.10 0.50 0.40 
2.070 10.950 9.040 22.060 0.09 0.50 0.41 
3.050 12.020 7.880 22.950 0.13 0.52 0.34 
2.880 11.950 8.160 22.990 0.13 0.52 0.35 
3.260 12.350 7.910 23.520 0.14 0.53 0.34 
4.810 13.250 7.170 25.230 0.19 0.53 0.28 
4.030 12.900 7.860 24.790 0.16 0.52 0.32 
4.490 13.020 7.010 24.520 0.18 0.53 0.29 
5.200 13.810 7.000 26.010 0.20 0.53 0.27 
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6.580 14.260 6.150 26.990 0.24 0.53 0.23 
5.970 14.260 6.070 26.300 0.23 0.54 0.23 
8.170 14.970 5.440 28.580 0.29 0.52 0.19 
9.080 15.390 5.140 29.610 0.31 0.52 0.17 
8.960 14.860 4.930 28.750 0.31 0.52 0.17 
11.310 15.830 4.310 31.450 0.36 0.50 0.14 
8.320 16.010 7.330 31.660 0.26 0.51 0.23 
10.460 16.060 4.040 30.560 0.34 0.53 0.13 
15.100 17.430 3.900 36.430 0.41 0.48 0.11 
15.150 17.140 3.430 35.720 0.42 0.48 0.10 
15.000 17.000 3.300 35.300 0.42 0.48 0.09 
21.060 18.270 2.610 41.940 0.50 0.44 0.06 
22.750 18.010 1.860 42.620 0.53 0.42 0.04 
20.100 17.780 2.556 40.436 0.50 0.44 0.06 
38.500 19.410 0.880 58.790 0.65 0.33 0.01 
33.200 19.660 1.260 54.120 0.61 0.36 0.02 
38.960 18.820 1.760 59.540 0.65 0.32 0.03 
7.990 12.310 4.150 24.450 0.33 0.50 0.17 
8.200 12.190 4.060 24.450 0.34 0.50 0.17 
8.740 12.100 3.410 24.250 0.36 0.50 0.14 
10.120 9.850 1.850 21.820 0.46 0.45 0.08 
10.140 9.700 1.690 21.530 0.47 0.45 0.08 
10.290 9.920 1.970 22.180 0.46 0.45 0.09 
12.040 8.480 1.170 21.690 0.56 0.39 0.05 
12.210 7.970 1.220 21.400 0.57 0.37 0.06 
11.760 8.270 1.050 21.080 0.56 0.39 0.05 
14.126 5.930 0.870 20.926 0.68 0.28 0.04 
14.060 6.030 0.970 21.060 0.67 0.29 0.05 
14.410 6.100 0.850 21.360 0.67 0.29 0.04 
16.440 4.100 0.590 21.130 0.78 0.19 0.03 
16.570 3.930 0.690 21.190 0.78 0.19 0.03 
16.350 3.660 0.560 20.570 0.79 0.18 0.03 
19.190 2.010 0.810 22.010 0.87 0.09 0.04 
18.650 2.170 0.530 21.350 0.87 0.10 0.02 



















0.600 0.930 19.150 20.680 0.03 0.04 0.93 
0.570 1.300 19.040 20.910 0.03 0.06 0.91 
0.500 1.010 18.870 20.380 0.02 0.05 0.93 
0.370 2.030 17.950 20.350 0.02 0.10 0.88 
0.320 1.980 18.180 20.480 0.02 0.10 0.89 
0.220 2.040 18.100 20.360 0.01 0.10 0.89 
0.480 3.000 16.990 20.470 0.02 0.15 0.83 
0.580 2.970 17.540 21.090 0.03 0.14 0.83 
0.730 3.080 16.990 20.800 0.04 0.15 0.82 
0.210 3.930 16.140 20.280 0.01 0.19 0.80 
0.016 4.200 16.060 20.276 0.00 0.21 0.79 
0.180 4.070 16.040 20.290 0.01 0.20 0.79 
0.220 4.950 14.900 20.070 0.01 0.25 0.74 
0.130 5.160 15.120 20.410 0.01 0.25 0.74 
0.130 5.200 15.350 20.680 0.01 0.25 0.74 
0.170 6.160 13.920 20.250 0.01 0.30 0.69 
0.150 5.820 14.270 20.240 0.01 0.29 0.71 
0.220 5.930 13.980 20.130 0.01 0.29 0.69 
0.230 7.020 13.230 20.480 0.01 0.34 0.65 
0.230 7.100 13.080 20.410 0.01 0.35 0.64 
0.520 6.910 12.960 20.390 0.03 0.34 0.64 
0.750 8.060 11.860 20.670 0.04 0.39 0.57 
0.580 8.080 12.550 21.210 0.03 0.38 0.59 
0.650 7.920 12.250 20.820 0.03 0.38 0.59 
0.600 9.040 11.120 20.760 0.03 0.44 0.54 
0.600 8.840 11.990 21.430 0.03 0.41 0.56 
0.780 8.840 10.940 20.560 0.04 0.43 0.53 
0.900 9.870 9.990 20.760 0.04 0.48 0.48 
0.700 9.990 9.980 20.670 0.03 0.48 0.48 
0.800 10.100 10.250 21.150 0.04 0.48 0.48 
0.850 10.970 9.040 20.860 0.04 0.53 0.43 
0.940 10.910 9.220 21.070 0.04 0.52 0.44 
0.870 10.920 9.040 20.830 0.04 0.52 0.43 
1.150 12.080 8.090 21.320 0.05 0.57 0.38 
1.180 12.100 8.020 21.300 0.06 0.57 0.38 
1.280 12.120 8.000 21.400 0.06 0.57 0.37 
1.480 13.090 7.520 22.090 0.07 0.59 0.34 
1.420 13.110 7.850 22.380 0.06 0.59 0.35 
1.470 13.050 6.980 21.500 0.07 0.61 0.32 
2.090 14.090 6.050 22.230 0.09 0.63 0.27 
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2.070 14.080 6.100 22.250 0.09 0.63 0.27 
1.970 14.020 6.260 22.250 0.09 0.63 0.28 
2.893 15.080 5.080 23.053 0.13 0.65 0.22 
3.250 14.970 5.000 23.220 0.14 0.64 0.22 
2.940 14.980 5.100 23.020 0.13 0.65 0.22 
4.870 15.980 3.840 24.690 0.20 0.65 0.16 
4.270 15.970 4.200 24.440 0.17 0.65 0.17 
4.873 16.410 4.010 25.293 0.19 0.65 0.16 
7.060 16.954 2.990 27.004 0.26 0.63 0.11 
7.270 17.350 2.970 27.590 0.26 0.63 0.11 
6.610 16.870 3.040 26.520 0.25 0.64 0.11 
10.140 17.910 2.140 30.190 0.34 0.59 0.07 
12.840 18.250 1.970 33.060 0.39 0.55 0.06 
10.890 18.330 2.000 31.220 0.35 0.59 0.06 
18.560 19.130 1.000 38.690 0.48 0.49 0.03 
17.430 18.990 1.100 37.520 0.46 0.51 0.03 
17.080 19.060 1.014 37.154 0.46 0.51 0.03 
9.340 11.930 0.930 22.200 0.42 0.54 0.04 
7.720 11.910 1.130 20.760 0.37 0.57 0.05 
8.510 12.090 1.040 21.640 0.39 0.56 0.05 
9.930 9.650 0.860 20.440 0.49 0.47 0.04 
9.860 9.620 0.850 20.330 0.48 0.47 0.04 
10.090 9.990 0.720 20.800 0.49 0.48 0.03 
12.120 8.770 0.760 21.650 0.56 0.41 0.04 
13.440 8.330 0.880 22.650 0.59 0.37 0.04 
12.840 8.270 0.670 21.780 0.59 0.38 0.03 
13.790 6.400 0.290 20.480 0.67 0.31 0.01 
13.900 6.470 0.270 20.640 0.67 0.31 0.01 
13.910 5.930 0.220 20.060 0.69 0.30 0.01 
15.910 4.100 0.480 20.490 0.78 0.20 0.02 
16.550 4.000 0.210 20.760 0.80 0.19 0.01 
16.160 4.130 0.250 20.540 0.79 0.20 0.01 
18.680 1.860 0.240 20.780 0.90 0.09 0.01 
19.260 2.100 0.220 21.580 0.89 0.10 0.01 





This part of Appendix A corresponds to Section 4.2 in Chapter 4. Here, the raw data from Aspen models 
is presented for each bridging liquid in-turn. Note, Aspen does not produce results in mass fractions, 
but mole fractions. The data was extracted and then converted into mass fractions. The values of 
molecular weight to do this can be found in Table A.6.  
 
Table A.6. Standard properties of solvents used at 1 atmosphere and 25 oC [76]. 
 Molecular Formula Molecular Weight Density 
Solvent (-) (g mol-1) (g cm-3) 
Acetone C3H6O 58.079 0.7845 
Chloroform CHCl3 119.378 1.4788 
Heptane C7H16 100.202 0.6795 
MIBK C6H12O 100.158 0.7965 
n-Butyl acetate C6H12O2 116.158 0.8825a 
Toluene C7H8 92.139 0.8668a 
Water H2O 18.015 0.9970 
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Table A.7. Raw data from Aspen for the phase envelope of chloroform ternary phase diagrams from 
UNIF-LL. Mass fractions were calculated from the molecular weight of each component.  
Mole Fraction Mass Fraction 
Water Acetone Chloroform Water Acetone Chloroform 
0.999 0.000 0.001 0.993 0.000 0.007 
0.970 0.029 0.002 0.903 0.086 0.011 
0.951 0.047 0.002 0.850 0.136 0.013 
0.933 0.064 0.003 0.806 0.178 0.016 
0.914 0.082 0.003 0.761 0.220 0.019 
0.890 0.106 0.004 0.706 0.271 0.022 
0.852 0.143 0.006 0.630 0.340 0.029 
0.791 0.199 0.010 0.528 0.429 0.043 
0.675 0.303 0.022 0.376 0.543 0.081 
0.606 0.360 0.034 0.304 0.584 0.112 
0.606 0.361 0.032 0.305 0.587 0.108 
0.609 0.360 0.030 0.309 0.589 0.102 
0.591 0.375 0.034 0.292 0.598 0.110 
0.578 0.385 0.038 0.280 0.600 0.120 
0.542 0.411 0.047 0.249 0.609 0.142 
0.536 0.416 0.048 0.244 0.612 0.144 
0.235 0.598 0.167 0.072 0.590 0.338 
0.112 0.607 0.281 0.029 0.498 0.473 
0.067 0.547 0.386 0.015 0.402 0.583 
0.043 0.464 0.493 0.009 0.311 0.680 
0.028 0.367 0.604 0.005 0.227 0.768 
0.018 0.260 0.721 0.003 0.149 0.848 




Table A.8. Raw data from Aspen for the tie-lines of the UNIF-LL chloroform prediction. 
LEFT SIDE POINT (Mole Frac.) RIGHT SIDE POINT (Mole Frac.) 
Water Acetone Chloroform Water Acetone Chloroform 
0.005 0.000 0.995 0.999 0.000 0.001 
0.006 0.025 0.969 0.993 0.006 0.001 
0.007 0.050 0.943 0.988 0.011 0.001 
0.008 0.076 0.916 0.982 0.016 0.001 
0.009 0.103 0.888 0.977 0.021 0.002 
0.010 0.131 0.859 0.972 0.026 0.002 
0.012 0.159 0.829 0.967 0.031 0.002 
0.013 0.188 0.798 0.962 0.036 0.002 
0.015 0.218 0.767 0.957 0.041 0.002 
0.017 0.249 0.734 0.952 0.045 0.002 
0.020 0.280 0.700 0.947 0.050 0.002 
0.023 0.312 0.665 0.942 0.055 0.002 
0.026 0.344 0.630 0.937 0.060 0.003 
0.030 0.377 0.593 0.931 0.066 0.003 
0.034 0.411 0.555 0.925 0.072 0.003 
0.040 0.444 0.516 0.919 0.078 0.003 
0.046 0.478 0.476 0.911 0.085 0.003 
0.055 0.511 0.435 0.902 0.094 0.004 
0.065 0.543 0.392 0.892 0.104 0.004 
0.079 0.572 0.348 0.878 0.117 0.005 
0.100 0.598 0.303 0.861 0.133 0.005 
0.131 0.615 0.254 0.839 0.155 0.007 
0.187 0.613 0.199 0.808 0.183 0.009 
0.309 0.564 0.127 0.773 0.216 0.011 
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Table A.9. Processed data from Aspen for the tie-lines of the UNIF-LL chloroform prediction. 
LEFT SIDE POINT (% w/w) RIGHT SIDE POINT (% w/w) 
Water Acetone Chloroform Water Acetone Chloroform 
0.001 0.000 0.999 0.993 0.000 0.007 
0.001 0.012 0.987 0.974 0.018 0.008 
0.001 0.025 0.974 0.957 0.034 0.009 
0.001 0.039 0.960 0.941 0.050 0.009 
0.001 0.053 0.945 0.925 0.065 0.010 
0.002 0.069 0.930 0.910 0.079 0.011 
0.002 0.085 0.913 0.896 0.093 0.011 
0.002 0.103 0.895 0.882 0.106 0.012 
0.003 0.121 0.876 0.869 0.119 0.012 
0.003 0.141 0.856 0.855 0.132 0.013 
0.004 0.162 0.834 0.842 0.144 0.014 
0.004 0.185 0.811 0.829 0.156 0.015 
0.005 0.209 0.786 0.816 0.169 0.015 
0.006 0.235 0.759 0.802 0.182 0.016 
0.007 0.263 0.730 0.787 0.196 0.017 
0.008 0.293 0.699 0.771 0.211 0.018 
0.010 0.325 0.665 0.753 0.228 0.019 
0.012 0.359 0.629 0.733 0.246 0.020 
0.015 0.396 0.589 0.710 0.268 0.022 
0.019 0.436 0.545 0.683 0.293 0.024 
0.025 0.478 0.498 0.649 0.324 0.027 
0.034 0.522 0.444 0.607 0.361 0.032 
0.054 0.567 0.379 0.555 0.406 0.039 





Table A.10. Raw data from Aspen for the phase envelope of heptane ternary phase diagrams from 
UNIFAC. Mass fractions were calculated from the molecular weight of each component.  
Mole Fraction Mass Fraction 
Water Acetone Heptane Water Acetone Heptane 
0.001 0.000 0.999 0.000 0.000 1.000 
0.004 0.168 0.828 0.001 0.105 0.894 
0.006 0.228 0.767 0.001 0.147 0.852 
0.008 0.278 0.714 0.002 0.184 0.815 
0.011 0.338 0.652 0.002 0.230 0.767 
0.013 0.371 0.616 0.003 0.258 0.739 
0.016 0.410 0.574 0.003 0.292 0.705 
0.020 0.459 0.521 0.005 0.337 0.659 
0.040 0.577 0.383 0.010 0.461 0.529 
0.039 0.594 0.367 0.010 0.479 0.511 
0.047 0.621 0.333 0.012 0.513 0.475 
0.057 0.629 0.314 0.015 0.529 0.456 
0.111 0.685 0.204 0.032 0.639 0.328 
0.173 0.687 0.140 0.055 0.700 0.246 
0.239 0.664 0.097 0.082 0.733 0.186 
0.309 0.624 0.067 0.115 0.747 0.138 
0.384 0.572 0.045 0.155 0.745 0.100 
0.463 0.509 0.028 0.205 0.726 0.069 
0.548 0.436 0.016 0.268 0.688 0.043 
0.639 0.353 0.008 0.351 0.625 0.024 
0.738 0.259 0.003 0.464 0.526 0.011 
0.839 0.161 0.001 0.616 0.381 0.003 
0.925 0.074 0.000 0.793 0.206 0.001 
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Table A.11. Raw data from Aspen for the tie-lines of the UNIFAC heptane prediction. 
LEFT SIDE POINT (Mole Frac.) RIGHT SIDE POINT (Mole Frac.) 
Water Acetone Heptane Water Acetone Heptane 
0.001 0.000 0.999 1.000 0.000 0.000 
0.001 0.032 0.967 0.982 0.018 0.000 
0.001 0.062 0.936 0.962 0.038 0.000 
0.002 0.090 0.908 0.940 0.060 0.000 
0.002 0.116 0.882 0.916 0.084 0.000 
0.003 0.139 0.858 0.888 0.112 0.000 
0.003 0.159 0.838 0.856 0.143 0.001 
0.004 0.176 0.820 0.820 0.179 0.001 
0.004 0.190 0.805 0.780 0.218 0.002 
0.005 0.203 0.793 0.738 0.259 0.003 
0.005 0.214 0.781 0.693 0.302 0.005 
0.006 0.225 0.769 0.648 0.345 0.007 
0.006 0.237 0.757 0.603 0.387 0.011 
0.006 0.249 0.744 0.557 0.428 0.015 
0.007 0.262 0.731 0.512 0.467 0.020 
0.008 0.277 0.716 0.467 0.505 0.027 
0.008 0.292 0.700 0.422 0.542 0.036 
0.009 0.309 0.682 0.377 0.576 0.046 
0.010 0.327 0.663 0.332 0.608 0.059 
0.011 0.347 0.641 0.287 0.637 0.075 
0.013 0.370 0.617 0.242 0.662 0.096 
0.015 0.396 0.589 0.195 0.681 0.124 
0.017 0.428 0.555 0.147 0.690 0.162 





Table A.12. Processed data from Aspen for the tie-lines of the UNIFAC heptane prediction. 
LEFT SIDE POINT (% w/w) RIGHT SIDE POINT (% w/w) 
Water Acetone Heptane Water Acetone Heptane 
0.000 0.000 1.000 1.000 0.000 0.000 
0.000 0.019 0.981 0.943 0.056 0.000 
0.000 0.037 0.963 0.887 0.113 0.000 
0.000 0.055 0.945 0.830 0.170 0.001 
0.000 0.071 0.929 0.771 0.228 0.001 
0.001 0.086 0.914 0.711 0.288 0.002 
0.001 0.099 0.900 0.648 0.349 0.003 
0.001 0.110 0.889 0.585 0.411 0.004 
0.001 0.120 0.879 0.523 0.470 0.007 
0.001 0.129 0.870 0.464 0.526 0.011 
0.001 0.137 0.862 0.409 0.575 0.016 
0.001 0.145 0.854 0.360 0.617 0.022 
0.001 0.153 0.845 0.316 0.653 0.031 
0.001 0.162 0.836 0.276 0.683 0.041 
0.001 0.172 0.827 0.240 0.706 0.053 
0.002 0.183 0.816 0.208 0.725 0.068 
0.002 0.194 0.804 0.178 0.738 0.084 
0.002 0.207 0.791 0.151 0.745 0.103 
0.002 0.222 0.776 0.127 0.748 0.125 
0.002 0.238 0.759 0.104 0.744 0.152 
0.003 0.257 0.740 0.083 0.734 0.184 
0.003 0.280 0.717 0.063 0.714 0.223 
0.004 0.308 0.688 0.045 0.679 0.276 
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Table A.13. Raw data from Aspen for the phase envelope of MIBK ternary phase diagrams from UNIFAC. 
Mass fractions were calculated from the molecular weight of each component.  
Mole Fraction Mass Fraction 
Water Acetone MIBK Water Acetone MIBK 
0.087 0.000 0.913 0.017 0.000 0.983 
0.109 0.220 0.671 0.024 0.156 0.820 
0.122 0.299 0.579 0.028 0.224 0.748 
0.154 0.417 0.429 0.040 0.346 0.614 
0.173 0.458 0.369 0.047 0.399 0.554 
0.246 0.521 0.233 0.077 0.521 0.402 
0.278 0.524 0.198 0.091 0.550 0.359 
0.335 0.510 0.155 0.118 0.578 0.304 
0.353 0.511 0.136 0.128 0.597 0.275 
0.349 0.513 0.138 0.126 0.598 0.276 
0.369 0.503 0.127 0.137 0.601 0.262 
0.375 0.500 0.125 0.140 0.601 0.259 
0.403 0.483 0.114 0.155 0.601 0.244 
0.447 0.456 0.097 0.182 0.599 0.219 
0.489 0.428 0.083 0.210 0.592 0.198 
0.545 0.389 0.066 0.251 0.578 0.170 
0.604 0.344 0.052 0.301 0.554 0.144 
0.663 0.297 0.040 0.360 0.520 0.120 
0.724 0.247 0.030 0.430 0.473 0.097 
0.783 0.196 0.021 0.510 0.412 0.077 
0.838 0.147 0.015 0.600 0.340 0.060 
0.887 0.103 0.011 0.694 0.259 0.047 




Table A.14. Raw data from Aspen for the tie-lines of the UNIFAC MIBK prediction. 
LEFT SIDE POINT (Mole Frac.) RIGHT SIDE POINT (Mole Frac.) 
Water Acetone MIBK Water Acetone MIBK 
0.087 0.000 0.913 0.996 0.000 0.004 
0.090 0.034 0.876 0.988 0.007 0.005 
0.092 0.068 0.840 0.980 0.015 0.005 
0.095 0.100 0.805 0.971 0.024 0.005 
0.098 0.131 0.770 0.961 0.033 0.006 
0.102 0.162 0.737 0.951 0.042 0.006 
0.105 0.191 0.704 0.940 0.053 0.007 
0.109 0.219 0.672 0.928 0.064 0.008 
0.113 0.247 0.640 0.915 0.076 0.009 
0.117 0.273 0.609 0.902 0.089 0.010 
0.122 0.299 0.579 0.886 0.103 0.011 
0.127 0.324 0.550 0.870 0.118 0.012 
0.132 0.347 0.521 0.852 0.134 0.014 
0.138 0.370 0.492 0.833 0.152 0.016 
0.145 0.392 0.464 0.812 0.171 0.018 
0.152 0.412 0.436 0.788 0.191 0.021 
0.160 0.432 0.408 0.763 0.213 0.024 
0.169 0.451 0.380 0.736 0.237 0.028 
0.179 0.469 0.352 0.705 0.262 0.032 
0.191 0.485 0.324 0.672 0.290 0.038 
0.206 0.499 0.295 0.635 0.320 0.045 
0.224 0.512 0.264 0.592 0.353 0.055 
0.248 0.521 0.231 0.542 0.391 0.067 
0.286 0.523 0.191 0.477 0.436 0.087 
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Table A.15. Processed data from Aspen for the tie-lines of the UNIFAC prediction. 
LEFT SIDE POINT (% w/w) RIGHT SIDE POINT (% w/w) 
Water Acetone MIBK Water Acetone MIBK 
0.017 0.000 0.983 0.977 0.000 0.023 
0.018 0.022 0.961 0.952 0.023 0.025 
0.019 0.044 0.938 0.927 0.047 0.026 
0.019 0.066 0.915 0.901 0.071 0.028 
0.020 0.088 0.891 0.874 0.096 0.030 
0.022 0.110 0.868 0.847 0.122 0.032 
0.023 0.133 0.844 0.818 0.148 0.034 
0.024 0.155 0.821 0.788 0.175 0.037 
0.025 0.178 0.797 0.758 0.203 0.040 
0.027 0.201 0.772 0.726 0.231 0.043 
0.028 0.224 0.748 0.694 0.259 0.047 
0.030 0.247 0.723 0.660 0.288 0.051 
0.032 0.270 0.698 0.626 0.318 0.056 
0.034 0.293 0.673 0.591 0.347 0.062 
0.036 0.317 0.647 0.555 0.376 0.068 
0.039 0.341 0.620 0.519 0.405 0.075 
0.042 0.365 0.593 0.482 0.434 0.084 
0.045 0.389 0.566 0.445 0.462 0.093 
0.049 0.414 0.537 0.407 0.489 0.104 
0.054 0.440 0.507 0.369 0.514 0.117 
0.060 0.466 0.474 0.331 0.538 0.131 
0.067 0.493 0.440 0.291 0.560 0.149 
0.077 0.523 0.400 0.249 0.579 0.172 





Table A.16. Raw data from Aspen for the phase envelope of n-butyl acetate ternary phase diagrams 
from UNIQUAC. Mass fractions were calculated from the molecular weight of each component.  
Mole Fraction Mass Fraction 
Water Acetone NBA Water Acetone NBA 
0.074 0.000 0.926 0.012 0.000 0.988 
0.089 0.125 0.786 0.016 0.073 0.911 
0.118 0.295 0.587 0.024 0.196 0.780 
0.135 0.361 0.504 0.030 0.256 0.714 
0.155 0.416 0.430 0.036 0.314 0.650 
0.177 0.459 0.364 0.044 0.369 0.586 
0.202 0.491 0.307 0.054 0.421 0.526 
0.230 0.513 0.256 0.065 0.468 0.467 
0.264 0.525 0.211 0.080 0.510 0.410 
0.302 0.527 0.172 0.097 0.546 0.357 
0.369 0.514 0.117 0.133 0.596 0.272 
0.386 0.504 0.111 0.142 0.596 0.262 
0.440 0.474 0.087 0.174 0.604 0.222 
0.509 0.430 0.061 0.222 0.606 0.172 
0.569 0.387 0.044 0.271 0.593 0.136 
0.627 0.342 0.032 0.324 0.570 0.106 
0.683 0.295 0.022 0.385 0.535 0.080 
0.738 0.247 0.015 0.453 0.488 0.059 
0.790 0.200 0.010 0.528 0.430 0.042 
0.839 0.154 0.006 0.610 0.361 0.029 
0.884 0.112 0.004 0.697 0.284 0.020 
0.925 0.073 0.002 0.788 0.199 0.013 
0.961 0.037 0.001 0.881 0.110 0.009 
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Table A.17. Raw data from Aspen for the tie-lines of the UNIQUAC n-butyl acetate prediction. 
LEFT SIDE POINT (Mole Frac.) RIGHT SIDE POINT (Mole Frac.) 
Water Acetone NBA Water Acetone NBA 
0.074 0.000 0.926 0.999 0.000 0.001 
0.078 0.034 0.888 0.990 0.009 0.001 
0.082 0.067 0.851 0.980 0.019 0.001 
0.085 0.100 0.815 0.970 0.029 0.001 
0.089 0.131 0.780 0.959 0.039 0.002 
0.094 0.162 0.745 0.948 0.050 0.002 
0.098 0.191 0.711 0.936 0.062 0.002 
0.103 0.220 0.677 0.923 0.074 0.002 
0.108 0.248 0.644 0.910 0.087 0.003 
0.114 0.275 0.612 0.896 0.101 0.003 
0.119 0.301 0.580 0.881 0.115 0.004 
0.126 0.326 0.548 0.865 0.131 0.005 
0.132 0.351 0.517 0.847 0.147 0.006 
0.139 0.374 0.487 0.829 0.164 0.007 
0.147 0.397 0.456 0.809 0.183 0.008 
0.156 0.418 0.426 0.788 0.202 0.010 
0.165 0.438 0.396 0.765 0.223 0.012 
0.176 0.458 0.366 0.740 0.245 0.015 
0.188 0.476 0.336 0.712 0.270 0.018 
0.202 0.492 0.306 0.682 0.296 0.022 
0.219 0.506 0.274 0.648 0.324 0.028 
0.240 0.518 0.242 0.608 0.356 0.035 
0.268 0.526 0.206 0.561 0.393 0.046 





Table A.18. Processed data from Aspen for the tie-lines of the UNIQUAC n-butyl acetate prediction. 
LEFT SIDE POINT (% w/w) RIGHT SIDE POINT (% w/w) 
Water Acetone NBA Water Acetone NBA 
0.012 0.000 0.988 0.995 0.000 0.005 
0.013 0.019 0.968 0.965 0.029 0.006 
0.014 0.037 0.948 0.936 0.057 0.007 
0.015 0.057 0.928 0.906 0.086 0.008 
0.016 0.076 0.908 0.876 0.115 0.009 
0.017 0.096 0.887 0.845 0.144 0.010 
0.019 0.116 0.865 0.815 0.174 0.012 
0.020 0.137 0.843 0.784 0.203 0.013 
0.021 0.158 0.821 0.752 0.232 0.015 
0.023 0.179 0.798 0.721 0.262 0.018 
0.025 0.201 0.774 0.689 0.291 0.020 
0.027 0.223 0.750 0.657 0.320 0.024 
0.029 0.246 0.725 0.624 0.349 0.027 
0.031 0.269 0.700 0.591 0.377 0.032 
0.034 0.293 0.674 0.558 0.406 0.037 
0.037 0.317 0.646 0.524 0.433 0.043 
0.040 0.342 0.618 0.490 0.460 0.050 
0.044 0.368 0.588 0.455 0.487 0.058 
0.048 0.394 0.557 0.420 0.512 0.068 
0.054 0.422 0.524 0.383 0.536 0.081 
0.061 0.451 0.489 0.346 0.558 0.096 
0.069 0.482 0.449 0.307 0.579 0.115 
0.081 0.515 0.403 0.264 0.596 0.141 
0.102 0.554 0.344 0.212 0.607 0.181 
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Table A.19. Raw data from Aspen for the phase envelope of toluene ternary phase diagrams from 
UNIQUAC. Mass fractions were calculated from the molecular weight of each component.  
Mole Fraction Mass Fraction 
Water Acetone Toluene Water Acetone Toluene 
0.005 0.124 0.871 0.001 0.082 0.917 
0.008 0.220 0.771 0.002 0.152 0.846 
0.013 0.306 0.681 0.003 0.220 0.777 
0.020 0.380 0.599 0.005 0.284 0.711 
0.029 0.445 0.526 0.007 0.345 0.648 
0.053 0.544 0.402 0.014 0.454 0.532 
0.070 0.580 0.350 0.019 0.501 0.480 
0.112 0.626 0.262 0.032 0.582 0.386 
0.138 0.637 0.225 0.041 0.615 0.344 
0.170 0.640 0.191 0.053 0.643 0.304 
0.226 0.627 0.147 0.076 0.674 0.250 
0.229 0.627 0.144 0.077 0.677 0.246 
0.242 0.622 0.135 0.082 0.682 0.236 
0.283 0.603 0.114 0.100 0.691 0.208 
0.352 0.564 0.084 0.136 0.700 0.165 
0.406 0.528 0.065 0.166 0.697 0.137 
0.463 0.488 0.049 0.202 0.687 0.110 
0.519 0.445 0.037 0.243 0.670 0.087 
0.576 0.398 0.026 0.289 0.644 0.067 
0.688 0.300 0.012 0.401 0.564 0.035 
0.743 0.250 0.007 0.468 0.509 0.023 
0.795 0.200 0.004 0.544 0.442 0.014 
0.847 0.151 0.002 0.630 0.362 0.008 




Table A.20. Raw data from Aspen for the tie-lines of the UNIQUAC toluene prediction. 
LEFT SIDE POINT (Mole Frac.) RIGHT SIDE POINT (Mole Frac.) 
Water Acetone Toluene Water Acetone Toluene 
0.002 0.000 0.998 1.000 0.000 0.000 
0.003 0.036 0.961 0.984 0.015 0.000 
0.003 0.072 0.925 0.969 0.031 0.000 
0.004 0.107 0.889 0.953 0.047 0.000 
0.005 0.141 0.853 0.937 0.063 0.000 
0.006 0.175 0.818 0.920 0.079 0.001 
0.008 0.208 0.784 0.903 0.096 0.001 
0.009 0.241 0.750 0.885 0.114 0.001 
0.011 0.273 0.716 0.867 0.132 0.002 
0.013 0.304 0.682 0.848 0.150 0.002 
0.016 0.335 0.649 0.828 0.169 0.003 
0.019 0.365 0.617 0.807 0.189 0.004 
0.022 0.394 0.584 0.785 0.210 0.005 
0.026 0.422 0.553 0.762 0.232 0.006 
0.030 0.449 0.521 0.738 0.254 0.007 
0.035 0.476 0.489 0.713 0.278 0.009 
0.041 0.502 0.458 0.685 0.303 0.012 
0.047 0.526 0.426 0.656 0.329 0.015 
0.056 0.550 0.395 0.625 0.357 0.019 
0.065 0.572 0.363 0.590 0.386 0.024 
0.077 0.593 0.330 0.552 0.418 0.030 
0.092 0.611 0.296 0.509 0.452 0.039 
0.113 0.627 0.260 0.460 0.490 0.050 
0.143 0.638 0.219 0.398 0.534 0.068 
 
  
Appendix A. The TBSR Theory 
180 
Table A.21. Processed data from Aspen for the tie-lines of the UNIQUAC toluene prediction. 
LEFT SIDE POINT (% w/w) RIGHT SIDE POINT (% w/w) 
Water Acetone Toluene Water Acetone Toluene 
0.000 0.000 1.000 0.999 0.000 0.001 
0.001 0.023 0.976 0.951 0.048 0.001 
0.001 0.047 0.953 0.906 0.093 0.001 
0.001 0.070 0.929 0.862 0.136 0.002 
0.001 0.094 0.905 0.820 0.178 0.002 
0.001 0.119 0.880 0.780 0.217 0.003 
0.002 0.143 0.855 0.741 0.255 0.004 
0.002 0.168 0.830 0.704 0.292 0.005 
0.002 0.193 0.804 0.667 0.327 0.006 
0.003 0.219 0.778 0.631 0.361 0.008 
0.004 0.244 0.752 0.596 0.394 0.010 
0.004 0.270 0.725 0.562 0.425 0.013 
0.005 0.296 0.698 0.528 0.456 0.016 
0.006 0.323 0.671 0.495 0.485 0.019 
0.007 0.350 0.643 0.463 0.514 0.024 
0.009 0.377 0.615 0.430 0.541 0.029 
0.010 0.404 0.586 0.398 0.567 0.035 
0.012 0.432 0.556 0.366 0.591 0.043 
0.014 0.461 0.525 0.334 0.615 0.051 
0.017 0.490 0.493 0.302 0.636 0.062 
0.021 0.520 0.459 0.269 0.656 0.075 
0.026 0.551 0.423 0.235 0.673 0.091 
0.033 0.584 0.384 0.200 0.688 0.112 






 For more accurate calculation of the composition of both immiscible phases, a higher number 
of tie-lines was required. For each tie-line, the compositions at both the start and end point were 
known, as provided within Aspen. The change in height and width between the first two tie-lines was 
evaluated. The difference was divided by twenty and this value was added to the first tie-line values. 
This produced an additional tie-line. The process was repeated for each subsequent twentieth, to 
produce a further nineteen tie-lines. This process was repeated for each pair of adjacent tie-lines, up 
to the twenty-third and twenty-fourth tie-line. It should be noted that the twenty-fifth tie-line 
produced within Aspen was always along the X component axis. To improve accuracy, this tie-line was 
discarded. As such, the methods discussed here produced a total of four-hundred and eighty tie-lines. 
The equation of the line for each tie-line was calculated. These equations are required later.   
 
An Exemplar TBSR Calculation 
 In this section, an exemplar calculation of the True BSR is presented. This calculation shows 
answers to 2 decimal places only, for simplicity. Common properties of the species involved are given 
in Table A.22.  





Molecular Weight Density 
(g mol-1) (g cm-3) 
Acetone C3H6O 58.079 0.7845 
Chloroform CHCl3 119.378 1.4788 
Water H2O 18.015 0.9970 
 
 4.3 g of a solid active pharmaceutical ingredient is dissolved in 60 g of acetone, before the 










Equation A.1  
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 The following calculations are used in the calculation of the True BSR.  
 
𝐴𝑐𝑒𝑡𝑜𝑛𝑒 𝑀𝑎𝑠𝑠 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 =
60
60 + 140 +
18
1.48
~ 26.5 % Equation A.2  
 
𝑊𝑎𝑡𝑒𝑟 𝑀𝑎𝑠𝑠 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 =
140
60 + 140 +
18
1.48
~ 61.8 % Equation A.3  
 
𝐶ℎ𝑙𝑜𝑟𝑜𝑓𝑜𝑟𝑚 𝑀𝑎𝑠𝑠 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 =
18
1.48
60 + 140 +
18
1.48
~ 11.7 % Equation A.4  
  Next, identify the closest tie-line to the agglomeration system (Figure A.1) and determine the 
co-ordinates of the tie-line start and end point.  
Figure A.1. An example Aspen ternary phase diagram plotted in Origin Pro. The blue line indicates the 
boundary between miscible (above) and immiscible (below) regions. Dashed lines show the tie-lines 
of the system.    
 
 These are given as:   
 𝑥1 = 0.733 ;  𝑦1 = 0.246 Equation A.5  
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 𝑥2 = 0.011 ;  𝑦2 = 0.359 Equation A.6  





= −0.157  Equation A.7  
 𝑦 = −0.157 𝑥 + 0.361 Equation A.8  
 If the mass fraction of water (Equation A.3) is substituted into Equation A.8, the answer 
calculated is equal to the mass fraction of acetone (Equation A.2). The total length of the tie-line was 
calculated according to Pythagoras Theorem, using the co-ordinates specified in Equation A.6: 
 𝐷𝑖𝑠𝑡𝑎𝑛𝑐𝑒 = √(0.733 − 0.011)2 + (0.246 − 0.359)2 = 0.731 Equation A.9  
 The location of the system of interest along the tie-line could also be calculated by evaluating 
the distance between its co-ordinates and those of Equation A.6: 
 𝐷𝑖𝑠𝑡𝑎𝑛𝑐𝑒 = √(0.618 − 0.011)2 + (0.265 − 0.359)2 = 0.614 Equation A.10  
 Through the inverse lever rule, the mass fraction of the bridging liquid poor phase is initially 
given and, thus, the bridging liquid rich phase: 
 
𝑀𝑎𝑠𝑠 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑜𝑓𝐵𝐿 𝑝𝑜𝑜𝑟 =
0.614
0.731
 ~ 0.86 Equation A.11  
 
𝑀𝑎𝑠𝑠 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑜𝑓𝐵𝐿 𝑟𝑖𝑐ℎ = 1 − (
0.614
0.731
) ~ 0.14 
Equation A.12  
Resultantly, the masses of each phase are then calculated: 
 𝑀𝑎𝑠𝑠 𝑜𝑓𝐵𝐿 𝑝𝑜𝑜𝑟 = 0.86 × 226.6 = 194.88 𝑔 Equation A.13  
 𝑀𝑎𝑠𝑠 𝑜𝑓𝐵𝐿 𝑟𝑖𝑐ℎ = 0.14 ×  226.6 = 31.72 𝑔 Equation A.14  
 As the tie-line co-ordinates provide the relative compositions of each phase (Equation A.5 and 
Equation A.6), the masses of each component within each phase could be calculated. If the bridging 
liquid poor phase is considered initially: 
 𝐴𝑐𝑒𝑡𝑜𝑛𝑒 𝑀𝑎𝑠𝑠 = 194.88 × 0.246 = 47.94 𝑔 Equation A.15  
 𝑊𝑎𝑡𝑒𝑟 𝑀𝑎𝑠𝑠 = 194.88 × 0.733 = 142.85 𝑔 Equation A.16  
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 𝐶ℎ𝑙𝑜𝑟𝑜𝑓𝑜𝑟𝑚 𝑀𝑎𝑠𝑠 = 194.88 × 0.021 = 3.91 𝑔 Equation A.17  
 And the chloroform rich phase is calculated as containing: 
 𝐴𝑐𝑒𝑡𝑜𝑛𝑒 𝑀𝑎𝑠𝑠 = 31.72 × 0.359 = 11.39 𝑔 Equation A.18  
 𝑊𝑎𝑡𝑒𝑟 𝑀𝑎𝑠𝑠 = 31.72 × 0.011 = 0.35 𝑔 Equation A.19  
 𝐶ℎ𝑙𝑜𝑟𝑜𝑓𝑜𝑟𝑚 𝑀𝑎𝑠𝑠 = 31.72 × 0.021 = 19.95 𝑔 Equation A.20  
 To check the accuracy, a mass balance across both immiscible phases can be performed, and 
the error in calculations evaluated.  
 𝐴𝑐𝑒𝑡𝑜𝑛𝑒 𝑀𝑎𝑠𝑠 𝐵𝑎𝑙𝑎𝑛𝑐𝑒: 47.94 𝑔 + 11.39 𝑔 = 59.33 𝑔 Equation A.21  
 𝑊𝑎𝑡𝑒𝑟 𝑀𝑎𝑠𝑠 𝐵𝑎𝑙𝑎𝑛𝑐𝑒: 142.85 𝑔 + 0.35 𝑔 = 143.10 𝑔 Equation A.22  
 𝐶ℎ𝑙𝑜𝑟𝑜𝑓𝑜𝑟𝑚 𝑀𝑎𝑠𝑠 𝐵𝑎𝑙𝑎𝑛𝑐𝑒: 3.90 𝑔 + 19.95 𝑔 = 23.85 𝑔 Equation A.23  
 Note that the chloroform mass equates to 16.11 ml approximately. The errors are given as 
approximately 1.2 %, 2.2 % and 0.7 % for acetone, water and chloroform respectively. As the TBSR is 
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= 𝟔. 𝟔𝟏 
Equation A.24  
 If these calculations are repeated, a BSR vs TBSR graph can be yielded for the system in 
question. From this, the graph can be used to calculate the bridging liquid volume required, for any 
desired TBSR. In this example: 
 
 𝑇𝐵𝑆𝑅 = 0.5 ; 𝐵𝑆𝑅 = 0.9 Equation A.25  
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Common Properties of Agglomerates 
 This section lists the common size properties of the agglomerates yielded from TBSR validation 
experiments. Here, all values are calculated from the mean of a minimum of three repeats. 
Table B.1. A variety of different parameters describing the agglomerate profile of salicylic acid-




 Parameter (µm) 
D10 D50 D90 Span D32 D43 
Butyl Acetate 
0.025 1702 5177 6653 0.96 6302 6622 
0.050 1700 5675 7231 0.97 6842 7102 
0.075 2001 5590 7078 0.98 6638 6919 
0.100 2830 5744 7028 0.73 6595 6842 
0.125 4094 6797 7501 0.50 7785 8235 
0.150 4050 6623 7482 0.51 7721 8165 
Chloroform 
0.025 600 4629 6943 1.37 7134 7900 
0.050 850 5021 6956 1.22 7026 7701 
0.075 5423 7181 8400 0.41 8420 8861 
0.100 5427 7089 7633 0.31 7913 8198 
0.125 5431 8263 10104 0.57 9402 9796 
0.150 7736 8730 10299 0.29 9655 9974 
MIBK 
0.025 698 3928 6112 1.38 6800 7870 
0.050 835 4566 6955 1.34 7756 8713 
0.075 984 4661 6965 1.28 7441 8312 
0.100 834 4779 7078 1.33 8566 9510 
0.125 697 4211 8264 1.80 8664 9619 
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Table B.2. A variety of different parameters describing the agglomerate profile of salicylic acid-
chloroform experiments, with variations in bulk solution composition. 
Bulk Solution 
Composition 
TBSR  Parameter (µm) 
D10 D50 D90 Span D32 D43 
95 % W, 5 % A 
0.050 600 2782 6943 2.28 8765 9850 
0.100 502 4788 7110 1.38 7634 8399 
0.150 500 5624 9379 1.58 8957 9730 
90 % W, 10 % A 
0.025 600 4629 6943 1.37 7134 7900 
0.050 850 5021 6956 1.22 7026 7701 
0.075 5423 7181 8400 0.41 8420 8861 
0.100 5427 7089 7633 0.31 7913 8198 
0.125 5431 8263 10104 0.57 9402 9796 
0.150 7736 8730 10299 0.29 9655 9974 
85 % W, 15 % A 
0.025 - 2424 5110 - 6047 6653 
0.050 - 4959 9533 - 9318 10129 
0.075 - 6260 10202 - 9928 10423 
0.100 301 6608 10316 1.52 10022 10502 
0.125 712 7587 10512 1.13 10210 10610 
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Agglomerate Size Distributions 
Figure A.1. Agglomerate size distribution for salicylic acid-MIBK systems with an initial bulk solution of 
95 % w/w water and 5 % w/w acetone. Error bars represent standard error of a least three repeats. 
  
 
Figure A.2. Agglomerate size distribution for salicylic acid-butyl acetate systems with an initial bulk 
solution of 95 % w/w water and 5 % w/w acetone. Error bars represent standard error of a least three 
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TBSR Influence on Agglomerate Properties 
Figure C.1. Agglomerates at 56 minutes after bridging liquid addition (TBSR = 0.9) with a) and b) 
isolated from the reactor and c) and d) filtered and dried. 
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Figure C.3. Agglomerates at 3 minutes after bridging liquid addition (TBSR = 6), all sampled from the 
reactor.  
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Table C.1. Summary of the time to paste in minutes, for different TBSR values and different solid 
loading percentages. Standard deviations are given in brackets 
TBSR Value (-) 
Solid Loading (% w/w) 
1 % (SD) 5 % (SD) 9 % (SD) 
0.20 - - - 
0.50 - - - 
0.70 - - - 
0.75 - - - 
0.80 - - - 
0.90 68.33 (3.21) 74.83 (4.80) 96.00 (4.36) 
1.00 57.00 (1.73) 59.83 (4.37) 76.00 (2.52) 
1.50 49.00 (3.61) 38.67 (3.21) 35.67 (0.58) 
2.00 31.33 (3.69) 26.50 (1.32) 20.67 (1.15) 
2.50 25.83 (0.29) 19.17 (1.25) 13.33 (1.53) 
3.00 20.50 (2.29) 15.33 (1.15) 10.67 (2.08) 
4.00 - 11.00 (0.50) - 
6.00 11.67 (1.15) 03.00 0.50 
8.00 06.00 (0.50) 02.00 - 
 
Agglomerate Structure Development 
Agglomerate structure development was studied at TBSR = 0.75 with 5 % w/w solid loading. Samples 
at 10 mins, 30 mins, 50 mins, 70 mins and 90 mins are shown here, whilst remaining data is shown in 
Section 6.2.4.  
Figure C.5. Observations of spherical agglomerates, nuclei and paracetamol flocs formed 10 minutes 
after bridging liquid addition. 
a) c) b) 
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Figure C.6. Observations of spherical agglomerates, nuclei and paracetamol flocs formed 30 minutes 
after bridging liquid addition. 
 
Figure C.7. Observations of spherical agglomerates, nuclei and paracetamol flocs formed 50 minutes 
after bridging liquid addition. 
  
Figure C.8. Observations of spherical agglomerates, nuclei and paracetamol flocs formed 70 minutes 
after bridging liquid addition. 
a) c) b) 
a) c) b) 
a) c) b) 
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Figure C.9. Observations of spherical agglomerates, nuclei and paracetamol flocs formed 90 minutes 
after bridging liquid addition. 
a) c) b) 
